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Abstract 
Insulin maintains glucose homeostasis through its binding of the insulin receptor and 
activation of the insulin signalling cascade in insulin sensitive tissues. Skeletal muscle is a 
major endocrine organ, and is responsible for the majority of post-prandial glucose disposal. 
The maintenance of glucose homeostasis is a delicate balance and impairments in glucose 
disposal can have significant physiological effects, resulting in the onset of metabolic 
diseases such as diabetes mellitus. 
Insulin stimulated glucose uptake involves a number of signalling proteins to enable uptake 
to occur. In order to understand the complexities associated with the insulin signalling 
cascade, cell culture models have provided a controlled and easily manipulated environment 
in which to investigate insulin stimulated glucose uptake in skeletal muscle. While the 
majority of these experiments have been conducted in conventional monolayer cultures, the 
growing field of three-dimensional tissue engineering provides an alternative environment in 
which skeletal muscle cells can be grown to investigate their physiological function.  
The purpose of this thesis was to investigate the use of different cell culture models for 
investigating the effects of acute and chronic insulin exposure on skeletal muscle. 
Initial investigations aimed to establish glucose uptake in tissue engineering skeletal muscle 
constructs using tritium labelled (H3) 2-deoxy-d-glucose. Monolayer cultures were used to 
developed base line conditions. In these cultures, concentrations greater than 0.5 µCi for 15 
minutes of insulin stimulation suggested an initial  assay window for investigating insulin 
stimulated glucose uptake. However, the duration of insulin stimulation was not effective in 
measuring uptake in tissue engineered skeletal muscle constructs based upon western blot 
experiments of Akt phosphorylation, therefore insulin stimulation in skeletal muscle tissue 
engineered constructs was increased to 30 minutes. 
Glucose uptake is mediated via specific glucose transporter protein, GLUT1 and GLUT4. 
Therefore, the transcriptional profile of these transporters was elucidated in monolayer 
culture and tissue engineered skeletal muscle constructs. Time course experiments showed an 
increase in GLUT4 transcription in tissue engineered and monolayer culture systems which is 
associated with an increase in the transcription of skeletal muscle development and myogenic 
genes.  
XXII 
 
In two dimensional culture, skeletal muscle cells were  exposed to insulin during 
differentiation and in post-mitotic skeletal muscle myotubes to investigating the potential 
effects upon metabolic genes and proteins involved in insulin signalling. Chronic exposure to 
insulin during skeletal muscle differentiation reduced insulin signalling and resulted in an 
increase in basal glucose uptake and ablated insulin stimulated glucose uptake. In contrast, 
post-mitotic skeletal muscle myotubes did not shown similar changes and were not as 
responsive to acute insulin exposure. Therefore future experiments exposed skeletal muscle 
to insulin during differentiation.  
Using the previous findings as a basis for experimentation, the effects of chronic and acute 
insulin exposure upon three dimensional skeletal muscle constructs were investigated. Fibrin 
and collagen constructs were grown for a total period of 14 days. Constructs were exposed to 
insulin during differentiation and acutely stimulated for 30 minutes at day 14. Although there 
was a mean increase in Akt protein phosphorylation in both types of tissue-engineered 
constructs, these changes were not significant following acute insulin stimulation. In addition, 
glucose uptake in fibrin skeletal muscle constructs increased as a result of acute insulin 
stimulation however was not significantly difference to unstimulated constructs. 
The work presented in this thesis provides initial experimental data of the use of different 
skeletal muscle cell culture models for investigating insulin signalling and glucose uptake. 
Further research should further characterise these in vitro models for investigating skeletal 
muscle metabolism.   
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1.1 Introduction 
Since the time of Hippocrates, the promotion of a healthy diet and sufficient exercise in the 
treatment of metabolic disease has been a major priority (Hawley & Gibala, 2012). Despite 
health guidelines and the associated benefits of changes in habitual routines in order to 
attenuate the prevalence of chronic disease, poor diet and inadequate levels of physical 
activity remain a major health concern in the modern era (Blair, 2009). Connected to this, and 
despite advancements in modern medicine, the increase in prevalence of non-communicable 
diseases such as diabetes mellitus is escalating on a pandemic scale and it is estimated that 
5.4% of the global population will be affected by 2025 (King, Aubert, & Herman, 1998).  
In a healthy individual, circulated blood glucose is maintained at approximately 3-5mmol/L-1, 
or approximately four grams of blood glucose (Wasserman, 2009). Although the amount of 
circulating blood glucose is small, a delicate balance exists between hypo and 
hyperglycaemia and both can have adverse effects upon an organisms function (individual 
circulated blood glucose is maintained at approximately 3-5mmol/L-1, Figure  1-1) 
(Wasserman, 2009). Glucose provides the primary source of cellular energy through its 
conversion to ATP by anaerobic and aerobic pathways (Bouché, Serdy, Kahn, and Goldfine, 
2004). The hydrophilic nature of glucose means that it is obtained up into the cell via 
facilitated diffusion. This process occurs following a series of signalling cascade events 
mediated by the hormone, insulin. Insulin stimulates the rapid recruitment of glucose 
transporters to the cell membrane (Pessin, Thurmond, Elmendorf, Coker, and Okada, 1999) 
upon which, glucose is obtained up and rapidly phosphorylated into glucose-6-phosphate by 
hexokinase the initial step in the process of glycolysis (Bouché et al., 2004). 
In order to maintain euglycemia in the blood, several tissues are involved in controlling 
preserving blood glucose. While insulin sensitive tissues such as adipose tissue and skeletal 
muscle play a crucial role in glucose disposal (DeFronzo, Gunnarsson, Bjorkman, Olsson, & 
Wahren, 1985), tissues including skeletal muscle but also the liver, which store glucose in the 
form of glycogen, breakdown glycogen stores by glycogenolysis, at equal rates to glucose 
disposal by insulin sensitive tissues to maintain blood glucose concentrations (Wasserman, 
2009). In contrast, during periods of hypoglycaemia, the release of glucagon from alpha cells 
in the pancreases increases endogenous glucose production release from the liver in order to 
maintain blood glucose concentrations (Wasserman, 2009). Hepatic clearance of glucagon is 
approximately 20-30% (D’Alessio, 2011). Administration of glucagon increases blood 
glucose concentrations in healthy individuals (Del Prato, Castellino, Simonson, and 
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DeFronzo, 1987), however, in addition to impaired β-cell function and insulin secretion, there 
is some evidence to suggest that impaired α-cell function could contribute to the pathogenesis 
of NIDDM (Dunning and Gerich, 2007).  Insulin resistance, which is characterised as the 
inability of a target cell or organ to respond to a normal physiological concentration to which 
it has been exposed can result in detrimental effects upon glucose homeostasis, leading the 
onset of metabolic diseases such as, diabetes mellitus , tissues including skeletal muscle but 
also the liver, which store glucose in the form of glycogen, breakdown glycogen stores by 
glycogenolysis, at equal rates to glucose disposal by insulin sensitive tissues to maintain 
blood glucose concentrations (Wasserman, 2009) In contrast, during periods of 
hypoglycaemia, the release of glucagon from alpha cells in the pancreases increases 
endogenous glucose production release from the liver in order to maintain blood glucose 
concentrations (Wasserman, 2009). Hepatic clearance of glucagon is approximately 20-30% 
(D’Alessio, 2011). Administration of glucagon increases blood glucose concentrations in 
healthy individuals (Del Prato et al., 1987), however, in addition to impaired β-cell function 
and insulin secretion, there is some evidence to suggest that impaired α-cell function could 
contribute to the pathogenesis of NIDDM (Dunning and Gerich, 2007). The cellular 
mechanisms required for effective insulin stimulated glucose uptake are highly complex and 
require several signalling protein kinases working in unison to enable cellular glucose uptake. 
As a result, any impairment within the signalling cascade can significantly abate glucose 
uptake (Shulman, 2000). Therefore, due to the increase in prevalence of diabetes globally 
(Amos, McCarty, & Zimmet, 1997), research investigating the molecular mechanisms of the 
disease is of utmost interest.  
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Figure  1-1 The maintenance of glucose homeostasis. Several lines of communication between organs 
maintain euglycemia. Skeletal muscle and adipose tissue contribute to a large proportion of glucose 
disposal. Image from Wasserman (2009). 
Skeletal muscle has been described as a major endocrine organ, with ~80% of glucose uptake 
occurring within skeletal muscle under hyperinsulineamic-euglycemic conditions (DeFronzo, 
Gunnarsson, Bjorkman, Olsson, & Wahren, 1985). Glucose uptake is regulated by both 
insulin dependent and independent mechanisms (Pereira & Lancha, 2004). Regulation of 
glucose uptake by insulin dependent mechanisms involves activation of the insulin signalling 
pathway through binding of the hormone, insulin to its receptor, leading to downstream 
activation of a number of proteins kinases which lead to GLUT4 translocation to the 
membrane (Taniguchi, Emanuelli, and Kahn, 2006)(Taniguchi et al., 2006). while the prior 
accounts for the majority of post-prandial glucose uptake, insulin independent mechanisms, 
which is often associated with skeletal muscle contraction, results in GLUT4 mediated 
glucose uptake, independent of insulin (Holloszy, 2003).(Holloszy, 2003) Both in vitro 
(Zierath et al., 1996), and in vivo work (DeFronzo et al., 1985), have shown that type II 
diabetes mellitus (NIDDM) patients’ present marked decreases in insulin stimulated glucose 
uptake. Furthermore, both lean and obese populations exhibit the defects associated with 
skeletal muscle insulin resistance (Kelley, Mokan, & Mandarino, 1993; Zierath et al., 1996). 
While in vivo research has begun to elucidate some of the mechanisms associated with insulin 
resistance in skeletal muscle (Karlsson et al., 2005; Krook et al., 2000), in vitro research can 
provide further insight into the effects of insulin resistance upon the cellular signalling 
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pathways involved in glucose uptake (Lambernd et al., 2012; Sell et al., 2008). The use of 
cell culture models to investigate this phenomenon has been, and continues to be, a well-
established scientific method. An additional approach to cell culture has been through the use 
of three-dimensional (3D) skeletal muscle tissue engineering. Skeletal muscle tissue 
engineering is a rapidly growing field with regards to regenerative medicine (Mertens, Sugg, 
Lee, and Larkin, 2014), and has recently been used for implantation to replace damaged or 
degenerative tissue (Juhas, Engelmayr, Fontanella, Palmer, and Bursac, 2014; Williams, 
Kostrominova, Arruda, and Larkin, 2013). What is more, the use of these models for research 
purposes could provide a more replicable and effective model both morphologically and 
physiologically to investigate metabolic and physiological functions (Khodabukus, Paxton, 
Donnelly, and Baar, 2007). 
The advancement in the use of skeletal muscle tissue engineered constructs has resulted in a 
number of methods using various extracellular matrices (Hinds, Bian, Dennis, and Bursac, 
2011). Such models have produced constructs, which result in the formation of uniaxial 
myotubes under tension (Dennis & Kosnik, 2000), and develop cylindrical muscle bundles as 
found in vivo (Huang, Dennis, Larkin, & Baar, 2005). Constructs of this nature have already 
been used to characterise early muscle development, (Cheema, Yang, Mudera, Goldspink, & 
Brown, 2003; Smith et al., 2012), as well as the molecular responses to exercise (Passey, 
Martin, Player, & Lewis, 2011; Player et al., 2014). However, despite a number of challenges 
currently within the field (Cheng, Davis, Madden, Bursac, and Truskey, 2014), little research 
has explored the role of glucose uptake (Baker, Dennis, and Larkin, 2003) or the responses of 
tissue engineered constructs to insulin and the associated proteins implicated in this signalling 
pathway. Research into the development of a culture model could provide further in vitro 
model with which to investigate some of the mechanisms associated with insulin signalling 
and glucose uptake in skeletal muscle. Therefore, the aim of this thesis is to develop a 
skeletal muscle model of insulin resistance through exposure of skeletal muscle cells to 
chronically high levels of insulin, in monolayer culture and in three dimensional tissue 
engineered cultures.  
The objectives of this thesis are described through the following experimental objectives: 
I. To investigate the suitability of tissue engineered constructs to investigate glucose 
uptake. 
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II. To determine if insulin signalling and insulin stimulated glucose uptake can be 
observed in skeletal muscle tissue engineered constructs. 
III. To determine if insulin sensitivity can be manipulated in vitro in 2D and 3D cultures. 
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2 Literature Review
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2.1 Skeletal Muscle Structure and function 
2.1.1 Skeletal muscle structure 
Skeletal muscle fibres are surrounded by layers of extracellular matrix (ECM), which 
maintains their structure and function (Kjaer, 2004; Lewis, Machell, Hunt, Sinanan, and 
Tippett, 2001). Individual fibres are contained by the endomysium, which are grouped in 
bundles to form the perimysium, with the epimysium surrounding the whole muscle 
( Figure  2-1) (Gillies and Lieber, 2011).  
2.1.2 Extracellular matrix  
The ECM is comprised of four components, collagenous and non-collagenous glycoproteins, 
proteoglycans and elastin (Lewis et al., 2001). A number of adhesion molecules are involved 
in cell-cell and cell-ECM interaction the dystrophin-dystroglycan complex and integrins, 
(Lewis et al., 2001). Collagen is a highly abundant protein accounting for approximately one 
quarter of protein mass in skeletal muscle (Alberts, Bray, and Lewis, 1986). It is a major 
component of intramuscular connective tissue, and although several types of collagen have 
been identified, type I collagen represents the highest proportion of intramuscular collagen 
content (Kjaer, 2004).   
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Figure  2-1 The structure of skeletal muscle. The whole muscle is encompassed by the epimysium with 
muscle bundles surrounded by the perimysium. Each muscle fibre is surrounded by the endomysium. 
Image from Gillies and Leiber, (2011). 
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2.2 Skeletal Muscle adaption and maladaptation 
Skeletal muscle is very adaptable in its response to external stimuli resulting in 
transcriptional and translation changes following exercise (Egan and Zierath, 2013), 
nutritional intake (Greenhaff et al., 2008) and environmental exposures, such as hypoxia 
(D’Hulst et al., 2013). Likewise, skeletal muscle also responds rapidly both morphologically 
and physiologically as a result of disuse atrophy (Brooks and Myburgh, 2014), ageing, and to 
severe illness like cancer cachexia (Fearon, Glass, and Guttridge, 2012). The aforementioned 
problems can have major effects upon skeletal muscle metabolism, often leading to further 
complications (Egan and Zierath, 2013). 
Skeletal muscle is major endocrine organ, accounting for the majority of glucose disposal 
(DeFronzo, Ferrannini, Hendler, Felig, & Wahren, 1983). Interventions such as exercise 
training have shown to improve insulin sensitivity and glycaemic control (Kasumov et al., 
2015; Little et al., 2011). In contrast, physical inactivity and poor nutritional intake can have 
negative effects upon skeletal muscle metabolism. Metabolic diseases such as metabolic 
syndrome X and diabetes mellitus are a result of changes in glucose metabolism and insulin 
signalling (Roberts, Hevener, and Barnard, 2013). Although, genetics can contribute to the 
risk of non-communicable disease development, poor dietary intake and physical inactivity 
contribute to the onset and potential development of these metabolic diseases which result in 
molecular changes at the transcriptional (Rome et al., 2009), and translational (Bouzakri et al., 
2003; Krook et al., 2000) level, which attenuate skeletal muscle glucose metabolism. 
2.3 Activation, proliferation and differentiation of skeletal muscle cells. 
Skeletal muscle cells can be described as syncytial as they are comprised of several nuclei 
within the cytoplasm (Alberts et al., 1986). More commonly referred to as muscle fibres, 
these structures can be up to two to three centimetres in length and 100µm in diameter. As 
well as this variation in size, skeletal muscle also has the ability to regenerate (Zammit et al., 
2002). Satellite cells, or skeletal muscle stem cells, are quiescent muscle precursor cells, 
located below the basal lamina (Scharner & Zammit, 2011, Mauro, 1961) and are activated 
by a variety of stimuli such as chemical damage or mechanical loading (Cosgrove, Sacco, 
Gilbert, and Helen, 2010). Activated skeletal muscle cells proliferate extensively before 
committing to the myogenic lineage and terminally differentiating to form new muscle fibres, 
fuse to regenerate existing fibres. Cells that do not commit to the myogenic linage return to 
the satellite cell niche and replenish the satellite cell pool (Figure  2-2). The development of 
skeletal muscle cells from activation to differentiation is regulated by a number of 
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transcriptional factors (Buckingham et al., 2006). Proliferating cells express paired box 
transcription factors, Pax 3 and Pax 7 which maintain these cells in the cell cycle (Zammit et 
al., 2004). During differentiation, these cells show a reduction in the expression of Pax genes, 
increasing the expression of basic helix loop helix (b-HLH) transcription factors which are 
imperative for skeletal muscle development (Rudnicki et al., 1993). The b-HLH transcription 
factors such as, desmin (MyoD), myogenic regulatory factor 5 (Myf 5), Myogenin (MyoG) 
and myogenic regulatory factor 4 (MRF4), are important in the commitment of these cells to 
the myogenic lineage and the regulation of differentiation into mature skeletal muscle fibres 
(Buckingham et al., 2003). 
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Figure  2-2 The role of skeletal muscle satellite cells in skeletal muscle regeneration. Satellite cells (SC) are in a state of quiescence located below the basal 
lamina of the myofiber. Upon activation by external stimuli, satellite cells undergo asymmetric division and either commits to the myogenic lineage through 
the expression of myo-regulatory factors (Myf5, MyoD), differentiating into new myofibres, or alternatively maintain expression of Pax7 and aid 
replenishment of the SC pool. Figure adapted from Perdiguero et al., (2009). 
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2.4 Culture of skeletal muscle cells in monolayer 
The development and regeneration of skeletal muscle cells can be recapitulated in vitro 
(Cosgrove et al., 2010). Isolation of skeletal muscle cells for in vitro culture has been 
established for several decades (Blau & Webster, 1981; Yaffe & Saxel, 1977), and has 
subsequently furthered the understanding of the mechanisms behind skeletal muscle 
development (Zammit et al., 2004). Extraction of muscle derived cells from rodents (Smith, 
Passey, Greensmith, Mudera, and Lewis, 2012) and humans (Blau and Webster, 1981; Brady, 
Lewis, and Mudera, 2008; Mudera, Smith, Brady, and Lewis, 2010) amongst many species 
has successfully been performed. Primary skeletal muscle cells have been found to replicate 
their physiological characteristics in vivo (Aas et al., 2013), and have been cultured in vitro in 
a manner which recapitulates their native environment (Brady et al., 2008; Martin et al., 
2013).  
In addition to primary cell sources, the establishment of myogenic cells lines such as C2C12 
and L6 rodent cells lines are alternative cell source that have been characterised and used to 
investigate skeletal muscle physiology. These cell lines, which are homogenous in population, 
have been used to develop an in vitro system. Both C2C12 and L6 cells are well established 
within the literature for investigating the molecular basis of growth and development 
(Burattini et al., 2004; Cheema, Yang, Mudera, Goldspink, & Brown, 2003), skeletal muscle 
hypertrophy and atrophy (Sharples, Al-Shanti, and Stewart, 2010), as well as insulin 
signalling and glucose uptake (del Aguila, Claffey, and Kirwan, 2011; Nedachi and Kanzaki, 
2006).insulin 
2.5 The culture of skeletal muscle cells in three dimensional (3D) constructs 
A plethora of research relives on 2D culture of skeletal muscle cells on tissue culture plastic. 
However, removal of cells from a 3D environment into 2D, or monolayer environment can 
affect cell behaviour (Tibbitt and Anseth, 2009). As a result researchers have begun to 
employ the use of artificial and biological matrices in which cells can be grown in a 3D 
environment (Hinds et al., 2011). The culture of cells in a 3D environment has been shown to 
result in differential gene expression compared to 2D cultures (Vergani, Grattarola, and 
Nicolini, 2004) and  improve functional capacity of cells (Weber, Hayda, and Anseth, 2008). 
As with many cell types including skeletal muscle, 2D culture models provide a basic 
platform for investigating mechanistic responses without the confounding systemic factors 
found in vivo. Furthermore, the morphological differences between 2D and 3D cell cultures, 
mean that the development of 3D cultures provides a systems which better recapitulates in 
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vivo skeletal muscle (Huang, Dennis, Larkin, & Baar, 2005; Vandenburgh, Karlisch, & Lynee, 
2012). 
2.5.1 Skeletal muscle cell types in tissue engineering 
The development of skeletal muscle tissue engineered constructs was arguably started with 
the work Vandenburgh and colleagues who seeded skeletal muscle cells within a collagen gel 
fixed between two anchor points (Vandenburgh, Karlisch, & Farr, 1988). The resulting 
tension from the fixation of the constructs results in spontaneous contraction (Vandenburgh, 
Hatfaludy, Karlisch, & Shansky, 1991; Vandenburgh et al., 1988), as well as enhancing 
myogenesis (Vandenburgh, Hatfaludy, Karlisch, & Shansky, 1991). Differences in 
metabolism, phenotype and development lead to alterations in the excitability and 
contractility of established cell lines and primary cultures differs within a 3D environment 
(Dennis, Kosnik, Gilbert, & Faulkner, 2001; Kosnik, Faulkner, & Dennis, 2001). These 
differences in excitability and contractual responses are potentially due to the role of the 
ECM (Brady et al., 2008; Kosnik et al., 2001; Mudera et al., 2010). In addition, the use of 
C2C12 skeletal muscle cells have been utilised and characterised within the 3D environment 
(Khodabukus & Baar, 2009; Sharples et al., 2012; Player et al., 2014) and have subsequently 
provided a replicable system to further investigate the skeletal muscle physiology and 
function. 
2.5.2 The use of extracellular matrices in tissue engineering.    
Optimisation of tissue-engineered constructs has used varying biological organic matrices 
such as laminin (Dennis & Kosnik, 2000; Dennis et al., 2001), collagen (Cheema et al., 2003; 
Okano & Matsuda, 1997; Smith et al., 2012) or fibrin (Huang et al., 2005; Martin et al., 2013) 
as a surrogate ECM. This is supported by data which has shown that the ECM plays an 
important role in the generation of force in 3D tissue engineering constructs (Hinds et al., 
2011).   
 Fibrin 2.5.2.1.
Later work by Strohman and colleagues observed the formation of three dimensional skeletal 
muscle constructs using a self-assembly model (Strohman et al., 1990). Later work using 
fibrin as a ECM has subsequently been used (Huang et al., 2005), which developed formation 
of connective tissue and expression of mature skeletal muscle characteristics (Strohman et al., 
1990). More recent work has substituted theses matrices with a major structural protein 
involved in blood clotting, fibrin (Grassl, Oegema, and Tranquillo, 2002). Fibrinogen is the 
monomeric form of fibrin which undergoes fibrinogensis by thrombin enzyme which cleaves 
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fibro-peptides, enabling for lateral formation of linear fibrils (Grassl et al., 2002). Fibrin 
enables for free migration and proliferation of cells on the gel, but also the development of an 
ECM, which upon formation results in degradation of the excess fibrin (Ross and Tranquillo, 
2003). The ding of primary myoblast cells of rats in fibrin coated gels has been found to lead 
the formation of unidirectional, multinucleated myotubes, (Huang et al., 2005; Khodabukus 
& Baar, 2009). In addition, recent research by Martin and colleagues has further characterised 
the phenotype and optimal myogenic cell population for growth of human muscle derived 
cells in a fibrin ECM (Martin et al., 2013). 
 Collagen 2.5.2.2.
The use of collagen as an ECM provides a physiologically relevant matrix with which 
skeletal muscle cells reside in vivo (Cheema et al., 2005; Powell, Smiley, Mills, and 
Vandenburgh, 2002). Similar to earlier 3D tissue engineered models, cells grown within this 
environment differentiate into uniaxial, multi-nucleated myotubes, which is a result of the 
mechanical signals that are present within these models. The use of collagen gels provide 
repeatable cellular architecture of culturing primary skeletal muscle cells in three-
dimensional culture (Smith et al., 2012). Similar to other models of tissue engineering, 
primary MDC’s require an optimal population of myogenic cells in order to form into 
multinucleated myotubes (Brady et al., 2008; Mudera et al., 2010).  In addition, C2C12 
skeletal muscle cells in this system has been shown to alter their transcriptional expression of 
genes involved in myogenic development (Cheema et al., 2005), Furthermore, mechanical 
loading upon these constructs has been shown to induce a transcriptional change in splice 
variants of IGF-I (mechano growth factor (MGF) and insulin like growth factor -1 (IGF-1Ea)) 
(Cheema et al., 2005; Cheema, Yang, Mudera, Goldspink, and Brown, 2003). In addition to 
investigation of skeletal muscle development within these constructs (Cheema et al., 2003), 
more recent work by Sharples and collages has investigated skeletal muscle cell development 
of multiple populations doubled C2C12 myoblast cells as a model of skeletal muscle 
hypertrophy and atrophy (Sharples et al., 2012). Previously used in two dimensional culture 
(Sharples, Al-Shanti, Lewis, and Stewart, 2011), MPD cells within collagen based tissue 
engineered constructs showed to have impaired mRNA expression of genes involved in 
matrix remodelling (MMP9) as well expression of IGF and IGF binding protein expression 
(Sharples et al., 2012). Previous work by Player and colleagues had briefly elucidated to the 
metabolic response of these constructs by the measurement of extracellular lactate production 
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following mechanical load and mRNA expression of genes implicated in matrix remodelling 
and hypertrophy (Player et al., 2014). 
2.6 In vitro investigation of insulin signalling and glucose uptake 
2.6.1 Investigating insulin signalling and glucose uptake using skeletal muscle cell lines 
Skeletal muscle cell lines (Table 2-2) have been used to investigate insulin signalling and 
glucose uptake (Sarabia, Ramlal, and Klip, 1990), and to elucidate the mechanisms of 
GLUT4 exocytosis to the plasma membrane (Ishikura, Antonescu, and Klip, 2010). The work 
by Klip and colleagues has extensively investigated the roles of glucose transporters within 
skeletal muscle culture through transfection of a myc-tagged GLUT4 protein into L6 
myoblast cells (L6GLUT4myc) (Antonescu, Randhawa, and Klip, 2008). Work with the 
L6GLUT4myc has enabled visualisation of GLUT4 vesicle trafficking within skeletal muscle 
and the associated mechanisms of mechanical remodelling which occurs during GLUT4 
translocation (Klip, Sun, Chiu, & Foley, 2014; Sun, Chiu, Foley, Bilan, & Klip, 2014). 
However, C2C12 muscle cells have been used to investigate insulin signalling and have been 
reported to respond to insulin stimulation (Nedachi and Kanzaki, 2006) and manipulated 
through hormonal and pro-inflammatory cytokine exposure (del Aguila et al., 2011; Kumar 
and Dey, 2003). In addition, C2C12 cells have been used as a model to investigate insulin 
independent mechanisms of glucose uptake, due to their contractile activity and ability to 
generate force production (Nedachi, Fujita, and Kanzaki, 2008). Through the use of electrical 
pulse stimulation (EPS) as a method for inducing skeletal muscle contraction, Nedachi and 
colleagues have shown both AMPK and p38 MAPK signalling to be activated following EPS 
(Nedachi et al., 2008). In addition, uniaxial stimulation has be used has shown calcium 
dependent mechanism of glucose uptake in C2C12 skeletal muscle cells (Iwata et al., 2007; 
Iwata, Suzuki, Hayakawa, Inoue, and Naruse, 2009). These studies provide evidence that this 
cell line has been used to investigate cellular signalling through insulin stimulation and EPS 
to investigate the mechanisms of glucose uptake and GLUT4 recycling (Nedachi et al., 2008; 
Nedachi and Kanzaki, 2006). Similar to previous research using the L6GLUT4myc, 
transfection of the myc-tagged GLUT4 has been successfully transfected into C2C12 skeletal 
muscle cells (Niu et al., 2010). The use of the C2C12GLUT4myc line has helped to further 
elucidate the mechanisms of contraction mediated GLUT4 translocation to the cell membrane 
through a both AMPK and Calcium mediated signalling pathways (Niu et al., 2010). 
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Table  2.1 the use of skeletal muscle cells lines to investigate insulin signalling and glucose uptake 
Rodent Skeletal Muscle Cell Lines 
L6 Skeletal Muscle Cells C2C12 Skeletal Muscle Cells 
Reference Summary Reference Summary 
Sarabia et al., (1990), 
Ishikura et al., (2010) 
Antonescu et al., (2008)  
Michael et al., (2001) 
• Initially used to investigate insulin 
stimulated glucose uptake 
• Used to investigate GLUT4 vesicle 
trafficking 
• Used to investigate myogenic development 
and glucose transporter expression 
• Have been successfully transfected to 
further elicited the mechanism of glucose 
transporter vesicle trafficking 
Nedachi et al., (2009)  
Nedachi et al., (2006);  
Kumar & Day, (2003)  
Philp et al., (2011)  
Iwata et al., (2009) 
 Niu et al., (2010) 
• Investigate Insulin dependent and 
independent glucose uptake 
• Effects of metabolic stressors upon 
glucose uptake 
• Have been successfully transfected to 
further elicited the mechanism of 
glucose transporter vesicle trafficking 
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2.6.2 Human skeletal muscle cells, insulin signalling and glucose uptake 
In addition to the use of cell lines, the culture of human primary cells is a well-established 
technique (Blau and Webster, 1981). These cells, derived from biopsies, proliferate and 
differentiate into multi nucleated myotubes and provide an in vitro model for investigating 
the mechanisms of a number of skeletal muscle diseases, such as skeletal muscle insulin 
resistance. In addition to the use of cell lines, the culture of human primary cells is a well-
established technique (Blau and Webster, 1981). These cells, derived from biopsies, 
proliferate and differentiate into multi nucleated myotubes and provide an in vitro model for 
investigating the mechanisms of a number of skeletal muscle diseases, including  insulin 
resistance (Table 2-1) (Aas et al., 2013). The use of skeletal muscle cells has offered some 
insight into such questions independently of the systemic environment with which they 
normally inhabit (Cosgrove et al., 2010). The extraction of skeletal muscle cells from 
NIDDM populations has been successfully achieved since the mid-nineties (Henry, Abrams, 
Nikoulina, and Ciaraldi, 1995). While skeletal muscle cells from both healthy and diseased 
populations express the fundamental genes of the myogenic linage, characterising these cells 
as skeletal muscle (Thompson, Pratley, and Ossowski, 1996), importantly, the characteristics 
of skeletal muscle from NIDDM patients is conserved in culture, with impaired glucose 
uptake and reduced glycogen synthase activity compared to muscle cells from healthy donors 
(Ciaraldi, Abrams, Nikoulina, Mudaliar, & Henry, 1995; Gaster, Petersen, Højlund, Poulsen, 
& Beck-nielsen, 2002; Thompson et al., 1996). More recent research by Feng and colleagues 
has shown that skeletal muscle cells from NIDDM populations in addition to impaired insulin 
stimulated glucose uptake, skeletal muscle cells from this population retain the impaired 
insulin signalling that is associated NIDDM (Feng et al., 2015). Additionally, experiments 
investigating the cross talk between skeletal muscle cells and adipocytes have been 
performed by culturing healthy human MDCs in adipocyte-conditioned media (Eckardt, Sell, 
and Eckel, 2008; Sell et al., 2008). Eckardt and colleagues reported impaired insulin 
signalling through impaired Akt protein phosphorylation and subsequently insulin stimulated 
glucose uptake in healthy human skeletal muscle cells incubated with adipocyte conditioned 
media (Eckardt et al., 2008). 
Further attenuation in metabolic flexibility has been observed in cultured skeletal muscle 
cells from NIDDM (Gaster, 2007). One hypothesis for the differences in free fatty acid (FFA) 
oxidation between healthy and insulin resistant individuals is resultant of differences in 
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mitochondrial lipid oxidation, which has been found to be attenuated in skeletal muscle cells 
from both obese and NIDDM individuals (Boyle, Zheng, Anderson, Neufer, and Houmard, 
2012; Cha et al., 2005). Boyle and colleagues reported a reduction in mitochondrial DNA 
(mtDNA) copy number in skeletal muscle cells from obese individuals as well as a reduction 
in respiration content (Boyle et al., 2012). More recently the investigation of adipocyte 
conditioned medium upon healthy skeletal muscle cells have shown to have negative effects 
upon distal and proximal insulin signalling proteins (Dietze et al., 2002; Sell et al., 2008) and 
impaired mRNA expression of myogenin, a key marker of skeletal muscle myogenisis (Sell 
et al., 2008). Further attenuation in metabolic flexibility has been observed in cultured 
skeletal muscle cells from NIDDM insulin adipocyte conditioned medium upon insulin and 
impaired mRNA expression of myogenin, a key marker of skeletal muscle myogenisis 
The increased circulation of free fatty acids (FFA), and pro- inflammatory cytokines such as, 
tumor-necorsis factor- alpha (TNF-α) has been implicated in the alterations in insulin 
signalling and subsequently glucose utilisation. Animal models of obesity have shown an 
increase in expression of TNF-α, and the elevations in plasma TNF-α is correlated with an 
increase in fasting plasma and insulin concentrations (Hotamisligil, Arner, Caro, Atkinson, 
and Spiegelman, 1995). Furthermore, in vitro experiments have linked an increase in TNF-α, 
impairing insulin signalling through serine induced phosphorylation of the insulin receptor 
and insulin receptor substrate (Hotamisligil et al., 1996; Hotamisligil, Budavari, Murray, and 
Spiegelman, 1994). Later work using murine myoblast cells confirmed the earlier findings of 
the effects of TNF-α incubation upon insulin signalling by reducing IRS-1 associated PI-3 
kinase activity phosphorylation, in addition to the impairment in glucose uptake by ~20% 
(del Aguila et al., 2011). 
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Table  2.2 Subject characteristics of human skeletal muscle cell donors to investigating in vitro insulin signalling and glucose uptake 
Reference Subject  
No. 
Age (yr.) BMI 
(kg/M2) 
Fasting Plasma 
Glucose (mmol/l) 
Oral Glucose Tolerance Test 
(OGTT) 
Insulin (pmol/l) 
Concentrations 
 
Other 
Measures 
Glucose 
(mmol/l) 
Insulin 
(pmol/l) 
Henry et al., 
(1995) 
 
 
 
ND = 14 
NIDDM= 
11 
ND = 42 ± 
2  
NIDDM = 
50 ± 2* 
ND 27.5 ± 
1.0 
NIDDM = 
30.4 ± 1.2* 
ND 5.2 ± 0.1 
NIDDM = 8.8 ± 
0.9* 
ND 6.0 ± 0.1 
NIDDM = 14.9 
± 1.2* 
ND 382 ± 93 
NIDDM = 293 
± 71* 
ND 36 ± 12 
NIDDM = 102 ± 3* 
HEC 
Ciaraldi et al., 
(1995) 
ND = 15 
NIDDM= 
11 
ND = 42 ± 
2  
NIDDM = 
50 ± 2* 
ND 27.5 ± 
1.0 
NIDDM = 
30.4 ± 1.2* 
ND 5.2 ± 0.1 
NIDDM = 10.2 ± 
1.6* 
ND 6.1 ± 0.3 
NIDDM = 16.8 
± 2.1* 
ND 424 ± 84 
NIDDM = 371 
± 106* 
NS 75 ± 14 
NIDDM = 137 ± 
17* 
 
Henry et al., 
(1996) 
ND = 8 
NIDDM = 
11 
ND = 42 ± 
2  
NIDDM = 
50 ± 2** 
ND 23.9 ± 
1.0 
NIDDM = 
30.6 ± 0.8** 
ND 5.5 ± 0.1 
NIDDM = 10.7 ± 
1.4** 
ND 6.3 ± 0.5 
NIDDM = 16.0 
± 2.5‡ 
ND 254 ± 84 
NIDDM = 271 
± 85 
ND 32 ± 12 
NIDDM = 108 ± 
15** 
 
Thompson et al., 
(1996) 
IR = 11 29 ± 7  85 ± 7 mg/dl 117 ± 33 mg/dl   HEC 
IMGD 
% Fat 
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Reference Subject  
No. 
Age (yr.) BMI 
(kg/M2) 
Fasting Plasma 
Glucose (mmol/l) 
Oral Glucose 
Tolerance Test 
(OGTT) 
 Insulin (pmol/l) 
Concentrations 
 
Other 
Measures 
Gaster et al., 
(2002) 
ND = 8 
NIDDM = 8 
ND = 26.9 
± 0.2  
NIDDM = 
49.5 ± 1.8‡ 
ND 23.6 ± 
0.7 
NIDDM = 
30.4 ± 1.1‡ 
ND 5.3 ± 0.1 
NIDDM = 9.9 ± 
0.1‡ 
  ND 42.0 ± 8.4 
NIDDM = 71.8 ± 
10.6* 
 
Dietze et al., 
(2002) 
ND = 3 M= 9, 28 
F= 10 
      
Bouzakri et al., 
(2003) 
ND = 9 
NIDDM = 9 
ND = 42 ± 
6 
NIDDM = 
56 ± 4 
ND = 24 ± 1 
NIDDM 32 
± 2 
ND = 5.0 ± 0.2 
NIDDM = 9.6 ± 
0.9 
  31 ± 4 HbA1c % 
Al-Khalili et al., 
(2003) 
ND = 8 55 ± 5 25.6 ± 1.5 5.4 ± 0.3     
Dietze et al., 
(2004) 
ND = 4 M = 9, 5 
F = 10, 48 
      
Dietze-
Schroeder et al., 
(2005) 
ND = 4 M = 9, 5 
F = 10, 48 
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Reference Subject  
No. 
Age (yr.) BMI 
(kg/M2) 
Fasting Plasma 
Glucose (mmol/l) 
Oral Glucose 
Tolerance Test 
(OGTT) 
 Insulin (pmol/l) 
Concentrations 
 
Other 
Measures 
Cha et al., 
(2005) 
ND = 39 
NIDDM = 
30 
ND = 44 ± 
2 
NIDDM = 
53 ± 2  
ND 29.0 ± 
1.1 
NIDDM = 
34.7 ± 1.5† 
ND 5.1 ± 0.1 
NIDDM = 9.6 ± 
0.6† 
  NS 68 ± 6 
NIDDM = 208 ± 
33* 
FFA† 
TG† 
GDR† 
HbA1c %† 
Pender et al., 
(2005) 
NO = 9 
Ob = 16 
NO = 44 ± 
1 
Ob = 38 ± 
3 
NO 25.5 ± 
0.9 
Ob = 54 ± 
4.2‡ 
NO = 83 ± 6 
mg/dl 
Ob = 91 ± 3 mg/dl 
  NO 3.6 ± 1.7 
Ob = 20.1 ± 3.2 
(µU/mL)* 
HOMA 
Sell et al.,  
(2008) 
ND = 4  M= 9, 47 
F= 10, 48 
      
Lambernd et al., 
(2012) 
ND = 5 M= 16, 21, 
47 
F= 33, 37 
      
ND, Non-diabetic; NIDDM, Non-insulin dependent diabetes mellitus; IR, Insulin resistant; NO, Non-Obese; Ob, Obese; M, Males; F, Females; 
BMI, body mass index; HEC, Hyperinsulineamic  euglycemic clamp; FFA, free fatty acid; TG, triglycerides; GDR, glucose disposal rate; HbA1c, 
haemoglobin A1 glycosylate; IMGD, Insulin mediated glucose disposal; HOMA, Homeostasis model assessment; Significantly difference vs. ND 
*p <0.05, †p<0.025, **p<0.01, ‡p<0.001
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2.7 Glucose metabolism in skeletal muscle 
As previously eluded too (Section  1.1), the balance of blood glucose is carefully maintained 
(Wasserman, 2009). All cells require glucose in order to function; although some tissues are 
greater than others. The brain accounts for a large proportion of glucose disposal along with 
liver and insulin sensitive tissues such as adipose tissue and skeletal muscle. Skeletal muscle 
is a major endocrine organ, accounting for approximately 30% of the body’s metabolic 
turnover at rest (Zurlo, Larson, Bogardus, and Ravussin, 1990), and the majority of insulin 
stimulated glucose uptake (DeFronzo et al., 1983). Changes in metabolism either through diet 
or physical activity result in the alteration in blood glucose concentrations (Barnard and 
Youngren, 1992). The breakdown of glucose is mediated by aerobic and anaerobic pathways 
(Egan and Zierath, 2013), where it is metabolised for ATP resynthesis (Bouché et al., 2004). 
Upon entry to the cells glucose is rapidly phosphorylated by hexokinase to form glucose-6-
phosphoate, which is  further phosphorylated by phosphofructokinase to generate fructose 1,6 
diphosphate, the oxidation of glucose to pyruvate enables for the production of ATP (Bouché 
et al., 2004). While anaerobic glycolysis yields only a small proportion of ATP, aerobic 
glycolysis by which pyruvate is utilised within the tricarboxylic acid cycle within the 
mitochondria results in a net production of 38 molecules of ATP per molecule of glucose 
(Bouché et al., 2004).
24 
 
 
2.8 Insulin and Insulin Receptor Signalling 
2.8.1 Insulin as a hormone 
The discovery of insulin by Banting, Best and Colleagues in the early 1920s provided an 
instant cure for patients with diabetes mellitus and began a long journey to understanding the 
regulation of glucose by insulin in humans (Roth et al., 2012). The original experiments, 
involving the injection of pancreatic extracts into pancreatectomized dogs, gave light to the 
role of the secretions of the pancreas in glycaemic control (Banting, Best, Collip, Campbell, 
and Fletcher, 1922). Prior to, and leading up to the announcement of the discovery of insulin 
on May 3rd 1922, the successful extraction of insulin was inconsistent. Yet despite this, the 
successful injection of insulin into a human in 1922, and its subsequent use in the treatment 
of diabetes mellitus saw Banting Best and McCloud recipients of the Nobel Prize for 
physiology and medicine in 1923. In addition to its therapeutic use, insulin  was the first 
protein to be sequenced (Sanger and Tuppy, 1951a, 1951b) for which, Fredrick Sanger 
received the Nobel prize in 1958. Since these major contributions to science and medicine, it 
could be argued that insulin continues to have an influence upon the understanding of 
metabolism. 
Insulin is developed by proteolysis from preproinsulin in pancreatic β-cells ( Figure-2-3). 
Following synthesis, preproinsulin is released into the rough endoplasmic reticulum where it 
is cleaved by photolytic enzymes. The conversion into insulin is mediated through the action 
of prohormone converts 2 and 3 as well as carboxy peptidase H (Joshi, Parikh, and Das, 
2007). Insulin, a peptide hormone, consists of two chains, an A and B chain comprising of 21 
and 30 amino acids respectively, bound by disulphide bonds. Its basic structure of three 
helices and three disulphide bonds is existent in all members of the insulin peptide family (De 
Meyts and Whittaker, 2002). Two surfaces of the insulin hormone are reported to interact 
with the insulin receptor, the first which contacts with the primary binding site on the insulin 
receptor comprises of hormone-dimerising residues, the second, containing hormone-
hexamerising residues, is suggested to interact with the secondary insulin receptor site 
(Menting et al., 2013). 
At physiological concentrations plasma insulin has a short half-life of approximately 4-6 
minutes, with the majority of insulin degradation occurring as a result of binding to its 
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receptor tyrosine kinase, the insulin receptor, and by insulin degrading enzyme (IDE) where 
it is internalised and degraded (Duckworth, Bennett, & Hamel, 1998).  
2.8.2 Insulin resistance and hyperinsulinemia 
By definition, insulin resistance is the attenuated response of a target cell or organ to a 
normal physiological concentration of insulin to which it has been exposed. It is suggested 
that the symptom of hyperinsulinemia is implicated in alternations of metabolic homeostasis 
(Shanik et al., 2008), which characterise in part, metabolic syndrome X, but also pre-cede the 
onset of diabetes mellitus (Roberts et al., 2013). 
Although acute insulin exposure has a stimulatory effect upon several transcription factors 
(Coletta et al., 2008; Wu et al., 2007), as well as its role in metabolic signalling (Taniguchi et 
al., 2006), chronic exposure to insulin can result in desensitising effects between itself, its 
binding domain and downstream proteins (Roth et al., 2012). While short periods of 
hyperinsulinemia promote insulin sensitizing effects, chronic exposure results in abrogation 
of this effect in skeletal muscle (Cusin, Terrettaz, Rohner-Jeanrenaud, and Jeanrenaud, 1990). 
A suggested mechanism of impaired insulin signalling as a result of hyperinsulinemia is via a 
negative feedback loop through which activation of the mTOR/p70 S6 kinase pathways leads 
to serine phosphorylation of IRS-1 (Ueno et al., 2005). Ueno and colleagues reported a 
significant reduction in IRS-1 tyrosine phosphorylation and IRS-1/PI-3 kinase associated 
activity in skeletal muscle of rat under hyperinsulineamic conditions (Ueno et al., 2005). The 
effects of hyperinsulineamia upon skeletal muscle have been recapitulated in vitro, which 
when exposed to chronic insulin within the culture media, has resulted in attenuation in both 
insulin receptor (IR) and insulin receptor substrate 1 (IRS-1) phosphorylation and 
subsequently impaired insulin stimulated glucose uptake (Kumar and Dey, 2003). 
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Figure- 2-3 Production of insulin by proteolysis from preproinsulin. Proteolysis cleaves N-terminal 
signal sequence and c-peptide resulting in a two polypeptide chain structure. C-peptide (Black), A-
chain (White), B-chain (Grey). Figure adapted from Joshi et al., (2007). 
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2.8.3 The insulin receptor 
The insulin receptor is a receptor tyrosine kinase (RTK), which contains ligand-binding 
domains within the extracellular region, a trans membrane helix and a cytoplasmic region, 
which contains the tyrosine kinase domain that activates intracellular signalling pathways 
(Figure  2-4) (Lawrence, McKern, and Ward, 2007; Lemmon and Schlessinger, 2010). 
Exposure to insulin results in a conformational change in the insulin receptor, leading to 
trans-autophosphorlyation of the tyrosine kinase domain of the trans-membrane β subunit. In 
vitro, phosphorylation of the insulin receptor has been found to occur within a few seconds, 
phosphorylating upon three specific tyrosine residues enabling for sufficient kinase activity 
insulin of the insulin receptor (Tornqvist & Avruch, 1988; White & Kahn, 1989). The lucine 
rich domains (L1 and L2 respectively) are key binding sites in which insulin binds to the 
insulin receptor, as well as the fibronectin (FnIII), domain (De Meyts and Whittaker, 2002), 
and the two binding sites of insulin have been reported to interact with the insulin receptor 
(Menting et al., 2013). The high and low affinity of these binding sites can impact upon 
cooperatively between these respective proteins. Dose response curves have presented a bell 
shaped formation indicating a loss of dissociation at concentrations which exceed 100 nM 
(De Meyts and Whittaker, 2002). Subsequently, increasing concentrations ultimately leads to 
negative cooperatively1 and further chronic exposure has been shown to lead to alterations in 
high and low affinity isoforms (Shanik et al., 2008), resulting in desensitisation of the insulin 
receptor proteins (Ueno et al., 2005). 
  
  
                                                 
1 Negative cooperatively is defined by De Meyts et al., (2002) as ‘a property of a multi binding protein 
whereby the binding of one ligand molecule decreases the binding affinity of other ligand molecules to 
neighbouring binding sites.’  
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Figure  2-4 Structural domains of the insulin receptor homodimer. Leucine rich repeat domain (L1), 
Cysteine rich region (CR), Second leucine rich repeat domain (L2), Three fibrinectin type III domains 
(FnIII-1, FnIII-2, FnIII-3), Insert Domain (ID), C-terminus (CT), Tyrosine Kinase (TK). Black 
transverse lines represent disulphide bonds. Figure adapted from Lawrence et al., (2007). 
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2.8.4 Insulin Receptor Substrate 1 (IRS-1) 
Tyrosine kinase phosphorylation of the insulin receptor residues results in recruitment 
of insulin receptor substrate 1 (IRS-1). IRS-1, a docking protein, contains several key features 
that initiate the recruitment of downstream insulin signalling proteins including a NH2-
terminal which aids protein-protein interactions (White, 1998). Furthermore, IRS-1 has 
several COOH-terminal tyrosine residues that create a Sac Homology (SH) -domain binding 
site (White and Kahn, 1994). The SH-domain is important in the recruitment of the p85 
phosphoinositide 3-kinase (PI-3 kinase) subunit (Backer et al., 1992; Myers et al., 1992). 
Twenty-one tyrosine phosphorylation sites and thirty potential serine/threonine 
phosphorylation sites have been identified on IRS-1 (White & Kahn, 1994). Upon insulin 
stimulation, several tyrosine sites have been reported be phosphorylated (Mothe and Van 
Obberghen, 1996), of which Tyrosine 612 (Tyr612) and Tyrosine 632 (Tyr632) have found to 
be pivotal in the full activation of downstream PI-3 kinase activity and GLUT4 translocation  
(Esposito, Li, Cama, & Quon, 2001). 
The IRS-1 protein is considered critical in effective insulin signalling (Taniguchi, 
Emanuelli, & Kahn, 2006), and insulin resistance has been implicated as a result of impaired 
phosphorylation of downstream signalling proteins. In humans, genetic studies have showed 
the IRS-1 gene to be variable in NIDDM (10-20%) compared with healthy individuals (5%) 
(Almind et al., 1993; Laakso, Malkki, Kekäläinen, Kuusisto, and Deeb, 1994). Furthermore, 
Animal models expressing null alleles of the IRS-1 gene, which reduces the expression of 
IRS-1 protein present approximately (~60%) reduction in total IRS-1 protein, attenuates IRS-
1 phosphorylation and p85 PI-3 kinase associated activity (Brüning, Winnay, Cheatham, and 
Kahn, 1997). Yamauchi and colleagues have reported similar findings in knockout rodent 
models, which present approximately a 20% reduction in IRS-1 phosphorylation to that of 
wild-type mice (Yamauchi et al., 1996). Despite this reduction, IRS-1 null mice do not 
develop diabetes, but rather present an increased in insulin secretion resultant of beta cell 
hyperplasia suggesting the role of another protein which is implicated in the development of 
diabetes, potentially IRS-2 (Yamauchi et al., 1996). 
The impairment in IRS-1 phosphorylation with relation to insulin resistance in vivo has been 
speculated to be due to an increase in serine phosphorylation (Hotamisligil et al., 1996). 
Exposure to pro-inflammatory cytokines such as tumour necrosis factor – alpha (TNF-α), 
activates protein kinases such as inhibitor κB Kinase (IKK) (de Alvaro, Teruel, Hernandez, & 
Lorenzo, 2004), and c-Jun-N-Terminal Kinase (JNK), (Lee, Giraud, Davis, & White, 2003), 
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which increase serine phosphorylation. In vitro research in skeletal muscle cells has shown 
serine phosphorylation to impair IRS-1 associated phosphorylation of PI-3 kinase in skeletal 
muscle cells as a result of pro-inflammatory cytokine exposure (del Aguila et al., 2011).        
TNF-α activates the stress protein kinase, c-Jun N-terminal kinases (JNK), which result in 
serine phosphorylation of IRS-1 and impairs insulin stimulated glucose uptake in healthy 
humans (Plomgaard et al., 2005). In addition, skeletal muscle cells from diabetic subjects 
have shown to express a fourfold increase in TNF-α compared to insulin sensitive subjects 
(Saghizadeh, Ong, Garvey, Henry, & Kern, 1996). Furthermore, in vitro experiments using 
the myogenic C2C12 cell line have found TNF-α to impair IRS-1 associated PI-3 kinase 
activity to the p85 subunit, and reduction in insulin stimulated glucose uptake (Del Aguila, 
Claffey, & Kirwan, 1999), demonstrating the strong effect of TNF- α upon impaired IRS-1 
phosphorylation. 
2.9 Phosphatidylinositol 3-Kinase (PI 3-Kinase): A regulator of insulin 
signalling. 
 
Phosphatidylinositol 3-Kinase (PI 3-Kinase) is a hetero-dimer, composed of a p110 catalytic 
subunit (110 kDa) and p85 regulatory subunits (85 kDa). PI 3-Kinase is implicated in various 
signalling pathways, many of which are beyond the scope of this review, however, the 
implications upon insulin signalling are crucial in maintaining normal cell metabolism 
(Shepherd, Withers, & Siddle, 1998; Shepherd, 2005). 
The initiation of tyrosine-phosphorylated substrates is mediated by Src Homology (SH2) 
domains, which are critical for cytoplasmic protein binding with auto phosphorylated 
receptor tyrosine kinases (Pawson and Gish, 1992). All PI-3 kinase isoforms contain two SH2 
domains as well as inter SH2-domain to enable adaptor and catalytic unit interaction and 
recruitment of the complex to the membrane (Shepherd, 2005). Activation of PI-3 kinase 
through tyrosine phosphorylation by IRS-1 results in binding of the p85 subunit SH2 domain 
with the tyrosine phosphorylation sites (Myers et al., 1992). Insulin has been found to be a 
potent activator of PI-3 kinase (Navé, Haigh, Hayward, Siddle, and Shepherd, 1996) and cell 
permeable inhibitors of PI-Kinase activation (Wortmannin and LY294002), abate PI-3 kinase 
activity and subsequently insulin stimulated glucose uptake (Cusi and Maezono, 2000). 
The recruitment of PI3-kinase as a result of IRS-1 activation is dependent upon 
phosphorylation of multiple tyrosine sites (Sun, Crimmins, Myers, Miralpeix, & White, 1993). 
31 
 
In addition, IRS-1 contains a number of serine phosphorylation sites, however, due to the low 
serine activity of p110 and p85 units, IRS-1 serine phosphorylation sites leads to impaired 
IRS-1, and PI-3 kinase associated activity (Cusi and Maezono, 2000). Serine phosphorylation 
of IRS-1 has been shown impair PI3-Kinase associated activity in adipocytes (Hotamisligil et 
al., 1996) and cultured skeletal muscle cells (Bouzakri et al., 2003). Additionally, in vivo 
research subjected humans to a 3 hour hyperinsulineamic euglycemic clamp to investigate 
skeletal muscle insulin signalling. Kim and colleagues showed there to be a progressive 
reduction in IRS-1 associated p85 subunit PI-3 kinase activity in type 2 diabetics (2.4 fold), 
compared with lean controls (6.1 fold) and non-diabetic obese subjects (3.7 fold), when (Kim, 
Nikoulina, Ciaraldi, Henry, & Kahn, 1999).  
PI-3 kinase activity leads to the instigation of a number of phosphorylated inositol 
phospholipids (Shepherd, Navé, & O’Rahilly, 1996).  Insulin has specifically been shown to 
acutely increase phosphatidylinositol-3,4,5-triphosphate (PIP3) and phosphatidylinositol-
3,4,5-biphosphate (PIP2), a by-product of PIP3 breakdown (Ruderman, Kapeller, White, and 
Cantley, 1990). Ruderman and colleges showed maximal activity of phosphorylated inositol 
phospholipids within a minute of exposure to insulin which was subsequently maintained for 
up to 60 minutes (Ruderman et al., 1990). Furthermore, PIP3 has been shown to be an 
important mediator of downstream signalling. Pre-treatment with PI-3 kinase specific 
inhibitors have shown to attenuate PIP3 accumulation and subsequent activation of 
downstream signalling. The increase in PIP3 is important in enabling co-localisation between 
protein kinase b (Akt) and 3-phosphoinositide-dependent protein kinase-1 (PDK1) (Kandel 
and Hay, 1999).
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2.10 Metabolic role of Akt 
Since its identification over 20 years ago (Jones, Jakubowicz, Pitossi, Maurer, & Hemmings, 
1991), Protein Kinase B (Akt/PKB), or Akt as it will be referred to for the purpose of this 
review, has instigated a large amount interest within the literature with regards to its role in 
cellular signalling (Brazil and Hemmings, 2001; Kandel and Hay, 1999; Schultze, Jensen, 
Hemmings, Tschopp, and Niessen, 2011). Akt is a multifunctional protein kinase, that is 
implicated in various cellular responses, such as growth and development (Yang et al., 2003), 
as well as glucose homeostasis (Kohn, Summers, Birnbaum, and Roth, 1996; Wang et al., 
1999). 
Akt contains an amino terminal plackstrin homology (PH) domain and is a downstream target 
of PI3-Kinase (Hanada, Feng, and Hemmings, 2004). The PH domain of Akt, interacts with 
the phosphorylation of serine/threonine kinase, PI3-Kinase, by conversion PIP2, to (PIP3) at 
the plasma membrane (Alessi et al., 1997). PIP3 is required for maximal activity of Akt via 3-
phosphoinositide-dependent protein kinase (PDK) phosphorylation at the catalytic domain 
(Thr308) (Schultze et al., 2011). In addition to phosphorylation at Thr308, which accounts for 
10% of the basal activity, phosphorylation at the C-terminal domain (Ser473) is critical for 
complete kinase activity (Alessi and Cohen, 1998; Alessi et al., 1996). Activation of Akt 
leads to phosphorylation of a number of downstream molecules, such as glycogen synthesis 
via glycogen synthase (Friedrichsen et al., 2013), protein synthesis via the mTOR signalling 
pathway (Proud and Denton, 1997), and AS160, a Rab-GTPase protein that is implicated in 
GLUT4 exocytosis for insulin stimulated glucose uptake (Sano, 2003). 
 
The Akt family comprises of three isoforms (Akt1, Akt2 and, Akt3), which are expressed in 
numerous tissues (Yang et al., 2003). Both Akt1 and Akt2 isoforms are expressed in insulin 
sensitive tissues, such as liver and adipose tissue. Skeletal muscle expresses all three Akt 
isoforms (Brozinick, Roberts, & Dohm, 2003) and all of them have specific functions 
(Cleasby, Reinten, Cooney, James, and Kraegen, 2007). While Akt1 and Akt3 have been 
shown to be involved in normal growth and brain development respectively (Schultze et al., 
2011), Akt2 has predominantly been found to be involved in glucose homeostasis (Cho et al., 
2001; Garofalo et al., 2003). 
 
33 
 
Both Akt1 and Akt2 are important in the proliferation and differentiation of skeletal muscle 
cells (Rotwein and Wilson, 2009; Wilson and Rotwein, 2007). However, the regulation of 
skeletal muscle differentiation by Akt1 and Akt2 isoforms remains debatable. The literature 
is divided with respect to the roles that Akt1 and Akt2 play within skeletal muscle 
differentiation with some authors suggesting Akt1 (Rotwein and Wilson, 2009; Wilson and 
Rotwein, 2007), while others suggesting Akt2 (Heron-Milhavet et al., 2006; Heron-Milhavet, 
Mamaeva, Rochat, Lamb, & Fernandez, 2008) to be the main regulator of skeletal muscle 
differentiation. Akt2 contains promoter regions, which allow for myodesmin and myocyte 
enhance factor interactions, two important basic helix-loop-helix proteins implicated in 
skeletal muscle development (Kaneko et al., 2002). During differentiation the increase in 
Akt2 expression also increases expression of myogenin through a positive feedback loop 
(Kaneko et al., 2002). Silence of Akt2 in skeletal muscle cells impairs differentiation, 
morphological compared to control myotubes. In contrast, ablation of Akt1 completely 
prevented differentiation through the down regulation of transcriptional regulators of 
myogenesis without affecting cell viability or proliferation (Wilson and Rotwein, 2007). It is 
clear that both of these proteins play important roles in skeletal muscle development in some 
form and the expression of Akt is a critical factor in skeletal muscle differentiation and 
development (Gardner, Anguiano, and Rotwein, 2012). 
 
The transfection of mutant PKB/Akt1 in L6 myotubes reduces insulin stimulated Akt1 
phosphorylation and GLUT4 translocation (Wang et al., 1999). Additional work by Katome 
and colleagues has shown that RNA silencing of both Akt1, but more so the Akt2 isoform, is 
implicated in the reduction of insulin stimulated glucose uptake in 3T3- L1 adipocytes 
(Katome et al., 2003).  These findings have been further supported in skeletal muscle, with 
Akt2 knockout mice developing impaired insulin action and simulating a diabetic like 
syndrome (Cho et al., 2001; Garofalo et al., 2003). The over-expression of Akt increases 
glucose uptake in both L6 muscle cells (Hajduch, Alessi, Hemmings, & Hundal, 1998), and 
rat muscle fibres (Cleasby et al., 2007). Cleasby and colleagues have shown that the over-
expression of Akt2 isoform in rodent skeletal muscle significantly enhances insulin 
stimulated glucose uptake and glycogen synthesis activity by 36% and 59% respectively 
identifying Akt2 important in glucose metabolism (Cleasby et al., 2007). 
 
In human skeletal muscle, Akt expression is similar between NIDDM and controls subjects 
(Brozinick et al., 2003; Krook, Roth, Jiang, & Zierath, 1998), however, under 
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hyperinsulineamic euglycemic conditions, Akt phosphorylation is severely impaired in 
insulin resistant and type 2 diabetic individuals (Krook et al., 1998). More recent work has 
identified the reduction in phosphorylation of Akt to be a consequent of a significant 
reduction in Ser473 phosphorylation in comparison to Thr308, which does not differ at basal 
levels or following insulin stimulation in NIDDM patients (Cozzone et al., 2008). Further 
work by Cozzone and colleagues supported previous research presenting specific isoform 
impairments in phosphorylation of Akt2 in skeletal muscle of NIDDM patients.  
 
2.10.1 The role of AS160 substrate 
The protein TBC1 domain family member 4 (TBC1D4) or, Akt substrate at 160 kDa (AS160 
(160 kDa)) as it is more commonly known, has only recently emerged as a key protein in 
insulin stimulated glucose uptake. Since the identification of AS160 (Kane et al., 2002; Sano 
et al., 2003), there has been a profound interest in the mechanistic role that AS160 plays both 
in insulin dependent and independent glucose uptake (Cartee & Wojtaszewski, 2007; 
Sakamoto & Holman, 2008). 
Structurally, AS160 has been found to comprise of a COOH-terminal Rab-GAP (GTPase-
activating protein) domain, as well as several, but not exclusively, Akt phospho-motifs 
(Miinea et al., 2005). Rab proteins are highly implicated in vesicle trafficking (Lee, Mishra, 
& Lambright, 2009), and they are vital in the exocytosis of glucose transporters (Moyers, 
Bilan, Reynet, & Kahn, 1996). Under basal conditions, Rab-GAP activity remains in an 
inactive (guanosine-5’-diphosphate (GDP-loaded)) form, inhibiting GLUT4 translocation 
(Sakamoto & Holman, 2008). When AS160 is phosphorylated, Rab-GAP activity is 
subsequently inhibited, leading to GTP loading, which enables for translocation of GLUT4 
vesicles from the peri-nuclear region of the plasma membrane. 
Several serine and threonine sites are phosphorylated on AS160 following insulin stimulation 
(Kane et al., 2002; Sano et al., 2003). Although multiple phosphorylation sites have been 
identified, the work by Kane and colleagues identified Ser588 and, Thr642 as the major insulin-
stimulated phosphorylation sites, with later work identifying up to a further three sites to be 
implicated in insulin stimulated AS160 phosphorylation (Sano et al., 2003). The 
phosphorylation of these sites is imperative in GLUT4 trafficking (Mîinea et al., 2005). This 
has been shown through inhibition of the aforementioned phosphorylation sites insulin(Sano, 
2003). Research by Sakamoto’s laboratory has shown that knock in mutation of AS160 
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dramatically impairs glucose tolerance by 25% and 14% in male and female mice 
respectively; specifically identifying that mutation of the Thr649 AS160 residue to be 
implicated in the increase in intercellular GLUT4 content is  (Mîinea et al., 2005). This has 
been shown through inhibition of the aforementioned phosphorylation sites (Chen, 
Wasserman, MacKintosh, & Sakamoto, 2011). Skeletal muscle has also been shown to 
express AS160 (Bruss, Arias, Lienhard, and Cartee, 2005; Kramer et al., 2006), and is 
phosphorylated by insulin in a dose dependent manner  (Arias, Kim, & Cartee, 2004), via the 
upstream phosphorylation of Akt at ser473 (Bruss et al., 2005). 
2.11 Skeletal muscle glucose transporters. 
Glucose uptake is imperative for the maintenance of energy homeostasis (Pessin, 
Thurmond, Elmendorf, Coker, & Okada, 1999). Insulin stimulation glucose uptake results in 
rapid (~1 minute) entry of glucose into the cell (Daniel, Love, and Pratt, 1975). The 
intercellular concentration of glucose is small compared to extracellular concentrations, 
resulting in a significant concentration gradient. However, due to the hydrophilic nature of 
the glucose molecule its transport into the cell is mediated by a family of integral membrane 
proteins known as glucose transporters (Kahn, 1992). The control of glucose transporter 
exocytosis is regulated by proteins which initiate translocation to the plasma membrane, as 
well as regulate recycling following glucose uptake (Leto and Saltiel, 2012).   
Two glucose transporters, glucose transporter 1 (GLUT1) and glucose transporter 4 (GLUT4) 
are the primary regulators of glucose transport and are highly concentrated in both skeletal 
muscle and adipose tissue (DeFronzo et al., 1983). GLUT1, located at the plasma membrane, 
is responsible for basal glucose turnover, and is a mediator of glucose transport in prenatal 
skeletal muscle (Gaster, Handberg, Beck-Nielsen, and Schroder, 2000). In contrast, under 
basal conditions, GLUT4 is sequestered within intracellular glucose storage vesicles (Gould 
and Holman, 1993), with less than 5% located at the cell surface (Slot et al., 1991). Insulin 
stimulation, results in a 40-fold increase in cell surface GLUT4 concentrations in brown 
adipocytes (Slot et al., 1991). Both GLUT1 and GLUT4 mRNA and protein have been 
reported to be present within tissues from both humans and rats (Flier, Mueckler, McCall, 
and Lodish, 1987), including skeletal muscle (Klip & Pâquet, 1990). In human skeletal 
muscle, GLUT4 expression is approximately 400-fold higher in comparison to GLUT1 
(Stuart et al., 2006) and is proportionally higher within red, oxidative (7:1) compared to white 
glycolytic (4:1) skeletal muscle (Marette et al., 1992). In addition, the expression is highly 
correlated with glucose transport at both the transcriptional and protein levels (Kern et al., 
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1990), and is also reflected in the surface density of GLUT4 upon insulin stimulation and the 
rate of glucose uptake. 
Hormones such as insulin regulate transcriptional and translational turnover in insulin 
sensitive tissues (Flores-Riveros, McLenithan, Ezaki, and Lane, 1993). Prolonged exposure 
to insulin has been shown to decrease GLUT4 mRNA within a relatively short exposure 
period, subsequently leading to a reduction in cellular GLUT4 protein by approximately 50-
80% (Flores-Riveros et al., 1993; Sargeant and Pâquet, 1993). Contrary to this effect, GLUT1 
expression increases to steady state levels 6-fold greater than initial values, resulting in the 
increase in cellular protein concentration (Sargeant and Pâquet, 1993). The translational 
control of GLUT4 mRNA has been elucidated through transfection of GLUT1 and GLUT4 
cDNA in adipocytes and skeletal muscle cells, and has shown insulin to mediate increases in 
GLUT1 expression through a PI3-Kinase/Akt/mTOR signalling pathway (Taha et al., 
1999).In order to further investigate the role of glucose transporters within skeletal muscle, 
both skeletal muscle cells lines and human skeletal muscle cells have been used due to the 
expression of basal and insulin stimulated glucose transporters, as well as their ability to 
respond to insulin stimulated glucose uptake (Sarabia, Lam, Burdett, Leiter, and Klip, 1992) .  
The use of skeletal muscle cells can provide a valid in vitro model for investigation of 
metabolic response at the cellular level (Berggren, Tanner, and Houmard, 2007). Human 
muscle derived cells (MDC) in culture respond to insulin in a dose and time dependent 
manner (Al-Khalili et al., 2003; Ciaraldi, Abrams, Nikoulina, Mudaliar, & Henry, 1995; 
Henry et al., 1995). Both GLUT1 and GLUT4 have been shown to be present in human 
skeletal muscle cells maintained in culture from both healthy and NIDDM subjects (Al-
Khalili et al., 2003; Ciaraldi et al., 1995; Henry, Abrams, Nikoulina, & Ciaraldi, 1995). 
Furthermore, Al-khalili and colleagues observed differences between myoblast cell and 
differentiated myotube glucose transporter concentrations, which at the single cell level, 
express predominantly GLUT1 and upon differentiation express predominantly GLUT4 (Al-
Khalili et al., 2003). 
2.11.1 Glucose Transport Endo/Exocytosis 
Under basal conditions approximately 5% on the total transporter pool is located at the cell 
surface (Klip & Pâquet, 1990), while GLUT4 vesicles are mainly sequenced within the 
intracellular space, distributed between endosomes, the trans Golgi network and  specialised 
glucose storage vesicles (GSV) (Rea and James, 1997). The translocation of glucose 
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transporters from vesicle storage compartments within the cytoplasm to the sarcolemma and 
T-tubules is regulated by distinct signalling pathways (Jessen and Goodyear, 2005) 
(Figure  2-5). Insulin stimulation initiates an increase in cell surface concentrations of GLUT4 
within 5 minutes of exposure (Kern et al., 1990). Exocytosis 2 of GLUT4 to the plasma 
membrane is regulated by the hydrolysis of Rab-GTPase3 protein complexes, which regulate 
GLUT4 trafficking (Larance et al., 2005; Sano, 2003). Both Rab8 and Rab14 have been 
found to be present in skeletal muscle and as previously mentioned are targets of the Rab-
GTPase protein AS160 (Section  2.10.1). The final process of GLUT4 exocytosis is the 
binding between transporter and the plasma membrane. Proteins known as SNARE (soluble 
N-ethymaleimide-sensitive factor attachment protein receptor) proteins are regulated by the 
Sec1/Munc18 protein family, which regulate membrane fusion events allowing for docking 
GSV to the plasma membrane and enable facilitated diffusion of glucose across the 
membrane (Leto and Saltiel, 2012). In human skeletal muscle, glucose ingestion increases 
GLUT4 translation to the membrane (Goodyear et al., 1996). In contrast, GLUT4 dynamics 
have been shown to be reduced in human adipose cells from obese and insulin resistant 
donors compared to healthy controls (Lizunov et al., 2013). 
                                                 
2 GSV exocytosis has been described as three processes. Firstly translocation to the cell membrane, targeting 
and, fusion to the plasma membrane (Leto and Saltiel, 2012). 
3 Guanine activated proteins are small proteins which remained within an inactive state (GDP). Hydrolysis of 
GDP results in an active form (GTP). Activation of AS160 leads GSV exocytosis. 
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Figure  2-5 Insulin stimulated glucose uptake. Binding between the hormone, insulin and insulin receptor (IR) activates and autophosphorylates the insulin 
receptor substrate-1 (IRS-1). IRS-1 acts as a docking protein for the downstream subunit phosphatidylinositol 3-kinase (PI3-Kinase). Phosphorylation of PI3-
Kinase leads to the recruitment of phosphate dependent kinase (PDK) which causes translocation and subsequent phosphorylation of Akt. Phosphorylation of 
Akt leads to downstream phosphorylation of the Akt substrate AS160 and release of the glucose storage vesicles to the plasma membrane to enable facilitated 
diffusion of glucose across the plasma membrane. Figure adapted from Leng et al., 2004 and  Leto and Saltiel 2012.  
39 
 
2.12 Implication of insulin upon gene expression 
In addition to its role in post-prandial glucose disposal, insulin is also implicated in positive 
and negative transcriptional regulation (O’Brien and Granner, 1996). The regulation of gene 
transcription by insulin is mediated through two basic mechanisms. Firstly, through the 
phosphorylation/dephophorlyation of plasma membrane bound signalling cascades and, more 
directly through intracellular receptors (O’Brien and Granner, 1996). Research in human 
skeletal muscle has reported several insulin responsive and non-responsive genes as well as 
transcriptional factors that are involved in vesicle trafficking, protein turnover and signal 
transduction. Research by Wu and colleagues reported 70 transcriptional regulated genes by 
insulin which include the vesicle trafficking regulator, glucose transporter 4 (GLUT4), Ras-
related associated with diabetes (rRAD) and, peroxisome proliferative activated receptor γ 
(PGC-1α, a regulator of metabolism) (Table 2-3). The aforementioned transcriptional 
regulators could be considered what O’Brien and colleagues have previously described as 
candidate diabetic genes (diabetogenes), which have subsequently been found to be altered in 
skeletal muscle and adipose tissue of insulin resistance individuals (Bach et al., 2002; 
Ducluzeau et al., 2001). 
 Glucose Transporter 4 (GLUT4) 2.8.3.1.
Expression levels of GLUT4 are highly regulated during embryonic development of rats 
(Santalucía et al., 1992). During rat foetal development, GLUT4 concentrations have been 
found to be low; however during the prenatal phase of development continuous expression of 
GLUT4 mRNA, which is proceeded by increases in posttranslational protein expression, 
results in GLUT4 being the predominant isoform for glucose transport within rat skeletal 
muscle (Santalucía et al., 1992).  Both protein and transcriptional concentrations are highly 
present within mature skeletal muscle in humans (Stuart et al., 2006), and expression levels 
of GLUT4 are highly correlated with glucose transport (Kern et al., 1990).  Several 
mechanisms regulate GLUT4 expression in skeletal muscle (Zorzano, Palacín, and Gumà, 
2005). The use of transgenic animal models has identified the important transcriptional 
promoter regions which are responsible for increases in GLUT4 mRNA expression (Liu, 
Olson, Edgington, Moye-Rowley, and Pessin, 1994). Several authors have shown that insulin 
or pharmacological mediated stimulation significantly increases GLUT4 mRNA expression 
(Al-Khalili et al., 2005; Leick et al., 2010). 
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 Peroxisome proliferator-activated receptor coactivator – 1α (PGC-1α) 2.8.3.2.
Since its discovery within brown adipose tissue (Puigserver et al., 1998), Peroxisome 
proliferator-activated receptor (PPAR)-γ coactivator – 1α (PGC-1α), has received a large 
amount of interest within the literature due to its multi-faceted role in metabolism and 
physiological adaption (Lira, Benton, Yan, & Bonen, 2010; Olesen, Kiilerich, & Pilegaard, 
2010). DNA microarray of skeletal muscle biopsies from NIDDM has reported 
approximately a 20% reduction in PGC-1α mRNA expression, and a similar concurrent 
reduction in oxidative phosphorylation genes (Mootha et al., 2003). The mechanistic role of 
PGC-1α has been investigated both in vitro research using stable cells lines (Michael et al., 
2001), and in animal models (Leick et al., 2010). While the use of transgenic rodent models 
have shown some inconsistencies within the literature in relation  to the effects of  findings as 
to the effects of PGC-1α upon insulin sensitivity, research in the Zucker rat animal model 
have approximately a 50% reduction in PGC-1α expression in skeletal muscle (Jové et al., 
2004; Sriwijitkamol et al., 2006). The use of cell culture models has identified PGC-1α as an 
activator of genes implicated in the, tricarboylic acid cycle, electron transport chain and 
mediation of GLUT4 mRNA expression in skeletal muscle (Koves et al., 2005; Michael et al., 
2001). Koves and colleagues showed that PGC-1α overexpression also resulted in an increase 
in Peroxisome proliferator-activated receptor (PPAR) mediated genes, which regulated lipid 
metabolism (Koves et al., 2005). More recently, over expression of the PGC-1α related co-
activator, a structurally similar protein to PGC-1α, has been shown to significantly increase 
mRNA expression of oxidative phosphorylation (OXPHOS) genes and proteins as well as 
GLUT4 mRNA and protein concentrations by as much as 350% and 14% respectively in 
C2C12 skeletal muscle cells (Philp et al., 2011; Philp, Perez-Schindler, Green, Hamilton, and 
Baar, 2010). These changes in concentrations at both the transcriptional and protein levels 
have unsurprisingly been found to increase glucose uptake (Philp et al., 2011). 
These in vivo animal, and  in vitro cell culture models support findings observed within 
skeletal muscle of pre-diabetic, insulin resistant and diabetic and humans (De Filippis et al., 
2008). Recent work has shown that skeletal muscle cells from obese individuals increases 
lipid oxidation following over-expression of the PGC-1α gene, by as much as ~3.5 fold, 
similar to increases observed following exercise training (Consitt et al., 2010). The effect of 
exercise upon PGC-1α gene expression in skeletal muscle is clear within the literature based 
on the number of reviews in recent years (Handschin and Spiegelman, 2006; Olesen, 
Kiilerich, and Pilegaard, 2010). Exercise increases the expression of PGC-1α  (Burgomaster 
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et al., 2008) and  prolonged exercise training has been shown to transiently increase Increases 
in both PGC-1α mRNA and protein expression (Perry et al., 2010).  Augmentation of PGC-
1α expression by exercise has been attained through metabolic signalling via AMPK 
(Pilegaard, Saltin, and Neufer, 2003), as well as  stretch activated protein kinase, p38 MAP 
Kinase (Koves et al., 2005). Furthermore, recent research by Barrès and colleagues have 
shown exercise intensity play an important role in the epigenetic regulation of the PGC-1 α 
promoter region and subsequently its transcriptional expression (Barrès et al., 2012). In 
addition to increases in PGC-1α  expression, a number of whole body changes have been 
shown to be affected by exercise training including, aerobic capacity, lactate accumulation 
and, insulin sensitivity  (Hood, Little, Tarnopolsky, Myslik, and Gibala, 2011; Perry, 
Heigenhauser, Bonen, and Spriet, 2008). Although the research is somewhat limited, De 
Fillipis and colleagues have shown that mRNA PGC-1α expression is blunted during the 
acute recovery phase of aerobic exercise in obese non-diabetic males compared to lean 
controls, however increases above base line expression (De Filippis et al., 2008). Furthermore, 
exercise intensity has been shown to be important in both transcriptional regulation and DNA 
methylation status (Barrès et al., 2012; Egan and Zierath, 2013). Recent research by Barrès 
and colleagues has identified beneficial effects of exercise upon DNA methylation of the 
PGC-1α promoter region (Barrès et al., 2012). These acute responses have been supported by 
Sriwijitkamol and colleagues who have shown PGC-1α to recover following seven weeks of 
aerobic training (Sriwijitkamol et al., 2007). Increases in both PGC-1α mRNA and protein 
expression are transient with exercise training (Perry et al., 2010). Augmentation of PGC-1α 
expression by exercise has been attained signalling via AMPK, as well as  protein kinase, p38 
MAP Kinase Furthermore, recent research by Barrès and colleagues have shown exercise 
intensity play an important role in the epigenetic regulation of the PGC-1 α promoter region 
and subsequently its transcriptional expression (Barrès et al., 2012). In addition to increases 
in PGC-1α  expression, a number of whole body changes have been shown to be affected by 
exercise training including, aerobic capacity, lactate accumulation and, insulin sensitivity. 
 Hexokinase II gene expression 2.8.3.3.
The phosphorylation of glucose to glucose-6-phosphate is catalysed by hexokinase enzymes. 
These enzymes have a high affinity for glucose and are regulated by the feedback loop of 
glucose-6-phosphate. The hexokinase isoforms, hexokinase I and hexokinase II (HKII) are 
expressed in skeletal muscle (Lawrence & Trayer, 1985), with the latter more abundant (~6-
fold) compared to hexokinase I (Odoherty, Bracy, Osawa, Wasserman, & Granner, 1994). In 
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addition, the expression of HKII is fibre dependent with increased expression in slow 
compared fast twitch fibre skeletal muscle (Odoherty et al., 1994).   
The expression of HKII has been shown to be critical, as homozygous deficient rodents die 
during prenatal phase, while heterozygous deficient rodents present with severe glucose 
intolerance (Heikkinen et al., 1999). In contrast, overexpression of HKII increases insulin 
dependent and independent glucose uptake (Chang et al., 1996; Halseth, Bracy, and 
Wasserman, 1999). Insulin stimulation increases HKII mRNA expression in animal cell lines 
and humans (Mandarino et al., 1995; Printz et al., 1993). Mandarino and colleagues showed 
that insulin stimulation increased HKII mRNA concentrations by approximately 3-fold over 
basal levels, however the subsequent transcriptional responses observed did not affect HKII 
protein expression following a 4-hour hyperinsulineamic euglycemic clamp in healthy males 
(Mandarino et al., 1995). In contrast, individuals with NIDDM express both significantly 
lower mRNA concentrations of HKII, by as much as 3-fold, compared to healthy control 
subjects, therefore suggested that HKII expression is a secondary impairment to metabolic 
abnormalities in subjects with NIDDM (Vestergaard et al., 1995). 
 Ras-Associated diabetes 2.8.3.4.
Ras proteins are small GTP-ase activated proteins, which have been found to have multiple 
cellular functions, such as vesicle trafficking (Rudich and Klip, 2003). Ras Associated 
Diabetes (rRAD) is a member of the Ras superfamily and is increased upon insulin 
stimulation (~2-fold) in human skeletal muscle (Laville et al., 1996). rRAD has been termed 
based on the increases in gene expression in NIDDM patients, which has been speculated to 
be resultant of hyperinsulinemia observed in NIDDM populations insulin (Reynet & Kahn, 
1993). Both In vitro and in vivo research has further implicated rRAD in the reduced glucose 
uptake in both adipocytes and skeletal muscle cells (Moyers, Bilan, Reynet, and Kahn, 1996). 
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Table  2.3 Summary of the genes affected by insulin signalling 
Gene Summary References 
Peroxisome proliferator-activated receptor 
(PPAR)-γ coactivator – 1α (PGC-1-α) 
• Important mediator of mitochondrial 
biogenesis 
• Insulin stimulation increases PGC-1-α  
• PGC-1-α mRNA expression is reduced in 
NIDDM individuals 
• Overexpression of PGC-1-α increases 
insulin stimulated glucose uptake 
Jove et al., (2004), Mootha et al., (2003), Michael 
et al., (2001) 
Glucose Transporter 4 (GLUT4) • Insulin stimulated glucose transporter 
which aids facilitated glucose uptake 
• Highly expressed in insulin sensitivity 
tissues. 
• No difference in GLUT4 mRNA 
expression between healthy and NIDDM 
individuals 
Al-khalili et al., (2005), Zorzano et al., (2005) 
Hexokinase II (HKII) • Converting enzyme of glucose to glucose-
6-phosphate during anaerobic glycolysis 
• Insulin stimulation increases HKII 
expression by approximately 3-fold 
• Impaired HKII mRNA expression in 
NIDDM 
Vestergaard et al., (1995), Mandarino et al., 
(1995), Bouche et al., (2003) 
rRAD • rRAD involved in regulating vesicle 
trafficking 
• Increased mRNA expression in NIDDM 
• Increased rRAD expression reduces 
insulin stimulated glucose uptake 
Laville et al., (1996), Reynet & Kahn (1993) 
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2.13 Summary 
In summary, insulin stimulated glucose uptake in skeletal muscle is a major site of glucose 
disposal and the signalling cascade in which insulin initiates the translation of glucose 
transporters to the cell membrane for glucose uptake to occur is highly complex. The use of 
cell culture models has provided a platform for investigating the molecular basis of insulin 
stimulated glucose uptake. The use of tissue engineered skeletal muscle as a platform for 
investigating insulin signalling and glucose uptake is currently limited despite a rising interest 
in the use of these models for investigating skeletal muscle physiology. In order to further 
understand the potential role of these models for research in insulin signalling and glucose 
uptake, this thesis will firstly investigate if these models develop into mature skeletal muscle 
constructs which express the glucose transporters which are implicated in insulin stimulated 
glucose uptake.  The development of three dimensional tissue engineering using biological 
hydrogels as extracellular matrices in which cells and grow and differentiating into a bio 
mimetic models which recapitulates in vivo tissue could provide an alternative model to 
investigate both the molecular basis of insulin signalling and glucose uptake.    
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3 General Methodology 
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3.1. Cell Culture 
3.1.1 Cell culture  
All cell culture was performed in a class II microbiological flow hood under aseptic 
conditions. Cells were grown in a thermally controlled incubator (Thermo Scientific, Fisher-
Scientific, Loughborough, UK) (37ºC, 5% CO2) using standard growth medium (GM) 
(Dulbecco’s Modified Eagle’s Medium (DMEM) (Fisher- Scientific, Loughborough, UK), 
20% foetal bovine serum (FBS) (FBS Good, Dutscher Scientific, Germany), and 1% 
antibiotics (Penicillin/Streptomycin) (GIBCO/Invitrogen, Paisley, UK). Cells were grown in 
either T75 or T175 cell culture flasks (Fisher-Scientific, Loughborough, UK). The GM was 
changed every 2-3 days.  
3.1.2 Cell passage 
Once 80-90% confluence was attained, cells were counted and passaged. GM was removed 
and cells were washed 2X in PBS (Fisher-Scientific, Loughborough, UK). Trypsin-EDTA 
(TE) (Sigma-Aldrich, Dorset, UK) was used to detach cells from the flask surface. 
Detachment was confirmed by phase contrast microscopy. Double the volume of GM to TE 
was added to inhibit the action of the trypsin. The resultant solution was removed and placed 
into a test tube for cell counting. 
Cells were counted using a haemocytometer (Figure  3-1) using the equation below. An 
aliquot of cell suspension was added to an Eppendorf tube with trypan blue (Sigma-Aldrich, 
Dorset, UK). A volume of 10µl solution was placed into each chamber of the 
haemocytometer and counted under a phase contrast microscope (Leica DM IL LED, Leica 
Microsystems (UK) Ltd, Milton Keynes, UK). Cell count was determined by the number of 
cells within a sixteen square quadrant, in four quadrants. The total number of cells was 
determined by the total number of counted cells, dived by the number of quadrants, times the 
cell dilution factor. 
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Figure  3-1 A representative diagram of a haemocytometer used for counting of skeletal muscle cells. 
Image from life technologies. 
http://www.lifetechnologies.com/content/dam/LifeTech/migration/en/images/ics-
organized/references/cell-culture-basics/data-diagram/560.par.32479.image.557.637.1.counting-
cells-hemocytometer-gif.gif. Image downloaded on 14/01/2015. 
 
 
𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑐𝑐𝑐𝑐𝑇𝑇𝑇𝑇 𝑐𝑐𝑇𝑇𝑐𝑐𝑐𝑐𝑇𝑇 = �𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑁𝑁𝑇𝑇.𝑇𝑇𝑜𝑜 𝑐𝑐𝑐𝑐𝑇𝑇𝑇𝑇𝑐𝑐
𝑁𝑁𝑇𝑇.𝑇𝑇𝑜𝑜 𝑞𝑞𝑞𝑞𝑇𝑇𝑞𝑞𝑞𝑞𝑇𝑇𝑞𝑞𝑇𝑇𝑐𝑐�  × 𝐷𝐷𝐷𝐷 × 1 𝑥𝑥 10−4  × 𝐶𝐶𝑐𝑐𝑇𝑇𝑇𝑇 𝑠𝑠𝑐𝑐𝑠𝑠𝑠𝑠𝑐𝑐𝑐𝑐𝑠𝑠𝑠𝑠𝑇𝑇𝑐𝑐 (𝑚𝑚𝑚𝑚)4  
                                                 
4Df: Dilution factor is the proportion of cells suspension to trypan blue for counting. A 1:1 or 1:10 dilution was 
used for cell counting in this thesis 
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3.1.3 Freezing and cryopreservation of cells  
Excess cells were suspended in freezing media (90% GM with 10% DMSO) (DMSO, Fisher-
Scientific, Loughborough, UK) at 1 x 10-6 in cryovials (Corning, UK). Vials were placed in a 
‘Mr frosty’ (Fisher-Scientific, Loughborough, UK)5 and stored at -80ºC overnight before 
being placed in liquid nitrogen for long term cryopreservation. 
3.1.4 Resuscitation of cells 
Vials of cryopreserved cells were thawed by placing in a water bath at 37ºC until the cell 
solution had completely thawed. Cells were placed in cell culture flasks and grown as 
described above (Section  3.1.1). 
3.1.5 Monolayer experiments 
All monolayer experiments were conducted in 6 well cell culture plates (Fisher-Scientific, 
Loughborough, UK), unless otherwise stated. Cells were grown and passaged as previously 
described (Section  3.1.1  & 3.1.2). Cells were seeded at 15,000 cells·cm2 and grown in GM 
until 90% confluent before being changed to differentiation media (DM) (Dulbecco’s 
Modified Eagle’s Medium (DMEM) (Fisher- Scientific, Loughborough, UK), 2% horse 
serum (HS) (PAA, Somerset, UK), and 1% antibiotics (Penicillin/Streptomycin) 
(GIBCO/Invitrogen, Paisley, UK) for a period of 72 hours in order enable fusion of 
myoblasts into multinucleated myotubes. Chronic insulin exposure experiments 
differentiation media was supplemented with 100 nM of human recombinant insulin (Sigma-
Aldrich, Dorset, UK). All differentiation media was sterile filtered prior to use.   
  
                                                 
5 Storage of vials in this container provides a -1°C per minute cooling rate for reliable and repeatable 
cryopreservation and recovery of cells. 
49 
 
3.2 Tissue engineering skeletal muscle constructs 
The following Sections outline the methodologies used for the culture of two different 
skeletal muscle tissue engineering constructs. Both fibrin and collagen methods have 
previously been described within the literature from which these methods have been used 
with some slight modifications (Martin et al., 2013; Smith et al., 2012).  
3.2.1 Development of fibrin based tissue engineered constructs 
 Preparation of reagents 3.2.1.1.
All aliquots were thawed at 37°C unless otherwise stated. Fibrinogen was reconstituted in 
Hams F12 media (Sigma-Aldrich, Dorset, UK) at a concentration of 20 mg·mL and left to 
completely dissolve at room temperature. Prior to plating, fibrinogen was sterile filtered 
through a 0.45 µm syringe filter. Thrombin (Sigma-Aldrich, Dorset, UK) was dissolved in 
un-supplemented DMEM at a concentration of 200 U/mL. Aprotinin (Sigma-Aldrich, Dorset, 
UK) was dissolved in distilled water (dH2O) at a concentration of 10 mg·mL and sterile 
filtered prior to use. Powdered aminocaproic acid (Sigma-Aldrich, Dorset, UK) was dissolved 
in un-supplemented DMEM at a concentration of 50 mg·mL. 
 Preparation of sylgard plates 3.2.1.2.
Standard 35mm falcon petri dishes (VWR, Leicestershire, UK) coated with Sylgard (Sylgard 
184 elastomer kit, Dow Chemical, USA) according to the manufacturer’s instructions and 
allowed to cure for one week at room temperature. 
Two 6mm long pieces of silk suture were placed 12mm apart in pre-treated plates and 
anchored into place with stainless steel minutien pins (Figure  3-2). Plates were sterilised 
under UV light for 60 minutes before being rinsed in 70% ethanol for 60 minutes. 
 Tissue engineering of skeletal muscle in fibrin based gels 3.2.1.3.
Thrombin solution was made with growth media (DMEM, 20% FBS, 1% P/S), supplemented 
with 50 µl·mL of thrombin and, 4 µl·mL of aprotinin. Thrombin solution (500 µl·plate) was 
placed around both silk sutures before being evenly distributed evenly across the plate by 
gentle agitation. Fibrinogen was sterile filtered before 200 µl was placed around the plate. 
The solutions were mixed by gentle agitation before being allowed to stand at room 
temperature for 15 minutes. Plates were placed in the culture incubator for 1 hour. Cells were 
passaged (Section  3.1.2) as previously described and seeded at 10,000 cells·cm2 in GM 
supplemented with 250 mg/mL of aminocaproic acid (AA). In order to ensure longevity of 
the three-dimensional constructs, growth, differentiation and maintenance media were 
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supplemented with aminocaproic acid unless otherwise stated. The media was changed every 
other day until confluence was attained. Upon confluence (80-90%) media was changed to 
DM for 2 days before being placed in maintenance media (DMEM, 7% FBS, P/S, AA) for 
the remainder of the experiment (10 days). The media was replaced every 1-2 days. 
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Figure  3-2 A prepared plate for use in fibrin based tissue engineered construct. Falcon plates were 
layered with sylgard and allowed to cure prior to fixation of silk suture by two steel miniature pins. 
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3.2.2 Collagen based tissue engineered constructs 
The formation of collagen constructs using C2C12 skeletal muscle cells was based on 
previous literature (Player et al., 2014; Sharples et al., 2012), with some slight 
modifications.C2C12 
 Formation of flotation bars and anchor frames (A-Frames) 3.2.3.1.
Flotation bars were made by binding two 5x3 mm Sections of polyethylene plastic mesh 
(Darice Inc., Strongsville, Ohio, US) together using stainless steel dental wire (Scientific 
Wire Company, Great Dunmow, UK). The A-frames were constructed using 0.7mm thick 
stainless steel wire (Scientific Wire Company, Great Dunmow, UK) and fitted between the 
two bound pieces of plastic mesh (Figure  3-3A). Prior to use, floatation bars were washed 
with 70% ethanol and sterilised under UV light. 
A-frames were hooked over the edge of an 8-well square reservoir cell culture plate (NUNC, 
Thermo-Scientific, Fisher-Scientific, Loughborough, UK) (well dimensions: L37.6mm x 
W27.9mm x D11.6mm) (Figure  3-3B). Sylgard and a-cellular collagen were used to create 
moulds within the plates to set the collagen gel between the A-frames. 
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Figure  3-3 A prepared plate for use in collagen based tissue engineered construct. . A-frames (A) 
were constructed and placed within reservoir cell culture plates (B). Collagen gels (1mL) were set 
between A-Frames and cultured for 14 days (C). Diagram modified from Smith et al., (2012). 
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 Development of Collagen gels 3.2.5.1.
The preparation of collagen gel tissue engineered skeletal muscle constructs has been 
previously described in the literature (Cheema et al., 2003; Mudera et al., 2010; Sharples et 
al., 2012). In brief, cells were passaged and counted as previously described (Section  3.1.2). 
Cells at a density of 4x10-6 per mL were centrifuged at 2000 rpm for 5 minutes. A solution of 
type I rat tail collagen (2.6 g·mL-1, first link, Birmingham, UK), and 10X minimal essential 
medium (MEM) (GIBCO/Invitrogen, Paisley, UK) was neutralised in a drop wise manner 
using 1M and 5M sodium hydroxide (NaOH) (Fisher-Scientific, Loughborough, UK) 
respectively. Cells were homogenised with neutralised collagen solution, before being set in 
pre-sterilised chamber slides between the two A-frames. The constructs were allowed to set 
for 10-15 minutes in an incubator (37°C, 5% CO2) before being re-suspended in GM. The 
media was changed twice daily during the attachment phase before being changed to 
differentiation media (DMEM, 2% HS, 1% P/S), which was subsequently changed daily for 
the remainder of the culture period (10 days) (Figure  3-3C). 
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3.3. Transcriptional analysis 
3.3.1 Principle 
Transcriptional activity precedes translation of protein in response to external stimuli (Perry 
et al., 2007). Extraction of mRNA from lysates can be amplified by polymerase chain 
reaction (PCR) to investigate expression of specific target genes.  
3.3.2 RNA extraction of monolayer lysates 
RNA was extracted from samples using the TRIZOL method according to manufacturer’s 
instructions (Sigma-Aldrich, Dorset, UK). Samples were lysed in TRI reagent and titrated 
several times to form a homogenous sample. Samples were transferred to RNase free 
Eppendorf tubes and stored at -80ºC for subsequent RNA purification. In order to separate 
RNA from DNA and protein, samples were thawed at room temperature for 5-10 minutes. 
Once a completely homogenous liquid, 0.2 mL of chloroform (Sigma-Aldrich, Dorset, UK), 
per 1 mL of TRI reagent used was added. Samples were homogenised for 15 seconds before 
being left to stand for 15 minutes at room temperature. The samples were centrifuged for 15 
minutes at 12,000 g (4ºC) in order to separate liquid into RNA, DNA and, Protein phases 
respectively. The upper aqueous phase containing RNA was removed and placed into 
separate RNase free Eppendorf tubes with 0.5 mL 2-propanol (Sigma-Aldrich, Dorset, UK), 
per mL of TRI reagent used. Samples were left at room temperature for 10 minutes before 
being centrifuged at 12,000 g (4ºC). The supernatant was removed leaving the RNA pellet. 
The RNA pellet was washed in 1 mL of 75% ethanol and centrifuged at 7,500 g for 5 minutes. 
Excess supernatant was removed and samples were allowed to air dry for 10 minutes before 
being homogenised in RNAse free water (Sigma-Aldrich, Dorset, UK). Samples were stored 
at -20ºC for later PCR analysis. The concentrations (ng/µl) and purity of RNA samples were 
determined using UV spectroscopy (Nanodrop, Fisher Scientific, Loughborough, UK). 
Samples were deemed to be of sufficient RNA purity when they possessed an A260/A280 ratio 
of ≥1.7. All samples were analysed in duplicate. 
3.3.3 RNA extraction of tissue engineered constructs 
Tissue engineered constructs were prepared for RNA extraction by washing in PBS and blot 
dried to remove excess PBS. Constructs were placed in RNAs free tubes containing Trizol. 
Prior to extraction, constructs were homogenised using a handheld homogeniser in order to 
breakdown the extracellular matrix. The homogeniser was washed in dH2O, 70% ethanol, and 
dH2O between each construct. RNA extraction was performed as described above 
(Section  3.3.2). 
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3.3.4 Primer design 
Primers were synthesised by Sigma Aldrich in according with guidelines outlined below 
(Table  3-1). Primers were purchased from Sigma-Aldrich and were reconstituted to a 
concentration of 100 µM in Tris-EDTA buffer (Sigma-Aldrich, Dorset, UK) as recommended 
by the manufacturer. The primers and their respective sequences used for this thesis are 
outlined below (Table  3-3). Primer specificity was confirmed by BLAST search 
(http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) and primer specificity with their respective 
target genes were confirmed by melt-curve analysis following the PCR run (Section  10.1), 
and by identification through agarose gel electrophoresis as described below (Section  3.3.7).  
 
Table  3.1 Considerations and guidelines for primer design using quantitative-PCR. 
 
  
Consideration Guideline 
Primer Length 18-24 base pairs 
Amplification Length ≤ 200 base pairs long 
% GC content 40-60% 
Annealing Temperature (Tm) 60°C is the optimal annealing 
temperature for SYBR 
quantifast chemistries 
General Consideration Primers should span exon-exon 
boundaries 
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3.3.5 Conventional and Real-Time PCR (PCRRT) analysis 
Gene expression was analysed using One-step PCR (Stratagene Mx3005P, Aglient 
Technologies, Cheshire, UK). RNA samples were diluted in a concentration of 70 ng in 9.5 
µl. PCR reactions were made to a total reaction volume of 20 µl. Master mix was made up 10 
µl of Syber green fluorescent mix, and 0.2 µl RT mix (Qiagen Chemistries, Crawley, UK) 
and 0.15µl forward and reverse primers respectively. The specific primers sequences are 
outlined below (Table  3-3) and are described with each Chapter. A one-step thermal profile 
was used as outlined in the table below (Table  3-2). Primer specificity was assessed by 
running a dissociation/melt phase at the end of the profile or by agarose gel electrophoresis 
(Section  3.3.7). An example of Ct profile and dissociation/melt curves can be found in 
appendices A. 
 
Table  3.2 Thermal profile setup for one-step PCR using Stratgene Mx3000P 
Profile Stage Temperature Duration of cycling 
(min:sec) 
Denaturation 50ºC 10:00 
Initial Activation 95ºC 05:00 
Two step-cycling (40 cycles)   
Denaturation 95ºC 00:10 
Annealing and Extension 60ºC 00:30 
  
3.3.6 qPCR data analysis 
Gene expression data were analysed using the ΔΔCt method as previously described (Livak 
and Schmittgen, 2001; Schmittgen and Livak, 2008). The principle involves the use of a 
normalisation gene, or reference gene to compare changes in expression between conditions. 
All gene expression data were compared to RNA polymerase II β (RPII-β) which has been 
reported as a suitable reference gene for when conducting qPCR analysis (Radonić et al., 
2004), and has previously been used as a reference gene when conducting experiments with 
the C2C12 myoblast cell line (Sharples et al., 2011). 
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Table  3.3 primer sequences of mouse mRNA genes used for one-stop qPCR 
  
Gene Primer Sequence Accession No: 
RNA Polymerase II -Beta (RPIIβ) F: 5’-GGTCAGAAGGGAACTTGTGGTAT 
R: 5’-GCATCATTAAATGGAGTAGCGTC 
NM_153798 
Myogenin (MyoG) F: CCAACTGAGATTGTCTGTC  
R: GGTGTTAGCCTTATGTGAAT  
NM_031189 
Myocyte enhancer factor 2a (MEF2a) F: TAGCGGAGACTCGGAATT 
R:  GCTGCCGTTGAAATTGTC 
NM_001033713 
Peroxisome Proliferator-Activated coactivator (PGC1-α) F: 5’-AGACTATTGAGCGAACCT 
R: 5’-TATGAGGAGGAGTTGTGG 
NM_008904.2  
 
Hexokinase II (HKII) F: 5’- GGAGGAGGAGCAGTATGG 
R: 5’-TTCAGCCGTGTGAGGTAA 
NM_013820 
GLUT4 F: 5’-CATCAGGATAAACAGCAGGG 
R: 5’-GGAGGCAGGGCTAGATTT 
NM_011480 
GLUT1 
 
F:  CAGAGGCTTGCTTGTAGAG 
R:  GTCACCTTCTTGCTGCTG 
NM_011400 
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3.3.7 Agarose Gel Electrophoresis  
If a melt curve analysis was not conducted, PCR products were determined through agarose 
gel electrophoresis. Two percent agarose gels were prepared in 1X Tris Borate EDTA (pH 
8.3) (TBE) and heated until a homogenous solution. SYBR safe staining solution (Thermo 
fisher, Fisher Scientific, Loughborough, UK) was added and gels were subsequently allowed 
to set for approximately 30 minutes in casting trays. PCR products were mixed with 6X DNA 
loading dye (Thermo fisher, Fisher Scientific, Loughborough, UK) and 10 µl of sample 
loaded into each well and 10 µl of DNA reference ladder (Thermo fisher, Fisher Scientific, 
Loughborough, UK) was loaded at the end of each gel. Gels were run at 110 volts for 
approximately 60 minutes before being visualised using a Chemi-Doc image analyser (Bio-
Rad) and Lab View analysis software (Lab View Version 4.1, Bio-Rad) (Figure  3-4). 
 
 
Figure  3-4 Agarose gel electrophoresis of PCR products alongside non-template controls (NTC). 
Ladder: 100 base pairs (bp). 
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3.4. Immunohistochemical Analysis 
3.4.1 Immunofluorescence Staining 
Myoblast numbers and fusion efficiency were determined through immunocytochemical 
staining of samples. In brief, cells were washed in cold PBS before being incubated in a 1:1 
solution of cold PBS and fixative (1:1 methanol/acetone) solution (Fisher-Scientific, 
Loughborough, UK). The solution was removed and replaced with 100% fixative for five 
minutes before being washed twice in PBS and stored for later analysis. Samples were 
blocked and permeabilised using 1X TRIS buffered saline solution (TBS), 5% goat serum 
(GS) and, 0.2% Triton X-100 for one hour. Coverslips were washed in TBS three times 
before being incubated for one hour at room temperature with a polyclonal, IgG, rabbit anti-
mouse Desmin antibody (anti-desmin antibody, ab15200, Abcam, Cambridge, UK) diluted 
1:200 in TBS (+2% GS and 0.2% Triton X-100). Samples were again washed in TBS before 
being incubated in a darkened chamber with a polyclonal goat anti-rabbit IgG antibody 
conjugated to TRTIC (, ab35181, Abcam, Cambridge, UK) diluted 1:200 in TBS (+2% GS 
and 0.2% Triton X-100). Nuclei were identified using a florescent DNA binding probe 4',6-
diamidino-2-phenylindole, (DAPI) (Sigma-Aldrich, Dorset, UK), diluted 1:10,000 in purified 
water (dH2O) for 15 minutes. Coverslips were washed in dH2O before being mounted onto 
glass coverslips (Fisher-Scientific, Loughborough, UK) with 1µl of mounting medium 
(Fisher-Scientific, Loughborough, UK) and left to dry before being imaged by fluorescent 
microscopy. 
3.4.2 Image Analysis 
Images were obtained a fluorescent microscope (Leica DM 2500, fluorescent microscope, 
Leica DFC360 FX camera, Leica, Milton Keynes, UK).  Images were obtained under X20 
focus and analysed using image processing software (ImageJ, Version 1.46, 
http://rsbweb.nih.gov/ij/index.html). Cumulative frequency analysis was used to determine 
the number of images required from each slide. Images were analysed for the total number of 
myotubes per image, myotube width, and the number of nuclei formed into the myotubes.  
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3.5. Protein Extraction and Quantification 
3.5.1 Principle 
Exposure to various stimuli can result in the post-translational modification or re-localisation 
of cellular proteins. As a result the expression and phosphorylation of these proteins was 
investigated by the western blot technique. The technique of western blotting has been used 
for several decades in order to identify proteins of interest, which involves the separation of 
proteins by their molecular weight in kilo Daltons (kDa) through sodium-dodecyl-sulphate 
polyacrylamide gels (SDS-PAGE). 
3.5.2 Protein extraction in monolayer culture 
Cells were lysed in 200µl of protein lysis buffer protein lysis buffer (50mM HEPES, 150 mM 
NaCl, 1.5 mM MgCl2, 1 Mm EGTA, 50 mM NaF, 50 mM β-glycerolphosphate, 1 mM Na3-
VO4, 1% Triton X-100 and 2 mM PMSF) or RIPA lysis buffer (150 mM NaCl, 1.0% NP-40, 
0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0.). Cells were mechanically lifted 
by cell scraping from the well surface into a 1.5 mL Eppendorf and stored at -80°C ready for 
subsequent protein quantification. The specific lysis buffer are described in the respective 
Chapters and quantified using the protein assay as outline below (Section  3.5.5). 
3.5.3 Cellular protein extraction from collagen gels 
Following the experimental protocol, constructs were washed in cold PBS and blot dried 
before being snap frozen in liquid nitrogen. Samples were stored at -80°C until analysis. 1X 
laemmli buffer was added to samples, which were mixed by orbital rotation at 40 rpm for 60 
minutes at 4°C in order to dissolve cellular material. 250 µl of 100% 2-propanol per 500 µl of 
laemmli lysis buffer was added and samples were centrifuged at 17,000 g for 10 minutes. The 
supernatant was discarded and the pellet was re-suspended in 300 µl of laemmli lysis buffer 
and allowed to rotate for a further 60 minutes at 40 rpm at 4°C. Samples were centrifuged for 
5 minutes at 13,000 g after which, the supernatant was removed and placed in a fresh 
Eppendorf tube and quantified as described (Section  3.5.5). 
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3.5.4 Extraction of cellular protein from fibrin gels 
Other laboratories have successfully extracted and blotted for protein using fibrin tissue 
engineered constructs (Khodabukus and Baar, 2009a). Therefore, protein extraction was 
conducted as previously described (Khodabukus and Baar, 2009a) with some slight 
modifications. Following 14 days in culture, constructs were washed in cold PBS before 
being removed from sutures, blot dried, snap frozen in liquid nitrogen, and stored at -80°C 
for later analysis. Samples were homogenised in lysis buffer. In order to ensure continuity, 
protein extracted using the RIPA lysis buffer (Section  3.5.2), or a sucrose lysis buffer 
described by Khodabukus and colleagues (Khodabukus and Baar, 2009b). Samples were 
mixed in the respective lysis buffer by orbital rotation for 1 hour at 4°C. Lysates were briefly 
homogenised and centrifuged down for 1 minute at 11,000 g. The supernatant was aspirated 
and placed in a separate Eppendorf tube and protein concentration quantified as previously 
described (Section  3.5.5). Protein concentrations were found to be greater using RIPA lysis 
buffer compared to sucrose lysis buffer (Figure  3-5) (t = 5.586, P<0.001). Subsequently, 
samples lysed in RIPA buffer when loaded onto 8% SDS-PAGE gels at serial dilutions of 
protein (0-20 µg protein) with laemmli loading buffer to identify the optimum loading 
concentration of protein (Figure  3-6). 
 
Figure  3-5 Protein concentrations of 14 day old fibrin skeletal muscle constructs using RIPA or 
Sucrose lysis buffers. Data are mean ± SD from four constructs (N=4). * Significance P < 0.001. 
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3.5.5 Protein quantification 
Protein quantification was determined using a pierce 660 nm protein assay according to the 
manufacturer’s instructions (Thermo Scientific, Fisher, Loughborough UK). Protein 
concentrations were determined against serially diluted BSA standards. Samples and 
standards (10µl) were analysed in triplicated in a 96 well plate with 150µl of assay reagent. 
Samples were shaken for 1 minute and incubated at 22°C for 5 minutes and measured at an 
absorbance of 660nm.  
3.5.6 SDS-PAGE Silver Staining Protocol 
 Principle 3.5.6.1.
Silver staining provides a simple and cheap method of detecting proteins particularly at low 
concentrations (nano-gram range) making it a highly sensitive method (Chevallet, Luche, and 
Rabilloud, 2006). Because proteins bind to silver ions, silver-staining SDS-PAGE gels results 
in visualisation of protein separation through the gel (Chevallet et al., 2006). Protein 
extraction from tissue engineered constructs has presented some complications with regards 
to the concentrations of protein, particularly from fibrin gels (Figure  3-7), but also the clear 
separation of protein extracted from collagen gels, (due to the high concentration of 
extracellular matrix) has led to difficulties presenting clear western blots from these 
constructs (Player, 2013). Based on these factors, silver-staining was conducted with serial 
dilutions of protein from fibrin and collagen gels were separated by SDS-PAGE to establish a 
suitable concentration of protein to investigate what the optimal concentration protein could 
be used to ensure clear separation of proteins throughout the SDS-PAGE gel.  
 Silver staining protocol 3.5.6.2.
In brief, following electrophoresis, the gel was removed from the glass plates, and washed in 
ultrapure water before being incubated for 1 hour in fixative solution (40% ethanol, 10% 
acetone, 50% dH2O). The gel was washed in ethanol and sensitising solution (30% Ethanol, 
10% Sensitizer, 60% dH2O) for 10 minutes. The gel was again washed in 30% ethanol for 10 
minutes followed by further 10 minutes incubation in dH2O. Staining solution (1% Stainer, 
99% dH2O) was applied for 15 minutes. Following aspiration of the staining solution the gel 
was briefly washed in dH2O and incubated in developing solution for 5 minutes. The reaction 
of the developing solution was arrested by the addition of stop solution. The gel was rinsed in 
ultrapure water for 10 minutes before being exposed under white transilluminecant light 
(Chemi-Doc, Bio-Rad, UK).  
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Figure  3-6 Silver stain with serial dilutions of cellular protein (µg). A: Collagen gels B; Fibrin Gels. 
Collagen gels (A) presented clearer protein separation at lower (5µg & 10µg) protein concentrations. 
Fibrin gels (B) showed clear separation at all concentrations of protein. Bands observed in figure B 
at 0µg are potentially a result of overspill within adjacent lanes. Lower concentrations of protein 
(5µg) were used for subsequent western blot analysis in both tissue engineering skeletal muscle 
models Image is of 1 experimental repeat. 
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3.5.7 Western Blotting 
Cells lysates were mixed in Laemmli buffer (4 mL H2O, 1 mL 1M TRIS HCl pH 6.8, 0.4 mL 
Glycerol, 0.4 mL 2-β-mercaptoethanol, 0.05% bromophenol blue), and boiled for 5 minutes 
at 95ºC. A volume equivalent to 20 µg of sample for monolayer experiments was  loaded into 
SDS-polyacrylamide gels (SDS-PAGE) (4% stacking (6.05 mL H2O, 1.3 mL 30% 
Acrylamide, 2.5 mL 1.5 M Tris HCl, pH 6.8, 0.2 mL 10% SDS, 0.1 mL ammonium 
persulfate (APS), 10 µl TEMED), and 12% resolving gels (6.7 mL H2O, 8mL 30% 
Acrylamide, 5mL 1.5 M Tris HCl, pH 8.8, 0.1 mL 10% SDS, 0.05 mL APS, 10 µl TEMED). 
Samples were separated in Tris-glycine running buffer (1:10 10X Running buffer, 1 L dH2O, 
30.3 g Tris-Base, 144 g Glycine, 10 g SDS) using Bio-Rad mini proton electrophoresis kits 
(Bio-Rad laboratories, Hertfordshire, UK). Voltage was set at 80V through the stacking gel 
and 120V through the resolving gel, until the proteins had ran to the bottom of the gel.  
Gels were wet transferred onto nitrocellulose membranes (Whatman Proton, Sigma-Aldrich, 
Dorset, UK), for 2 hours at a constant amplitude (0.35 Amps). Membranes were blocked (5% 
BSA/TBS) for 1h at 4ºC and rinsed three times in TBST (50 mL 5X TBS, 450 mL dH2O, 50 
µl Tween), before being incubated with primary antibody overnight at 4ºC. Details of the 
antibodies used and concentrations can be n in table 3.2. Following overnight primary 
antibody incubation, membranes underwent further 3 x 5 minute washes and were 
subsequently incubated for 1 hour with anti-rabbit horseradish peroxidase-conjugated 
secondary antibody in 5% Milk TBST (Table  3-4). 
Following secondary antibody incubation membranes were washed as above and incubated in 
chemiluminescence  reagent (ECL) (Supersignal, Thermo Fisher Scientific, Rockford, IIL, 
USA) for five minutes before being exposed using Bio-Rad Chemi-doc system (Bio-Rad 
Laboratories Ltd, Hertfordshire, UK). Band Densities were quantified using Quantity One 
image analysis software (Quality One 1-D analysis software version 4.6.8, Bio-Rad 
Laboratories Ltd, Hertfordshire, UK). 
 Protein separation in tissue engineered skeletal muscle constructs 3.5.7.1.
For tissue engineered constructs, dose dependent concentrations of protein was separated by 
SDS-PAGE (8% resolving gels), which have previously be used within the literature to 
investigate protein expression with fibrin based skeletal muscle tissue engineered constructs 
(Khodabukus and Baar, 2012, 2014a). SDS-PAGE gels were silver stained using a 
commercially available kit according to the manufacturer’s recommendations which is 
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outlined in Section 8expression 3.5.6.2 (Invitrogen, Life-Technologies, CA, USA) or 
transferred onto nitrocellulose membranes as described above and blotted for the expression 
of total Akt which is one of the main target proteins in this thesis. From both silver staining 
and western blots, it was determined that 5 µg of protein was sufficient for protein separation 
as well as quantification of western blots in both types of construct (Figure  3-7).  
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Table  3.4  Primary and Secondary antibodies used for immunoblotting in this thesis. 
Antibody Company Product No. Isotype Concentration Molecular Weight 
(kDa) 
Insulin Receptor 
Substrate 1 (IRS-1) 
Santa Cruz Biotech SC-559 Rabbit 1:1000 170-185 
Phosphor IRS-1 (Try632) Santa Cruz Biotech SC-17196 Rabbit 1:1000 170-185 
P85 PI-3 kinase Cell Signalling #4292 Rabbit 1:1000 85 
Akt Cell Signalling #9272 Rabbit 1:1000 60 
Phosphor Akt (Ser473) Cell Signalling #9271 Rabbit 1:1000 60 
Phosphor Akt (Thr308) Cell Signalling #9275 Rabbit 1:1000 60 
Glucose Transporter 4 
(GLUT4) 
Santa Cruz Biotech SC-7938 Rabbit 1:1000 50-63 
Beta-Actin (β-Actin) Cell Signalling #4967 Rabbit 1:1000 45 
      
Secondary Antibody      
Anti-rabbit IgG – HRP Cell Signalling #7074 Rabbit 1:1000 - 
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Figure  3-7 Immunoblot for total Akt with dose dependent protein concentrations (µg) from 14 day old 
A) collagen and B) fibrin gels. 
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3.5.8 Immunoprecipitation of Insulin Receptor Substrate-1 (IRS-1). 
 Principle 3.5.8.1.
The molecular weight of the IRS-1 protein has been determined to be 135kDa however, the 
high serine phosphorylation of IRS-1 results in migration to 185kDa when separated by SDS-
PAGE (White, 1998). Initial attempts to quantify the IRS-1 protein from western blots were 
unsuccessful; previously research has employed immunoprecipitation of the IRS-1 protein in 
order to quantify its phosphorylation status by western blot (Ma et al., 2013). 
 Immunoprecipitation of IRS-1 3.5.8.2.
Samples were lysed in 500 µl of RIPA buffer (Sigma-Aldrich, Dorset, UK) and 10 µl/mL of 
protease/phosphatase inhibitor cocktail mix (Fisher-Scientific, Loughborough, UK) and 
rotated for 30 minutes at 4ºC before being frozen at -80ºC for later analysis. 
Samples were sonicated at output 3 and 50% duty cycle for 10-30 pulses in order to 
completely homogenise the tissue within the lysis buffer. Samples were rotated for 60 
minutes at 4ºC before being quantified using Pierce Protein Assay as previously described 
(Section  3.5.5). 
1mg of total protein was diluted to 4 µg/µl in RIPA buffer and protease/phosphatase inhibitor 
cocktail mix. Samples were ‘pre cleared’ through adding 50 µl of protein A-conjugated 
agarose beads (Santa Cruz Biotechnology, CA, USA) and  rotated for 60 minutes at 4ºC. 
Samples were centrifuged at 4000 rpm for 10 minutes at 4ºC. The supernatant was aspirated 
and incubated overnight with 5 µl of insulin receptor substrate (IRS-1) or phosphor IRS-1 
(Tyr632) antibody at 4ºC (Santa Cruz Biotechnology, CA, USA). 
Following overnight incubation a further 50µl of protein agarose beads and samples were 
allowed to rotate for 60 minutes at 4ºC. Samples were washed three times by centrifugation at 
2500 rpm for one minute, following which the supernatant was discarded and replaced with 
fresh RIPA + protease/phosphatase inhibitor buffer. Following aspiration of the wash buffer 7 
µl of 3X reducing buffer (0.35 M Tris-HCl, 10% SDS, 36% Glycerol, 5% β-mercaptoethanol, 
0.012% bromophenol blue and 0.3% Tween-20) was homogenised with the sample and 
boiled for 5 minutes at 95ºC before being loaded onto SDS polyacrylamide gels for 
immunoblotting (Section  3.5.6).  
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3.5.9 Migration front 
A migration front was calculated (Figure  3-8) based on the distance travelled from the top of 
the gel to the point of the visual bands to confirm the visualised band was the protein of 
interest. The reference point was determined based upon the migration of the molecular 
weight ladder (New England Bio labs, Herts, UK). 
 
Figure  3-8 Migration front calculation based on distance of known molecular weight ladder. 
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3.5.10 Stripping and Re-probing of Nitrocellulose Membranes 
Due to the limited concentration of proteins which were extracted from cultures, it was 
necessary to maintain nitrocellulose membranes to investigate other proteins of interest. 
Therefore a membrane stripping method was used to remove primary and secondary antibody 
from the membrane for subsequent analysis of different proteins of interest.  
Following visualisation, nitrocellulose membranes were washed three times for 5 minutes in 
TBST. Membranes were agitated by rocking (60 rpm), twice for ten minutes in stripping 
buffer (0.15% Glycine, 0.01% SDS, and 10% Tween-20, pH 2.2) (Figure  3-9). Following the 
respective washes in stripping buffer, membranes were washed in TBST, before being 
blocked in BSA as previously described (Section  3.5.6) and incubated overnight at 4°C with 
appropriate primary antibody. 
 
 
 
 
Figure  3-9 Exposed nitrocellulose membranes pre (A) and post (B) membrane stripping protocol 
  
A B 
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3.6. Glucose Uptake Analysis 
3.6.1 Measurement of 3H-Deoxy-D-Glucose uptake in cell culture. 
Following four hours serum starvation, experimental plates were washed twice with Krebs 
Ringer HEPES (KRH) buffer and incubated for 15 minutes in the presence or absence of 100 
nM insulin. Glucose uptake was determined by the addition of 3H-Deoxy-D-Glucose (0.1 
mM, 0.5 µCi/mL; PerkinElmer Life and Analytical Science). After incubation, glucose 
uptake was stopped by the addition of 10 µM cytochalasin B (Sigma-Aldrich, Dorset, UK) in 
PBS. Cytochalasin B inhibits actin remodelling and subsequent vesicle trafficking of proteins 
from the cytoplasmic region to the plasma membrane (Jung & Rampal, 1977; Klip & Walker, 
1983). This inhibitor is repeatedly used within the literature as an inhibitor in order to prevent 
GLUT4 mediated glucose uptake. The cells were washed twice in PBS and lysed in 0.2 M 
NaOH, PBS. Glucose uptake was measured by liquid scintillation counting (Packard-Bell).  
Cytochalasin B (10 µM) is added to scintillation fluid for the measurement of nonspecific 
background. Total protein was also quantified in concurrent 24 well plates using the protein 
assay described previously (Section  3.5.5). 
3.6.2 Measurement of 3H-Deoxy-D-Glucose uptake in tissue engineered constructs 
Glucose uptake was measured as previously described (Baker et al., 2003), with some slight 
modifications. Following four hours serum starvation, experimental plates were washed twice 
with Krebs Ringer HEPES (KRH) buffer and either incubated for 30 minutes in the presence 
or absence of 100 nM insulin. Glucose uptake was determined by the addition of 3H-Deoxy-
D-Glucose (0.1 mM, 1 µCi/mL; PerkinElmer Life and Analytical Science). After incubation, 
the reaction was arrested by the addition of 10 µM cytochalasin B in PBS. Constructs were 
removed from the sutures, blotted and weighed. Individual constructs were dissolved in a 
1:10 (wt./vol) dilution of 1 M potassium hydroxide (KOH) solution, placed in boiling water 
for 2 min,  placed on ice for 5 min. Samples were neutralized by adding 1 M HCI in a 1:10 
(wt./vol) dilution of construct wet weight. Samples were homogenised with 250 µl solution 
added to scintillation fluid. Uptake was analysed by scintillation counting as described above 
(Section  3.6.1 ). 
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3.6.3 Calculating 3H-Deoxy-D-Glucose uptake in culture 
The following calculations were used to determine the concentrations of 3H-Deoxy-D-
Glucose uptake in both monolayer cultures and tissue engineered constructs. In order to 
Definitions and abbreviations of radioactive isotopes used for calculating glucose uptake  
• Curie (Ci): Is a unit of radioactivity, 1 Curie is defined as 3.7 X 10-10 disintegration 
per second (dps). 
• Disintegrations per minute (dpm): A unit of measurement which is directly 
obtained from the liquid scintillation counter. 
• Specific Activity (SA): the amount of radiolabelled mass within a sample (Ci·mmol) 
The calculation of curies (Ci) was determined using based on the conversation between the 
disintegrations per minute (dpm) which were given as the standard output from the 
scintillation counter. 
1Ci = 3.7 x 10-10 Bq = 3.7 x 10-10 disintegrations per second (dps) = 2.22 x 10-12 dpm 
Conversion of dpm to Ci =  𝑞𝑞𝑑𝑑𝑑𝑑
2.22 × 10−12  
Conversation of Ci to moles = 𝐶𝐶𝑇𝑇𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑇𝑇𝐶𝐶𝑇𝑇𝑇𝑇𝑠𝑠𝑇𝑇𝑐𝑐 𝑇𝑇𝐷𝐷 𝑔𝑔𝑇𝑇𝑐𝑐𝑐𝑐𝑇𝑇𝑠𝑠𝑐𝑐 (𝑚𝑚𝑚𝑚𝑇𝑇𝑇𝑇) × 10−6  ×(1𝑚𝑚𝑚𝑚𝑇𝑇𝑇𝑇 ÷ 𝑆𝑆𝑆𝑆) 
 
3.7. Statistical Analysis 
Statistical analysis was conducted using SPSS statistical software package (IBM SPSS, 
Version 19, NY, USA). Specific statistical analysis is outline within the respective Chapters 
of this thesis. 
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4. Method Optimisation: Measurement of glucose uptake in C2C12 
skeletal muscle cells using radioactive isotopes and fluorescent based 
methods. 
 
 
Preface: The following brief Chapter outlines the investigation and optimisation of two 
methods for the quantification of cellular glucose uptake using radioactive isotope tracers 
and fluorescent based glucose assays. 
Acknowledgement: I would like to thank Dr Joan Sutherland, Dr Julie Turner and Professor 
David Reid at the centre for environmental radiochemistry in the School of Science 
(Chemistry) for their help, support and expertise, and for providing the laboratory space for 
me to be able to carry out the radioactive isotope experiments which were conducted in this 
Chapter, and the subsequent experimental Chapters of this thesis.   
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4.1. Introduction 
Glucose uptake is controlled by distinct mechanisms (Krook, Wallberg-Henriksson, 
and Zierath, 2004). As glucose is non-permeable to the plasma membrane, an increase in 
glucose concentrations results in an increase in insulin concentrations in order to initiate 
glucose transporter exocytosis and facilitate glucose uptake into the cell (Leto and Saltiel, 
2012). The quantification of glucose uptake has provided a better understanding of the rate of 
glucose uptake and metabolism both in vivo and in vitro (Hansen, Gulve, and Holloszy, 1994; 
Sell, Jensen, and Eckel, 2012). Two methods have previously been used within the literature 
for the quantification of glucose uptake, using either fluorescence based glucose analogues 
(Manchester et al., 1990), and more conventionally, the use of radioactive isotopes for 
investigation of insulin sensitive tissues such as adipose and skeletal muscle (Sell et al., 2012; 
Tanti, Cormont, Grémeaux, and Le Marchand-Brustel, 2001). Therefore, the purpose of these 
optimisation experiments was to establish a method for investigating insulin stimulated 
glucose uptake in monolayer cell culture as well as tissue engineered skeletal muscle 
constructs. 
4.1.1. Measurement of 2-deoxy-d-glucose uptake to investigate glucose 
metabolism 
Investigation of glucose uptake has commonly used glucose analogues such as, 2-deoxy-d-
glucose (2-DG) (Molecular Weight (MW) 164.16) in order to quantify cellular glucose 
uptake (Tanti et al., 2001). 2-DG is obtained up by solute membrane transporters however 
unlike glucose and other glucose analogues, 2-DG is metabolised by the hexokinase reaction 
to form a stable and impermeable derivative 2-deoxy-glucose-6-phosphate which is not 
metabolised further (Wick, Drury, and Morita, 1955). Early studies by Wick and colleagues 
suggested that the accumulation of 2-deoxy-glucose-6-phosphate inhibits the hexokinase 
reaction and subsequently results in a ‘backing up’ in 2-deoxy-glucose accumulation (Wick, 
Drury, Henry, and Chem, 1957), however the concentrations required before 2-DG becomes 
rate limiting are extremely high (Hansen et al., 1994), and are not reached within cell culture 
experiments (Sell et al., 2012; Tanti et al., 2001). As a result, the use of 2-DG in 
quantification of 2-DG uptake in vitro using fluorescent and radioisotope-based assays 
methods has been established and used extensively within the literature. 
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4.1.1.1. Fluorescent based methods for measurement of 2-deoxy-d-glucose 
uptake 
Although the use of radioisotopes are a sensitive and accurate method for measuring glucose 
uptake, which will be discussed within the proceeding Section (Section  4.1.2), the expensive 
nature, and specialist equipment and expertise that are required in order to perform 
radioactive experiments can be problematic. The development of enzymatic assays using 
fluorescent based methods with fluorescent D-Glucose analogue 2-deoxy-2-[(7-nitro-2,1,3-
benzoxadiazol-4-yl)amino]-D-glucose (2-NBDG) have been established since the early 
1990’s as an alternative method for investigating cellular glucose uptake (Manchester et al., 
1990; Sasson, Oron, and Cerasi, 1993). It has been used to measure uptake in various tissues 
such as skeletal muscle, adipocytes and hepatocytes (Kanwal, Singh, Grover, and Banerjee, 
2012; Zou, Wang, and Shen, 2005). One of the main advantages of the use of this assay over 
the more conventional radioisotopes assay is its use for quantification of glucose uptake in 
single cells, through the use of flow cytometry (Zou et al., 2005). However, Zou and 
colleagues have reported large variation in 2-NBDG uptake between cells (Zou et al., 2005), 
meaning that this method of quantification of glucose uptake in highly metabolic tissues such 
as skeletal muscle is yet to be fully validated. Alternatively, a 96 well plate based assay has 
been established for investigating more insulin sensitive tissues such as skeletal muscle and 
adipocytes (Saito et al., 2011; Yamamoto, Sato, Kawasaki, Murosaki, and Yamamoto, 2006). 
The use of this method has shown to be sensitive enough to quantify glucose uptake within 
the pico mole (pmol) range in adipocytes (Saito et al., 2011). Yet, the use of 2-NBDG with 
skeletal muscle cells is sparse within the literature, with the majority of the work being 
performed in the L6 rat myoblast cell line (Yamamoto et al., 2006; Zou et al., 2005). The use 
of this cell line has commonly been used within the literature to investigate insulin stimulated 
glucose uptake using radioactive isotopes and has been shown to respond highly to insulin 
(Philp et al., 2011). While alternative cells lines such as the C2C12 skeletal muscle cell line 
have been used for investigation of insulin signalling and glucose uptake using traditional 
radioactive isotopes (Nedachi et al., 2008; Nedachi and Kanzaki, 2006) there is currently no 
evidence for the use of a fluorescent based glucose uptake assay within this cell line. 
Therefore the purpose of this experiment was investigate the fluorescent cell based glucose 
uptake assay could be used to investigate insulin stimulated glucose uptake in C2C12 skeletal 
muscle cells. Principles of radioactive isotopes for in vitro metabolic research  
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Tracers are compounds, which are chemically and functionally identical to their natural 
counterparts, yet they provide a form of identification through radioactive labelling which 
enables detection (Wolfe and Chinkes, 2005). The use of radioactive isotopes for in vitro 
research has provided a useful tool for investigation of a number of cellular functions such as 
glucose metabolism within insulin sensitive tissue such as adipocytes and skeletal muscle 
(Sell et al., 2012; Tanti et al., 2001). Radioactive isotopes provide several advantages for use 
in biological research; Firstly, the isotope in question can be easily incorporated into the 
biological compound being quantified, in this case the use of tritium (3H) (Figure  4-1), and 
secondly isotopes are required to have a suitable half-life. The half-life is the rate of decay to 
a non-radioactive state and in the case of tritium the half-life is approximately 12 years.  
The quantification of isotopes within biological samples is measured through liquid 
scintillation counting (LSC) which provides a reproducible and sensitive method for 
quantification of aqueous biological samples. LSC detects radioactivity through light 
emission between the radioisotope and scintillation fluid. A reaction between these molecules 
leads to decay of the molecule to ground state leading to the production of light or ‘photon’ 
which is counted (Figure  4-2).  
Radioactive isotopes using low beta emitting particles such as 3H or 14C are the two most 
common isotopes to be used to investigate glucose uptake and both of these radioactive 
isotopes have been utilised to investigate rates of glucose metabolism in skeletal muscle and 
adipocytes in vivo (Cooney, Astbury, Williams, and Caterson, 1987; Cooney, Caterson, and 
Newsholme, 1985; Hom and Goodner, 1984). In addition, the use of 3H-2DG has frequently 
been used to investigate glucose metabolism in culture from primary skeletal muscle cells 
(Sell et al., 2008, 2012) as well as skeletal muscle cell lines (Ma et al., 2013; Philp et al., 
2011) to investigate both mechanisms of insulin dependent (del Aguila et al., 2011; Kumar 
and Dey, 2003), and independent glucose uptake (Iwata et al., 2009; Lambernd et al., 2012). 
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Figure  4-1 Chemical structure of tritium labelled (3H) 2-deoxy-d-glucose used for investigation of 
glucose uptake in vitro. Image is obtained from Perkin Elmer certificate of analysis supplied with 
radioactive stock. Certificate of analysis for 3H-2DG used in this thesis can be found in appendices D. 
 
 
 
Figure  4-2 A simplistic schematic of the liquid scintillation process between a stable β emitting 
particle, such as tritium (3H), and scintillation fluid. A reaction between these two molecules results 
in the emission of light (photon) which is  quantified. Accessed 25.7.14 from Perkin-Elmer. 
http://www.perkinelmer.co.uk/resources/technicalresources/applicationsupportknowledgebase/radio
metric/liquid_scint.xhtmL  
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4.2. Methods and Results 
4.2.1. Non-labelled 2-DG glucose uptake assay 
The measurement of glucose uptake was quantified according to the manufactures 
instructions using a commercially available cell based glucose uptake assay kit (Cayman 
Chemical, Ann Arbor, MI, USA). In brief, cells were seeded into a black sided, clear bottom, 
96-well plate (Corning life sciences, Amsterdam, Netherlands). Cells were seeded at a 
density of 15,000 cells·cm2 (this is consistent with all plating densities used through this 
thesis and requires 3000 cells per well) in 100µl of standard growth medium. The cells were 
grown and differentiated as outlined within the methods Section (Section  3.1). Following 
differentiation for a period of 96 hours, C2C12 myoblasts had differentiated into skeletal 
muscle myotubes (Figure  4-3). Myotubes were serum starved for 4 hours as previously 
described (Nedachi and Kanzaki, 2006) before being stimulated with insulin for 30 minutes. 
Cells were incubated in 100 µl of glucose free medium (Life Technologies, Paisley, UK) with 
150µg/mL of 2-deoxy-2[(7-nitro-2, 1, 3-benzoxadiazol-4-yl) amino] – D-glucose) (2-NBDG) 
for 10 minutes. In parallel wells, cells were also incubated with the addition of 10µM of 
cytochalasin B with or without insulin (Figure 4.4B). Cytochalasin B inhibits insulin 
stimulated glucose uptake by impairing actin remodelling and GLUT4 translocation (Amira 
Klip et al., 2014), and was used as a negative control within these experiments. The 
supernatant was aspirated and 200 µl of cell based assay buffer was added to each well, the 
supernatant removed and replaced with 100 µl of fresh cell based assay buffer before being 
analysed on a fluorescent plate reader at a excitation/emission wavelength of 485/535 nm. 
However, despite the presence of the inhibitor the fluorescence emitted was similar between 
conditions (p = 0.99) (Figure  4-4A).  
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Figure  4-3 Light microscopy of differentiated C2C12 skeletal muscle cells in 96 well plates. Skeletal 
muscle cells were differentiated in black sided, clear bottom well plates for investigation of glucose 
uptake using the fluorescent based assay. Image was obtained at 10X magnification. Scale bar = 
25µm 
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Figure  4-4 A, 2-NBDG uptake in C2C12 myotubes expressed as fluorescence in 4 different conditions, 
US: unstimulated, ST: stimulated with 100 nM insulin, US+B: US + blocker (cytochalasin B), ST+B: 
ST + blocker. A one-way ANOVA was non-significant (P = 0.99). Values are absolute value (mean ± 
SD) from 3 independent experiments performed in triplicate (n = 9). B, Experimental design. 
 
4.2.2. Measurement of 3H-Deoxy-D-Glucose uptake. 
Following four hours serum starvation, experiment plates were washed twice in Krebs Ringer 
HEPES (KRH) buffer and either incubated for 15 minutes in the presence or absence of 100 
nM insulin. Glucose uptake was determined by the addition of 3H-2-deoxy-d-glucose (0.1 
mM, 0.5 µCi/mL; PerkinElmer Life and Analytical Science). Wells were incubated with 10 
µM cytochalasin B (Sigma-Aldrich, Dorset, UK) in PBS, in order to measure nonspecific 
uptake. The cells were washed two times in ice cold PBS, to remove any excess media. Cells 
were lysed in 0.2 M NaOH, PBS (Fisher Scientific, Loughborough, UK), with the whole cell 
lysate added to a scintillation vial containing scintillation cocktail (Gold Star scintillation 
fluid, Meriden biotechnologies, Surry, UK). Samples were briefly homogenised before being 
quantified by scintillation counting (Packard TRI-CARB 2750 TR/LL liquid scintillation 
counter). Total protein was also quantified in concurrent plates using 660 nM pierce protein 
assay as previously described (Section  3.5.5). 
 
A 
B 
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4.2.3. Optimisation experiments for 3H-De-oxy-D-Glucose uptake. 
Initial optimisation experiments were conducted in 24 well plates to investigate concentration 
and time dependent glucose uptake in skeletal muscle myotubes. C2C12 skeletal muscle cells 
were d at 15,000 cells·cm2 in standard growth media as previously described. Upon 
confluence cells were changed to standard differentiation media for 72 hours following which 
skeletal muscle cells had fused into skeletal muscle myotubes as observed by phase contract 
microscopy (Figure  4-5). 
 
Figure  4-5 Representative phase contrast micrographs of C2C12 skeletal muscle myotubes following 
72 hours of differentiation in 24 well cell culture plates for measurement of 3H-De-oxy-D-Glucose 
uptake A; X20 focus; B; X40 focus. Scale Bar 50µm. 
 
Glucose uptake was measured as described above (Section  4.2.2) following zero, five, ten, 
twenty and thirty minutes to 3H-2DG glucose radioactive concentrations of glucose which 
had previously been described within the literature using C2C12 skeletal muscle cells 
(Nedachi and Kanzaki, 2006) (0.1 mM, 0.5 µCi/mL). Incubation times were determined 
based on previous experiments in monolayer which had incubated with insulin these periods 
of time (Kumar and Dey, 2003; Nedachi and Kanzaki, 2006). 
Following the time response curve (Figure  4-6) it was established that thirty minutes was a 
potential time point that would provide a suitable assay window to investigate insulin 
stimulated glucose uptake in C2C12 skeletal muscle cells. It was therefore necessary to repeat 
the experiment at the same concentration but also investigate higher concentrations of 
radioactive glucose (0.1 mM, 1 µCi/mL) to investigate further improving the assay window.  
A B 
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The increase in concentration of 3H-2DG would resulting increase the specific activity of the 
concentrations being used and potentially reduce the possibility of quenching within the 
samples. As tritium has a low emission of energy, even compared to 14C, and the efficiency 
of scintillation counters themselves can be low (National Diagnostics, 2004), lower 
concentrations could result is production of photons below the detectable range and therefore 
would not register as a count.  Therefore, skeletal muscle cells were grown and differentiated 
as previously described (Section  3.1) and glucose uptake measured and quantified as 
previously outlined (Section 4.2.2). Cells were incubated for 30 minutes before being lysed 
and measure by scintillation counting. 
 
 
Figure  4-6 Time response of glucose uptake in C2C12 skeletal muscle myotubes incubated with 3H-2-
Deoxy-d-glucose (0.5µCi·mL). Samples are in duplicate (mean ± S.D) from one independent set of 
cells. Open bars represent unstimulated and Filled bars represent insulin stimulated (100 nM) cells. 
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After repeating the experiment with 0.5 µCi/mL 3H-2DG there was a large variation within 
each condition which resulted in no significance between the two conditions by independent 
samples t-test t (6) -0.900 p =0.403 (Figure  4-7). The variation between conditions could be 
resultant of the limits of the scintillation counter and therefore normalisation of the data could 
potentially be skewed due to the detection limits.). However, increasing the concentration (1 
µCi/mL) the variation between conditions was reduced and subsequently showed a 
significant difference between conditions t (2) -5.835 p = 0.028 (Figure  4-8). Therefore, 
based upon the findings of these optimisation experiments further experimental conditions in 
monolayer used a 30 minutes glucose incubation period using a radioactive concentration of 
1 µCi/mL. 
 
 
 
 
Figure  4-7 Glucose uptake in C2C12 skeletal muscle myotubes incubated for 30 minutes with 3H-2-
Deoxy-d-glucose (0.5 µCi·mL). Data is an accumulation of duplicate samples from two independent 
set of cells mean ± S.D. Open bars represent unstimulated and filled bars represent insulin stimulated 
(100 nM) cells for 15 minutes before 30 minutes incubation with 3H-2DG. 
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Figure  4-8 Glucose uptake in C2C12 skeletal muscle myotubes incubated for 30 minutes with 3H-2-
Deoxy-d-glucose (1µCi·mL). Data is mean ± S.D from one independent set of cells. Open bars 
represent unstimulated and filled bars represent insulin stimulated (100 nM) cells for 15 minutes 
before 30 minutes incubation with 3H-2DG. * Significantly different between conditions (p  < 0.05). 
 
4.2.4. Optimisation of insulin stimulation and 3H-Deoxy-D-Glucose uptake in 
tissue engineered constructs. 
Following the findings in monolayer culture, it was important to establish glucose uptake in 
tissue engineered constructs. Investigation of glucose uptake in tissue engineering within the 
literature is limited, having only been established in constructs ded with primary rat cells 
(Baker et al., 2003). The use of C2C12 skeletal muscle cells have been well established 
within the literature for their use within tissue engineering (Khodabukus & Baar, 2009, 2014a; 
Player et al., 2014), Furthermore, the use of skeletal muscle cells have commonly been used 
within the literature to investigate insulin signalling and glucose uptake in 2D culture (del 
Aguila et al., 2011; Philp et al., 2010). Therefore based on these two elements of cell culture, 
these cells provide the ideal candidate for further investigating insulin stimulated glucose 
uptake in skeletal muscle tissue engineered constructs.  
Using the collagen tissue engineered skeletal muscle constructs; C2C12 cells were grown and 
differentiated for a total of 14 days in culture as described within the methods Section 
(Section  3.2.2). In order to maintain consistency with the methods established in monolayer 
experiments (Section  3.6.1), constructs were stimulated with insulin for a period of 15 
minutes before being incubated with 3H-2DG (0.1 mM, 1.0 µCi/mL) for 30 minutes. 
Constructs were incubated in cytochalasin B (10 µM) for 5 minutes and washed twice with 
PBS, before being removed from the A-frames, blot dried and weighed. Despite following the 
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protocols established in monolayer there was no significant increase in insulin stimulated 
glucose uptake following 15 minutes insulin stimulation (Figure  4-9). 
 
 
 
 
Figure  4-9 Glucose uptake C2C12 skeletal muscle in collagen skeletal muscle constructs. Myotubes 
incubated for 30 minutes with 3H-2-Deoxy-d-glucose (1 µCi·mL). Data is mean ± S.D from two 
constructs per condition from one independent set of cells. Open bars represent unstimulated and 
filled bars represent insulin stimulated (100 nM) cells for 15 minutes before 30 minutes incubation 
with 3H-2DG.  
 
 
As a result of these findings it was important to establish if the lack of insulin stimulated 
glucose uptake was as result of the incubation time in insulin. Therefore, western blots were 
conducted for phosphorylation of Akt and key protein involved in insulin signalling. 
Collagen constructs were grown as previously described (Section  3.2.4). Prior to insulin 
stimulation constructs were washed twice and incubated twice for 30 minutes in KRH buffer 
as described in monolayer cultures (Section  4.2.2). Constructs were incubated in KRH 
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containing 100 nM of insulin at set time periods (Figure  4-10). KRH buffer was removed and 
constructs were washed in PBS, before being blot dried and snap frozen in liquid nitrogen. 
Protein from collagen constructs was extracted as outlined (Section  3.5.3 &  3.5.4) and 
separated by western blot (Section  3.5.6). Imaged bands for phosphorylation of Akt at serine 
473 (Ser473) and threonine 308 (Thr308) were darker beyond 20 minutes and therefore insulin 
stimulation in subsequent experiments in tissue engineered constructs was increased to thirty 
minutes for investigation of insulin signalling as well as prior to incubation with 3H-2DG 
(Figure  4-10). 
 
Figure  4-10 Immunoblots of time dependent response of phosphorylation of Akt (Ser437) and Akt 
(Thr308) (60 kDa) in response to insulin. A; Collagen gel skeletal muscle constructs B; Fibrin gel 
skeletal muscle constructs 
 
Following the findings in collagen western blots were also conducted on Fibrin based 
constructs. Similarly to collagen tissue engineered constructs, insulin stimulation appeared to 
show phosphorylation to be at its greatest beyond 20 minutes insulin stimulation 
(Figure  4-10B) and therefore the same incubation periods were used to investigate glucose 
uptake and insulin signalling in these constructs. Constructs were stimulated for 30 minutes 
and incubated with 3H-2DG for 30 minutes as described above. The data from these initial 
experiments was pooled into the control condition in fibrin experiments, which are outlined 
in this thesis (Chapter  7).  
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4.3. Discussion 
The purpose of these experiments was to establish a method for investigation of cellular 
glucose uptake in C2C12 skeletal muscle cells. The use of the glucose analogue 2-deoxy-d-
glucose is most suitable for investigation of glucose uptake within skeletal muscle due to the 
rapid flux across the membrane and the stability and impermeable nature of this analogue 
once phosphorylated to 2-deoxy-glucose-6-phosphate (Hansen et al., 1994).C2C12 
The first optimisation experiments investigated the use of a 96 well plate fluorescent based 
assay which has previously been used to investigate glucose uptake in L6 skeletal muscle 
cells (Yamamoto et al., 2006). Compared to the work performed by Yamamoto and 
colleagues, the use of this assay did present evidence of insulin stimulated glucose uptake 
using the C2C12 skeletal muscle cell line. This particular cell line has been used for 
investigating skeletal muscle glucose uptake using radioactive isotopes (Nedachi and Kanzaki, 
2006) and subsequently, the incubation periods used were based on the established work by 
Nedachi and colleagues. Although these time periods are effective in providing a suitable 
assay window between basal and insulin stimulated glucose uptake in a radioisotope based 
assay, the incubation period used within the fluorescent based assay using L6 myotubes was 
greater and therefore could potentially explain the differences in glucose uptake observed 
(Yamamoto et al., 2006). 
C2C12 skeletal muscle cells present a high basal glucose turnover, and although insulin 
stimulated glucose uptake increases 3H-2DG uptake by approximately 1.5 fold over basal 
levels (Nedachi and Kanzaki, 2006), it has been suggested that the effect of insulin stimulated 
glucose uptake are small compared to that of other skeletal muscle cell lines (Sarabia et al., 
1990). Although insulin stimulated glucose uptake has been reported in L6 myotubes using 
this method (Yamamoto et al., 2006), further experiments would be required to determine if 
the fluorescent based methods is sensitive enough for detection of insulin stimulated glucose 
uptake within this particular cell line. A method for investigating this is with the use of 
transfected myc-tagged GLUT4 skeletal muscle cells lines, which have been used within the 
literature to investigate GLUT4 translation in skeletal muscle cells (Amira Klip et al., 2014; 
Nedachi and Kanzaki, 2006). 
Due to the null findings observed with the fluorescent based assay, experiments were 
conducted using radioisotopes which have been well established and described within the 
literature for investigation of glucose uptake in vitro and have arguably termed the ‘gold 
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standard’ in this field of research (Sell et al., 2012; Tanti et al., 2001). The use of 2-DG 
radioisotopes have been used within the literature to investigate cellular glucose uptake in 
both primary (Sell et al., 2008), and myogenic cell lines (Iwata et al., 2009; Nedachi and 
Kanzaki, 2006; Philp et al., 2010). Initial optimisation experiments were performed based on 
previous research by Nedachi and colleagues, whereby a time course was performed to 
identify the most suitable incubation time with 3H-2DG. Contrary to previous findings, the 
greatest assay window to observed insulin stimulated glucose uptake was following 30 
minutes incubation with 3H-2DG. Yet, repeating the experiment shown there to be a large 
deviation within the mean between conditions (Figure  4-7). Although the variation between 
batches of cells could contribute to the variation observed, as outlined above (Section  4.2.3) 
the low efficiency of scintillation counters combined with the low specific activity that was 
used in these initial experiments would increase the risk of quenching and subsequently the 
counts per minute obtained from each sample. The radioactive concentrations of 3H-2DG 
used for experiments using C2C12’s has ranged (0.5 µCi·mL-1 µCi·mL) within the literature. 
The concentration of 3H-2DG used in skeletal muscle constructs is higher than those used in 
2D culture (1.5 µCi·mL) (Baker et al., 2003). Establishing a specific activity that would be 
detectable in both 2D and 3D systems, meant that for subsequent experiments, a specific 
activity of 1 µCi·mL would be used for the subsequent experimental Chapters (1 µCi·mL 
which has commonly been used within the literature to investigate glucose uptake within 
C2C12 skeletal muscle cells (Iwata et al., 2009; Philp et al., 2010). With this concentration, 
the difference in glucose uptake between insulin stimulated and unstimulated cells was 
discernible at 30 minutes and therefore these parameters were used in the subsequent chapters. 
Following optimisation of insulin stimulated glucose uptake in monolayer cell culture, 
experiments were conducted in tissue engineered skeletal muscle constructs. Initial 
experiments conducted using collagen based skeletal muscle constructs followed the same 
methodology as those previously used in 2D culture. However, there was no increase in 
insulin stimulated glucose uptake following 15 minutes insulin stimulation and therefore, 
western blots were conducted for phosphorylation of Akt which is a key insulin signalling 
protein in skeletal muscle (Schultze et al., 2011). This optimisation experiment showed that 
phosphorylation occurred at all-time points. Twenty minutes of insulin stimulation is 
consistent with what has previously been reported by Baker and colleagues who incubated 
with insulin for 20 minutes in skeletal muscle tissue engineered constructs using primary rat 
skeletal muscle cells. 
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Experiments in fibrin skeletal muscle constructs, (Chapter 7), were incubated with insulin for 
30 minutes prior to be exposed to 3H-2DG. These constructs showed an insulin stimulated 
glucose uptake of approximately 2-fold over basal level. These findings are similar to the 
methods previously described by Baker and colleagues, using a comparable protocol. The 
research into the metabolic characteristics of tissue engineered skeletal muscle is limited to 
the paper by Baker and colleagues (Baker et al., 2003). The subsequent Chapters within this 
thesis will attempt to further elucidate these characteristics in two separate skeletal muscle 
tissue engineered constructs.  
4.4. Chapter Summary 
The purpose of this Chapter was to establish a method for the measurement of glucose uptake 
in C2C12 skeletal muscle cells, which could be used within the following Chapters of this 
thesis. Two methods were investigated using fluorescent 96 well plate and radioisotope 
assays respectively. Optimisation experiments using the fluorescent 96 well plate assay 
showed no effect of insulin stimulated glucose uptake and therefore, further experiments 
would be required to optimise this method with C2C12 skeletal muscle cells. 
In contrast, the use of the radioisotope tracer assay with tritium labelled glucose showed 
through a time response experiment that 30 minutes of glucose exposure resulted in a 
significant assay window between unstimulated and stimulated C2C12’s in 2D culture. 
Furthermore, it was established that higher a higher specific activity of 3H-2DG was more 
suitable for investigating insulin stimulated glucose uptake in both monolayer cultures and 
subsequently tissue engineered skeletal muscle constructs. This increase in specific activity 
reduces the potential effect of quenching within samples; in addition to the inefficiency 
associated with scintillation counting. The findings in 2D culture correspond to those 
currently reported in the literature, and the concentrations used within these optimisation 
experiments are used in the subsequent Chapters of this thesis. In addition, these methods 
have shown that glucose uptake can be measured within skeletal muscle tissue engineered 
constructs using the myogenic C2C12 cell line and the response elicited within these 
constructs is similar to what has previously been shown within primary cell lines (Baker et al., 
2003). Further experiments within this thesis will establish the effects of both acute and 
chronic insulin exposure in both monolayer and tissue engineered constructs upon insulin 
stimulated glucose uptake using radioactive isotopes. 
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5. A time course of transcriptional and translational expression of glucose 
transporters in C2C12 skeletal muscle cultures. 
  
92 
 
5.1. Introduction 
A family of integral membrane proteins known as glucose transporters controls the regulation 
of glucose uptake. The importance of these proteins in glucose uptake has previously been 
discussed (Section  2.11). During foetal development, GLUT4 concentrations have been found 
to be low, while Glucose Transporter 1 (GLUT1) is the predominant mediator of glucose 
transport, however, during the perinatal phase of development continuous expression of 
GLUT4 mRNA, which is proceeded by increases in posttranscriptional protein expression, 
results in GLUT4 being the predominant isoform for glucose transport (Santalucia et al., 
1992). Both protein and mRNA expression of these glucose transporters are present within 
mature skeletal muscle (Stuart et al., 2006), and are highly correlated with glucose transport 
(Kern et al., 1990).  
GLUT4 mRNA expression is regulated by upstream promoter regions (Liu et al., 1992). One 
of these, Myocyte Enhancer Factor -2 (MEF-2), is an important developmental transcription 
factor. MEF-2 is implicated in the transcription of GLUT4 with a MEF-2 promoter region 
located upstream of the GLUT4 transcription site (Thai, Guruswamy, Cao, Pessin, and Olson, 
1998). Four isoforms of MEF-2 have been identified. Of those four, MEF-2A has been shown 
to regulate GLUT4 expression in both rat (Mora & Pessin, 2000), and human skeletal muscle 
(Knight, Eyster, Griesel, & Olson, 2003). The importance of MEF2A has been shown in 
skeletal muscle cells lines (Liu, Olson, Edgington, Moyerowley, & Pessin, 1994), as well as 
transgenic rodent models, which have shown reduced MEF2A activity in skeletal muscle of 
diabetic animals to be correlated with reduced GLUT4 expression and insulin stimulated 
glucose uptake (Thai et al., 1998). What is more, the GLUT4 muscle specific enhancer has 
been found to be fibre type dependent and requires the integrity of the MEF-2 binding site in 
both oxidative and glycolytic muscle fibres (Moreno et al., 2003). 
In the basal state, a high Concentrations of GLUT4 is located within the cytoplasmic region. 
The translocation of the GLUT4 vesicles to the cytoplasmic region to the plasma membrane 
as a result of insulin stimulation has been found to increase cell surface density within 
skeletal muscle from healthy individuals (Ryder et al., 2000). Furthermore, as previously 
discussed (Section  2.11.1), insulin or pharmacological mediated stimulation significantly 
increases transcriptional expression of GLUT4 both in vitro (Al-Khalili et al., 2005; Laville 
et al., 1996) and in vivo (Ryder et al., 2000).  Although no differences in the basal expression 
of mRNA GLUT4 in skeletal muscle between NIDDM and control subjects has been reported, 
diabetic animal models have shown to have reduced binding between the MEF2A-MEF2D 
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heterodimer, which is responsible for regulation in the expression of the GLUT4 gene (Mora 
and Pessin, 2000). 
While the developmental characteristics of glucose transporters within skeletal muscle have 
been elucidated in two dimensional cultures (Mitsumoto, Burdett, Grant, and Klip, 1991), and 
in vivo skeletal muscle (Jensen et al., 2008), less is understood about expression of glucose 
transporters, in particular their expression during myogenic development within skeletal 
muscle tissue engineered constructs. The work of Baker and colleagues has shown the 
expression of GLUT1 to be increased compared to GLUT4 in tissue engineered constructs 
using primary cell from rodents (Baker et al., 2003). Although these initial experiments have 
provided an insight into the expression of these proteins in tissue engineered skeletal muscle 
constructs (Baker et al., 2003), further work to characterise understanding of the expression 
of glucose transporters in these models is an area that remains a challenge within the field of 
tissue engineering and regenerative medicine (Cheng et al., 2014). 
Due to the significance of GLUT4 expression in cellular glucose transport, it is important to 
understand the changes in mRNA expression of GLUT4 and GLUT1 during skeletal muscle 
differentiation in culture. In addition, myogenic regulatory factors such as myogenin, an 
important marker of skeletal muscle differentiation, and developmental genes such as MEF-
2a, which are implicated in regulation of GLUT4 transcription, can provide further 
understanding of the development of skeletal muscle from single cells, to mature skeletal 
muscle fibres. Little is understood about the time course development of glucose transporter 
expression in tissue engineering particularly within a homogenous cell population from a 
murine skeletal muscle cell line. It is therefore important to understand the transcriptional and 
translation expression of glucose transporters within tissue engineered constructs in order to 
establish these models as a valid model for investigating insulin stimulated glucose uptake. 
Time course experiments were conducted to investigate the changes in expression of 
myogenic, development and glucose transporters during skeletal muscle myotube formation 
in monolayer culture and tissue engineered skeletal muscle constructs. It was hypothesised 
that with the formation of skeletal muscle myotube formation and increases in myogenic and 
developmental gene expression, there would be also an increase in expression of GLUT4, the 
insulin mediated glucose transporter expression 
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The objectives of this Chapter were to: 
I. Investigate the transcriptional response of glucose transporter mRNA expression in 
monolayer and tissue engineered constructs in order to establish if these culture 
models are suitable for investigating insulin stimulated glucose uptake. 
II. To investigate glucose transporter protein expression of GLUT4 in cell culture.  
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5.2. Methods 
5.2.1. Experimental protocol in monolayer 
C2C12 myoblasts were seeded in six well plates in standard growth media as previous 
described (Section  3.1). Upon confluence, cells were changed to differentiation media as 
previously described. Cells were lysed for RNA extraction (Section  3.3.2) at 0 days (D0), 3 
days (D3) and day 6 (D6) time points (Figure  5-1) 
 
Figure  5-1 Experimental protocol schematic of the time course changes in GLUT4 expression in 
C2C12 myoblast cells. 
 
5.2.2. Experimental protocol in collagen constructs 
Collagen gels were constructed as described in the methods Section of this thesis 
(Section  3.2.2), and grown in standard growth media until for 4 days, before being changed to 
differentiation media (2% HS, 1%P/S, DMEM) for the remaining time in culture. Growth 
media was changed twice daily, while differentiation media was changed daily during the 
experiment. At each respective time point constructs were washed in PBS before being lysed 
in Tri-reagent for subsequent RNA extraction. Constructs were lysed at early (day 0 & 2) and 
late differentiation time points (day 8 & 10). Macroscopic images were obtained to measure 
gel width throughout differentiation and the formation of myotubes was observed by phase 
contract microscopy  
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5.2.3. Experimental protocol in Fibrin constructs 
In addition, a similar time-course experiment was conducted in fibrin based tissue engineered 
constructs. The fibrin plates were developed and cultured as previously described 
(Section  3.2.1.3). Constructs were lysed at the change in constituents of the media to induce 
differentiation (day 2 to differentiation media) and when changed to maintenance media at 
day 4 (D4). Subsequent constructs were lysed every other day up until the constructs had 
been in culture for a total of 14 days. Constructs were lysed in tri-reagent for extraction of 
RNA for mRNA expression analysis (Section  3.3.3). 
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Figure  5-2 Time course experimental schematic of C2C12 skeletal muscle cells grown and differentiated in A, 1mL Collagen gels and B, Fibrin gels. Skeletal 
muscle constructs were grown in respective media and lysed at the time points on each timeline. Days (D). 
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5.2.4. RNA extraction and PCR 
RNA was extracted using TRI-reagent according to manufactures instructions and quantified 
as previously described (Section  3.3.2). PCR was performed as previously described with 
respective primer sets for RPIIβ, GLUT4, GLUT1, MyoG, and MEF2α (Table  3-3). Changes 
in gene expression were calculated using ΔΔCt method as previously outlined (Section  3.3.6). 
5.2.5. Protein Extraction and Immunoblotting of GLUT4 
Protein lysates were extracted from monolayer cultures with RIPA lysis buffer as previously 
described (Section  3.5.2) and quantified using piece 660nm protein assay (Section  3.5.5). 
Samples were mixed with laemmli buffer and loaded (10 µg) onto SDS-PAGE gels (8-12% 
resolving gels, 4% stacking gel). Western blots were performed as outlined in the methods 
section (Section  3.5.6), with some modifications. These modifications used due to the 
negative results obtained following the protocol outline in the methods section. The 
considerations and optimisation for investigating glucose transporter protein expression in 
cell culture models is outline in appendices C (Page 217). Membranes were blocked for one 
hour in 2% blotting milk (Bio-rad, Herts, UK) TBS, before being incubated overnight (4°C) 
with GLUT4 primary antibody (5% blotting milk, TBST). Membranes were washed and 
incubated with secondary antibody and exposed as described previously (Section  3.5.6). 
5.2.6. Statistical Analysis 
Statistical analysis was conducted using SPSS software (IBM SPSS statistics software, 
version 19.0.0, USA). Shapiro-Wilk was used to assess normality and Levine tests for 
homogeneity of variation. Log transformation was used if either normality or homogeneity 
assumptions were violated. Transformed data were analysed by One-way ANOVA to assess 
changes in mRNA expression with Bonferroni post-hoc differences used to identify 
differences between conditions when a significant F value was observed. An alpha level of p 
<0.05 was used as the criterion for statistical significance. An independent samples t-test was 
conducted for differences in the expression of GLUT4 relative to GLUT1 mRNA expression 
at each time point. Values are mean ± standard deviation number; of replicates and 
independent experiments conducted are outlined in each figure legend.  
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5.3. Results 
5.3.1. Glucose transporter expression in monolayer culture 
During the course of myotubes differentiation, Myogenin, a marker of myogenic 
differentiation, was measured at zero, three and six day’s differentiation. The mRNA levels 
of Myogenin were significantly different F (2, 13) = 726.03 p < 0.0001 with both 72HR and 
144HR expression levels significantly greater than at 0HR in differentiation media (p < 
0.0001). There was also a significant difference between 3 and 6 days in differentiation media 
(p < 0.005) (Figure  5-4A). There was a significant effect on MEF2a mRNA expression F (2, 
22) = 6.483, p = 0.06 following 3 and 6 days in differentiation media (3 days p = 0.016; 6 
days p = 0.003 vs. control). GLUT4 increased approximately 2-fold over the course of 
differentiation (Figure  5-4B), F (2, 20) = 4.592, p = 0.023 with both differentiated skeletal 
muscle expressing greater levels of GLUT4 mRNA at 72 (p = 0.011) and 144 hours (p = 
0.037) respectively compared to undifferentiated cells (Figure  5-4C). Despite this increase in 
GLUT4 during skeletal muscle differentiation there was no significant changes in GLUT1 
mRNA levels F (2, 22) = 0.232, p = 0.795 (Figure  5-4D). 
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Figure  5-3 Representative phase contrast images of C2C12 skeletal muscle cells at A) 0 days DM B) 3 
days DM and, C) 6 days DM in monolayer culture. Scale bar = 100µm of x20 magnification image. 
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Figure  5-4 Mean ± SD (N=3) of mRNA expression (ΔΔCt) of glucose transporters, myogenic and, 
developmental genes, A; Myogenin (MyoG) and B; Myocyte Enhancer Factor 2a (MEF2a), C; 
Glucose transporter 4 (GLUT4), D; Glucose transporter 1(GLUT1) and in single cell (Day 0) and 
mature (Day 3-DM; Day 6-DM) C2C12 skeletal muscle myotubes in monolayer cell culture. * 
Significant difference vs. GM (p<0.05).   
 
Table  5.1 Raw Ct Values (mean ± SD) genes of interest during skeletal muscle development of C2C12 
skeletal muscle in monolayer culture. 
Gene of Interest D0 D3 D6 
MyoG 23.69 ± 0.69 19.54 ± 0.72 20.32 ± 1.17 
MEF2a 20.00 ± 0.71 21.13 ± 2.75 19.20 ± 0.74 
GLUT4 25.81 ± 1.06 23.52 ± 2.42 25.04 ± 1.09 
GLUT1 20.75 ± 1.10 22.47 ± 2.70 20.69 ± 0.56 
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5.3.2. GLUT4 protein expression in undifferentiated and differentiated C2C12 
skeletal muscle 
 
In order to investigate if the transcriptional changes in GLUT4 mRNA expression translated 
to an increase in protein concentration, western blots were conducted on samples at 0, 3 and 6 
days of differentiation. (Figure  5-5). The data from this pilot experiment shows that GLUT4 
protein abundance in increased at days 3 (9.1 fold) and 6 (20.3 fold) differentiation relative to 
day 0. 
 
 
Figure  5-5 GLUT4 protein expression in C2C12 skeletal muscle myotubes differentiated at day 0, 3 
and 6 days. Data is mean abundance from 1 independent experiment. 
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5.3.3. Collagen gel contraction and myotube formation during differentiation 
 
In order to characterise the expression of glucose transporters in skeletal muscle tissue 
engineered constructs, time course experiments were conducted to investigate the 
transcriptional responses of these constructs. During differentiation, the formation of 
myotubes was observed by phase contrast microscopy (Figure  5-6). Furthermore, 
macroscopic images were obtained for the measurement of gel contraction during 
differentiation (Figure  5-7A). There was a reduction in gel width during differentiation which 
was significantly different between days 0 and 10 as identified by independent t-test t (26) = 
2.181 p =0.38 (Figure  5-7C).  
 
Figure  5-6 Phase contrast images of collagen based tissue engineered constructs culture for A) 0 days, 
B) 2 days, C) 8 days and D) 10 days in differentiation media Scale bar = 100µM of X20 magnification 
image. Arrows denote the formation of skeletal muscle myotubes. 
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Figure  5-7 Contraction of collagen skeletal muscle gels during differentiation. Constructs were 
incubated in standard growth media before being switched to differentiation media at A; Day 0 for B; 
10 days in culture C; Measurement of gel width (mm) of collagen gels. Data is mean ± SD. 
 
5.3.4. Transcriptional responses of glucose transporters in collagen tissue 
engineered constructs 
There was no significant differences in GLUT1 expression across time points, however it did 
approach significance F (3, 5.589) = 4.206 p = 0.069 (See Figure  5-8A). Interestingly, 
GLUT4 expression was shown to approach significance (F (3, 4.407) = 6.488 p = 0.055), 
with day 2 significantly greater than day 0 (p = 0.05), with expression returning to baseline at 
the later days in culture (Figure  5-8B). MEF2a expression significantly increased with time in 
culture F (3, 14) = 10.014 p = 0.002 increasing at day 2 (p = 0.01) and day 8 (p = 0.002) 
compared to day 0. Expression began to decline at day 10, approaching significance 
compared to day 0 (p = 0.055) (Figure  5-8C). Myogenin expression followed a similar trend 
F (3, 14) = 7.924 p = 0.004 with all days significantly greater than day 0 (p<0.05) 
(Figure  5-8D).  
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Figure  5-8 Time-course transcriptional response of glucose transporter (GLUT1 & GLUT4), 
developmental (MEF2a) and myogenic (Myogenin) genes in collagen based tissue engineered 
constructs. A; GLUT 1, B; GLUT4, C; Myocyte Enhancer Factor 2a (MEF2a), D; Myogenin (MyoG) 
* Significant difference vs. Day 0 (p<0.05).  Mean ± SD (N=4 constructs per time point). 
 
Table  5.2 Raw Ct Values (mean ± SD) genes of interest during skeletal muscle development of 
collagen C2C12 skeletal muscle tissue engineered constructs.  
Gene of Interest D0 D2 D8 D10 
MyoG 26.19 ± 0.36 22.79 ± 0.43 23.07 ± 1.00 22.97 ± 0.92 
MEF2a 21.67 ± 0.51 20.50 ± 0.27 20.63 ± 0.82 20.89 ± 0.85 
GLUT4 29.28 ± 0.63 25.50 ± 1.34 27.94 ± 1.07 27.96 ± 0.61 
GLUT1 20.24 ± 0.58 20.56 ± 0.40 21.25 ± 0.47 20.68 ± 0.54 
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5.3.5. Fibrin tissue engineered gel contraction during differentiation 
Macroscopic images were obtained daily for measurement of gel width during differentiation 
and maintenance within fibrin skeletal muscle constructs. Gel width significantly reduced 
with time in culture F (6) = 32.437, p < 0.0001 with all times points significantly lower than 
day 0 in differentiation (Figure  5-9).   
 
Figure  5-9 Gel width (mm) measurements of fibrin based tissue engineered constructs during 
differentiation period. *Significantly different vs D0 (p<0.05), ‡ significantly different vs D2 (p<0.05), 
† significantly different vs D4 (p<0.05). Data is presented as mean ± SD (N=4 constructs per time 
point). 
 
5.3.6. Transcriptional responses of glucose transporters in fibrin based tissue 
engineered constructs 
 Despite an increase in myogenin expression at day 2 of differentiation and its maintenance 
for the duration in culture thereafter (Figure  5-10B), there was no significant difference 
between time-points F (6, 8.608) = 2.473 p = 0.111. Similarly, as expected there was no 
significant differences in GLUT1 expression throughout the culture period (Figure  5-10C). In 
contrast, MEF2a expression significantly increased at day two and remained significantly 
elevated compared to day 0 for the duration of time in differentiation F (6, 9.121) = 25.050 p 
< 0.001. GLUT4 expression steadily increased over time in differentiation F (6, 7.235) = 
3.905 p = 0.047 with day 12 significantly different too day 0 (Figure  5-11). 
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Figure  5-10 Time-course of transcriptional responses of glucose transporter (GLUT1), developmental 
(MEF2a) and myogenic (Myogenin) genes in fibrin based tissue engineered constructs. A; MEF2a, B; 
Myogenin, C; GLUT1. * Significant difference vs. Day 0 (p<0.05).  Mean ± SD (N=4 constructs per 
time point). 
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Figure  5-11 Time-course of transcriptional responses of glucose transporter GLUT4, gene in fibrin 
skeletal muscle tissue engineered constructs. Mean ± SD (N= 4 Constructs per time point) * 
significantly difference compared to day 0 (p<0.05).  
 
Table  5.3 Raw Ct Values (mean ± SD) genes of interest during skeletal muscle development of fibrin 
C2C12 skeletal muscle tissue engineered constructs. 
Gene of 
Interest 
D0 D2 D4 D6 D8 D10 D12 
MyoG 26.23 ± 
1.33 
23.71 ± 
1.53 
23.37 ± 
1.60 
23.33 ± 
1.17 
23.40 ± 
0.93 
23.04 ± 
1.32 
22.87 ± 
0.98 
MEF2a 21.10 ± 
0.19 
20.40 ± 
0.68 
20.18 ± 
0.85 
20.34 ± 
0.59 
20.42 ± 
0.35 
20.08 ± 
0.53 
20.28 ± 
0.31 
GLUT4 26.69 ± 
1.85 
26.59 ± 
0.45 
26.17 ± 
1.04 
26.05 ± 
1.11 
25.41 ± 
0.89 
25.54 ± 
0.73 
25.10 ± 
0.77 
GLUT1 21.21 ± 
0.31 
21.89 ± 
0.80 
21.90 ± 
0.40 
21.90 ± 
0.50 
21.75 ± 
0.15 
21.46 ± 
0.27 
21.15 ± 
0.37 
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5.4. Discussion 
Insulin stimulated glucose uptake in skeletal muscle is mediated by specific glucose 
transporters, mainly GLUT4. In addition, skeletal muscle both in vivo and in vitro has been 
shown to express GLUT1 and GLUT4 at both the transcriptional and translation levels (Liu et 
al., 1994; Mitsumoto et al., 1991; Santalucía et al., 1992). Since little research has been 
conducted investigating glucose transporters in tissue engineered skeletal muscle constructs, 
the experiments aimed to determine both the gene and protein expression of glucose 
transporters in the two tissue engineered skeletal muscle models. Because GLUT1 and 
GLUT4 is the predominant transporter of cellular glucose uptake in skeletal muscle (Gaster, 
Handberg, Beck-Nielsen, & Schroder, 2000), time-course analysis experiments were 
conducted in order to investigate the transcriptional changes of GLUT1 and GLUT4 during 
differentiation. 
5.4.1. Glucose transporter expression in monolayer cell culture 
During the process of differentiation, cells exit the cell cycle and fuse together to form multi-
nucleated myotubes (Buckingham et al., 2006). The formation of these myotubes relies on an 
increases in gene expression of a number of myo-regulatory factors (Buckingham et al., 
2003). Myogenin and myocyte enhancer factor 2a (MEF2a) are implicated in myogenesis and 
the regulation of GLUT4 mRNA expression. This is due to their location on the GLUT4 
promoter region (Mora and Pessin, 2000). Exposure of cells to differentiation media, which 
resulted in the formation of multi-nuclear myotubes, unsurprisingly significantly increased 
Myogenin and MEF2a mRNA expression respectively (Figure  5-3). Despite the importance 
of MEF2a in GLUT4 expression, work by Jensen and colleagues using denervated skeletal 
muscle showed that MEF2a was not implicated in the down regulation of GLUT4 expression 
(Jensen et al., 2009), but rather the reduction in GLUT enhancer factor expression which 
further upstream of MEF2a on the GLUT4 transcription initiation site. These findings could 
potentially explain the increases in MEF2a that were observed with differentiation of skeletal 
muscle despite the small changes in GLUT4 expression which could be regulated by other 
promoter sites and signalling pathways (Jensen et al., 2009). 
Although low expression levels of GLUT4 mRNA and protein have previously been reported 
in C2C12 skeletal muscle cells (Kotliar and Pilch, 1992), subsequent research has 
investigated glucose transporter expression within this cell line (del Aguila et al., 2011; Ma et 
al., 2013; Nedachi and Kanzaki, 2006). The use of both wild-type and myc-tagged GLUT4 
110 
 
transfected C2C12’s (Nedachi and Kanzaki, 2006), has provided evidence that C21C12 
skeletal muscle cells express, albeit low levels of GLUT4 mRNA and protein (Philp et al., 
2010). The current findings showed that in response to differentiation these C2C12 skeletal 
muscle cells increase their mRNA expression of GLUT4. In addition, western blots of 
GLUT4 showed there to be an increase in GLUT4 abundance during skeletal muscle 
differentiation (Figure  5-5). This data initial data shows the potential for GLUT4 to be 
expressed in skeletal muscle myotubes. Following this, the expression of GLUT4 was 
investigated as a positive control in skeletal muscle lysate from a human biopsy; however 
identification of a clear band at 50kDa was not attainable and therefore unquantifiable despite 
clear visualisation of β-Actin, which was used as a normalisation protein (Section 10.2). 
Therefore further optimisation of for investigating the abundance of GLUT4 protein in 
skeletal muscle cultures and native tissue requires further optimisation and consideration 
(Section  10.3).   
5.4.2. Glucose transporter expression in tissue engineered skeletal muscle 
GLUT4 expression in vitro has been speculated to be of low abundance compared to the 
more embryonic GLUT1 transporter (Baker, Dennis, & Larkin, 2003). Within myoblasts, the 
expression of GLUT4 is relatively low compared to expression of GLUT1 (Santalucia et al., 
1992). However, upon differentiation of myoblasts into multinucleated myotubes from both 
primary satellite cells as well as established cell lines, the expression of GLUT4 mRNA and 
proteins is increased (Liu et al., 1994). In both fibrin and collagen skeletal muscle constructs 
differentiation resulted in a significant increase in GLUT4 mRNA expression. However, 
further research is required in order to identify changes in the ratio of GLUT4: GLUT1 
occurs during skeletal muscle development in vitro, particularly as denervation of skeletal 
muscle contributes to an elevation in GLUT1 expression. Denervation of in vivo skeletal 
muscle has shown to result in a reduction in GLUT4 expression within both oxidative and 
glycolytic skeletal muscle (Block, Menick, Robinson, & Buse, 1991; Handberg et al., 1996; 
Jones, Tapscott, Olson, Pessin, & Dohm, 1998). This results in greater basal glucose uptake 
and subsequently reduced insulin stimulated glucose uptake (Handberg et al., 1996). 
Although there was no observed increase in GLUT1 mRNA in these culture conditions, the 
fact that both the current tissue engineered skeletal muscle models and those developed 
previously (Baker et al., 2003), are a-neural, and could provide an alternative hypothesis for 
the expression profile observed in post-differentiated skeletal muscle cultures. 
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The high expression of GLUT1 in skeletal muscle is indicative of foetal development where 
it is expressed to a higher extent than GLUT4 (Gaster et al., 2000). Tissue engineered skeletal 
muscle models; in particular the fibrin based tissue engineered constructs, have been used to 
investigate electrical stimulation (Khodabukus et al., 2007), and more recently to investigate 
proteins involved in metabolism (Khodabukus and Baar, 2014a). Khodabukus and Baar have 
shown that growth of C2C12 fibrin tissue engineering constructs cultured in high glucose 
based medium express significantly higher GLUT4 protein levels compared to low glucose 
media. Similarly, the current findings concur with the continuous increase in GLUT4 mRNA 
expression during skeletal muscle development observed in the current experiments. 
In addition, the use of collagen based tissue engineered constructs has been used more in 
detail to investigate skeletal muscle development (Cheema et al., 2003). The peak in GLUT4 
mRNA expression in collagen gels during early skeletal muscle differentiation (day 2) is a 
similar expression profile to what has been observed previously for both IGF-1e and MGF 
mRNA (Cheema et al., 2003). The pattern of mRNA expression of both IGF-1e and MGF 
have been linked to force generation (Cheema et al., 2003), however the exact relevance in 
relation to the expression of GLUT4 remains to be elucidated. Additionally, although these 
constructs over time differentiate to form aligned skeletal muscle myotubes (Figure  5-6); 
further experiments are required to investigate the impact of the GLUT4 mRNA expression 
profile at the translational level, and ultimately its effect upon glucose uptake. 
The skeletal muscle tissue engineered constructs developed within the literature have 
repeatedly been used to investigate their force production characteristics (Dennis & Dow, 
2007; Dennis et al., 2001; Huang et al., 2005). However, in spite of the production of force in 
these constructs, and the advancements in the characterisation of in vitro models of skeletal 
muscle innervation (Larkin, Van der Meulen, Dennis, and Kennedy, 2006; Morimoto, Kato-
Negishi, Onoe, and Takeuchi, 2013), they have remained anural. The implications of 
denervation upon GLUT4 expression has been identified (Handberg et al., 1996; Jensen et al., 
2009; Jones et al., 1998). Several authors have reported a rapid reduction in GLUT4 mRNA 
and protein expression within skeletal muscle within less than a week of denervation within 
skeletal muscle from rodent models (Zhou, Vallega, Kandror, and Pilch, 2000). This 
reduction has been shown to result in an increase in GLUT1 expression both at the plasma 
membrane, but also within the cytosolic regions. Zhou and colleagues reported an increase 
GLUT1 protein concentration within intercellular fraction of skeletal muscle from rodents, 
which are separate from the GLUT4 storage vesicles (Zhou et al., 2000). This compensatory 
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mechanism leads to an increase in basal glucose uptake and GLUT1 mediated insulin 
stimulated glucose uptake within denervated skeletal muscle. 
5.5. Conclusion and Summary 
The purpose of this Chapter was to investigate the transcriptional and translation response of 
glucose transporters in cell culture and two tissue engineered skeletal muscle models using 
fibrin and collagen matrices. Time-course experiments using two-dimensional cultures and 
three-dimensional skeletal muscle tissue engineered constructs show that these systems 
express both GLUT1 and GLUT4 mRNA, the two main glucose transporters expressed in 
skeletal muscle. Furthermore, as skeletal muscle cells both in monolayer and skeletal muscle 
tissue engineered constructs differentiate to for multinucleated myotubes, all three models 
increase their expression of GLUT4, the major insulin stimulated glucose transporter 
expressed in mature skeletal muscle. As a result of these experiments, which have shown that 
the expression of the key insulin stimulated glucose transporter, GLUT4 increases its 
transcriptional expression during differentiation of tissue engineered constructs.
113 
 
 
6. The effects of acute and chronic insulin exposure upon C2C12 skeletal 
muscle cells in monolayer cell culture 
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6.1. Introduction 
Insulin stimulated glucose uptake in skeletal muscle accounts for the majority of postprandial 
glucose disposal (DeFronzo et al., 1983). Insulin signalling involves the phosphorylation of a 
number of key signalling proteins which initiate movement of glucose transporters to the cell 
membrane (Gaster et al., 2000). Although in principle the initiation of glucose uptake through 
insulin stimulation sounds simple, a number of proteins play critical roles in the successful 
activation of this signalling pathway, and impairments in activity of these proteins contributes 
to attenuated insulin signalling and subsequently, defective glucose homeostasis (Taniguchi 
et al., 2006). 
The culture of skeletal muscle cells in vitro provides a system to understand cellular 
mechanisms independent of a systemic environment using cells from primary, or cell line 
sources. Primary cell culture from human muscle has presented an intrinsic defect in insulin 
signalling when grown in vitro (Gaster et al., 2002; Henry et al., 1995; Thompson et al., 
1996). However, the use of primary human skeletal muscle cells in culture can have its 
limitations due to their reduced myogenic potential in vitro (Sell et al., 2008; Thompson et al., 
1996). Therefore, stable cell lines such as C2C12 and L6 rat myoblast cells have been used as 
alternative candidates for investigating the mechanisms of skeletal muscle insulin signalling 
and glucose uptake (del Aguila et al., 2011; Kumar and Dey, 2003; Philp et al., 2010). 
Although a number of proteins are involved in effective insulin signalling (Figure  2-5), a 
select group of proteins have been termed as ‘critical nodes’ of insulin signalling (Taniguchi 
et al., 2006). Insulin receptor substrate one (IRS-1) is a tyrosine kinase docking protein, 
which is phosphorylated by the insulin receptor upon insulin stimulation (White, 1998). 
Several tyrosine residues have been identified which enable recruitment of downstream 
proteins such as p85 subunit of phosphatidylinositol 3-kinase (PI-3 kinase) (Shepherd, 2005). 
However, serine/threonine phosphorylation of IRS-1 has been found to impair IRS-1 
signalling in adipocytes  and skeletal muscle (Bouzakri et al., 2003). In addition, Akt, a 14-3-
3 serine/threonine kinase is a downstream protein of p85 PI-3 kinase and is implicated in 
insulin stimulated glucose uptake (Brozinick & Birnbaum, 1998). Knockout models have 
implicated the importance of Akt in glucose metabolism which is severely impaired in Akt 
knockout rodents (Cleasby et al., 2007). Both Threonine 308 (Thr308) and Serine 473 (Ser473) 
are key phosphorylation sites (Cozzone et al., 2008). Phosphorylation of Ser473 is required for 
full kinase activity and has been found to be impaired in skeletal muscle from both obese and 
diabetic subjects (Cozzone et al., 2008; Krook et al., 2000, 1998).  
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In addition to the effects of insulin upon cellular signalling pathways, insulin is a major 
regulator of gene expression (O’Brien and Granner, 1996). The expression of metabolic 
genes such as hexokinase II, which catalyses glucose to glucose-6-phosphate (Printz et al., 
1993), and peroxisome proliferator-activated receptor coactivator – 1α (PGC-1α), an 
important mediator of fat oxidation and mitochondrial biogenesis (Mootha et al., 2003), are 
activated upon acute insulin stimulation. Similarly to the translational response, the 
transcriptional mRNA expression of these genes as well as others involved in membrane 
trafficking, and lipid metabolism, have been found to differ between healthy and insulin 
resistant skeletal muscle (Bach et al., 2002; Ducluzeau et al., 2001). 
Although the positive effects of insulin are well documented, chronic exposure to elevated 
insulin concentrations, which is often an associated symptom with hyperglycaemia, can have 
negative effects upon phosphorylation and activation of the insulin signalling cascade (Ueno 
et al., 2005). Previous research using C2C12 cells has found that hyperinsulinemia or 
exposure to inflammatory cytokines results in a reduction in insulin receptor signalling and 
glucose transport, leading to an insulin insensitive model of skeletal muscle (del Aguila et al., 
2011; Kumar and Dey, 2003). 
The exposure of differentiating skeletal muscle cells was a replication of the experiment and 
findings of Kumar and Dey (2003). Further experiments were conducted to investigate the 
effects of chronic insulin exposure upon post-mitotic skeletal muscle myotubes to determine 
if the findings observed previously in the literature and in the current experiments would 
translate in developed skeletal muscle myotubes. It was hypothesised that chronic exposure 
of skeletal muscle cells to insulin during and post differentiation would result in attenuated 
phosphorylation of proteins involved in insulin signalling and impaired mRNA expression of 
genes implicated in metabolism.   The findings from these experiments would define the most 
appropriate method of exposing skeletal muscle cells to insulin and to investigate the effects 
of chronic insulin exposure upon skeletal muscle tissue engineered constructs. Therefore the 
purpose of these experiments was to:  
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1. To identify the most appropriate method for inducing insulin insensitivity in C2C12 
skeletal muscle cells which could be used for experiments in three dimensional 
skeletal muscle tissue engineered constructs. 
2. Investigate the effects of exposure to a hyperinsulineamic environment upon 
differentiating and post-mitotic C2C12 murine myoblast mRNA expression, insulin 
signalling and glucose uptake.  
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6.2. Methods 
6.2.1. Experimental protocol 
 Chronic insulin exposure upon differentiating skeletal muscle cells 6.2.1.1.
C2C12 myoblasts were seeded into six well plates and grown until confluent as previously 
described (Section  3.1). Cells were changed to either a control (CON) differentiation media 
(DMEM + 2% HS), or an insulin treated (IT) media (DMEM + 2% HS and 100 nM Insulin) 
(Figure 6-1A). The media was changed twice daily for three days, before being stimulated 
with insulin as outlined below (Section  6.2.1.3)  
 Chronic insulin exposure upon post-mitotic skeletal muscle myotubes 6.2.1.2.
The purpose of this experiment was to investigate the effects of chronic insulin exposure 
upon insulin signalling, and glucose uptake in post-mitotic skeletal muscle myotubes. C2C12 
murine myoblasts were cultured as previously described in standard growth media 
(Section  3.1). Upon confluence the media was changed to standard differentiation media as 
previously described (Section  3.1.1). Cells were allowed to differentiate for 72 hours (PRE) 
(Figure 6-1B). This duration was determined based on results in the previous Chapter which 
shown 72 hours in differentiation media to induce a significant increase in myogenic 
regulatory factor expression (Chapter  5). Skeletal muscle myotubes were exposed to either 
control media (CON) or insulin treated media (IT) as described above (Section  6.2.1.1). To 
assess insulin signalling of differentiated skeletal muscle myotubes, differentiation media was 
changed 1 hour prior to exposure to 100 nM of human recombinant insulin in Krebs ringer 
HEPES buffer or left unstimulated. 
 Acute insulin stimulation of skeletal muscle in vitro 6.2.1.3.
The media was changed one hour prior to the start of the experiment, at which point cells 
were washed twice in Krebs Ringer HEPES (KRH) buffer (10mM HEPES pH7.4, 138mM 
NaCl, 4.7mM KCl, 1.25mM CaCl2, 1.25mM MgSO, 5mM Glucose and 0.05% BSA).  
Samples were incubated twice for 30 minutes before being stimulated for 5 minutes with 
insulin (100 nM) or left un-stimulated. Cells were washed twice in PBS before being lysed 
within the respective lysis buffers. 
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Figure  6-1 Experimental schematic for exposure of C2C12 skeletal muscle cells to insulin. A; 
Exposure to differentiating skeletal muscle cells. B; insulin exposure to post-mitotic skeletal muscle 
cells. 
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6.2.2. Immunostaining 
Skeletal muscle cells were ded onto gelatine coated glass coverslips coated with 0.5% gelatin 
in PBS. Following completion of the experiment (Section 6.2.1), plates were fixed for 
immunocytochemistry as described previously (Section  3.4). Cells were imaged at20X 
magnification and analysed for the number of myotubes, myotube width, length and the 
number of nuclei per myotube for all conditions. Images were collected from three coverslips 
per well, three wells per conditions from two independent experiments.  
6.2.3. RNA extraction and PCR analysis 
RNA was extracted using TRI reagent lysis buffer and quantified as previously described 
(Section 3.2). Samples were diluted (Section 3.2) and analysed for a group of genes which 
have previously been identified to be attenuated in an insulin resistant state (Ducluzeau et al., 
2001). The analysis of HKII, PGC-1-α, rRAD, GLUT4 and MyoG mRNA expression by 
qPCR as outlined (Table  3-2). Forward and reverse primer sequences are presented in the 
general methods Section of this thesis (Table  3-3). 
6.2.4. Immunoblotting 
Samples were lysed in protein lysis buffer (50mM HEPES, 150mM NaCl, 1.5 MgCl2, 1Mm 
EGTA, 50mM NaF, 50mM β-glycerolphosphate, 1mM Na3VO4, 1% Triton X-100 and 2mM 
PMSF) as previously used in C2C12 myoblasts (Kumar & Dey, 2003). Samples were stored 
at -80ºC until later analysis. Protein concentrations were determined in triplicate using a 
protein assay as previously described (Section  3.5.5). Samples were separated by 
electrophoresis on 12% SDS-PAGE gels before being transferred onto nitrocellulose 
membranes for blotting with specific primary antibodies (Table  3-4) at a concentration of 
1:1000 in TBST, 5% BSA. Following overnight incubation, membranes were washed and 
incubated in secondary antibody (1:1000 in TBST, 5% non-fat milk) for one hour before 
being exposed using ECL reagent as previously described (Section 3.4). 
6.2.5. Immunoprecipitation 
Samples were lysed in 500µl of Radio-Immunoprecipitation Assay (RIPA) buffer and 
10µl/mL of protease/phosphatase inhibitor cocktail mix (Fisher-Scientific, Loughborough, 
UK) and rotated for 30 minutes at 4ºC before being frozen at -80ºC for later analysis. IRS-1 
complex was isolated by immunoprecipitation as previously described (Section  3.5.8.2) 
before being boiled in 3X reducing buffer (0.35M Tris-HCl, 10% SDS, 36% Glycerol, 5% β-
mercaptoethanol, 0.012% bromophenol blue and 0.3% Twwn-20) for 5 minutes at 100ºC. 
Samples were loaded and separated on 8% SDS polyacrylamide gels and analysed for the 
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expression of total and phosphorylated IRS-1 by western blot as previously outlined 
(Section  3.5.8.2). 
6.2.6. 3H-Deoxy-D-Glucose uptake 
The measurement of glucose uptake was performed following insulin exposure to both 
differentiating and post-mitotic skeletal muscle cells (Figure 6-2), as described previously 
(Section  3.6.1). Concurrent 24 well plates were used to measure protein concentrations upon 
termination of the experiment (Section  3.5.5).  
 
Figure  6-2 Protocol schematic for investigating insulin stimulated glucose uptake in A; differentiating 
and B; Post-mitotic skeletal muscle myotubes.  
 
6.2.7. Statistical Analysis 
Statistical analysis was conducted using SPSS statistical software (IBM SPSS, Version 19, 
NY, USA). A difference between groups was investigated by analysis of variance (ANOVA) 
with Bonferroni post-hoc comparisons to identify any differences between conditions. Data 
which violated the assumptions of homogeneity of variance and normal distribution was 
analysed by non-parametric tests. Immunofluorescence data was analysed by multiple 
analyses of variance (ANOVA) from two independent experiments conducted in triplicate 
wells containing three coverslips. Transcriptional and translational data is presented as mean 
± SD and is an accumulation of three independent experiments (n=3). Differences in protein 
concentrations in differentiating skeletal muscle cells was analysed by independent samples t-
test, which differences in myotube experiments analysed by ANOVA.  
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6.3. Results 
The purpose of these experiments was to investigate the effects of chronic and acute insulin 
exposure upon differentiating skeletal muscle cells and post-mitotic skeletal muscle myotubes. 
Protein and gene expression data were obtained to investigate the molecular response and 
glucose uptake was investigated to establish the functional response of skeletal muscle cells 
as a result of insulin exposure. Therefore, this results Section will be divided into two 
Sections with the first Section presenting data relating to the effects observed in 
differentiating skeletal muscle cells and the second, the response of skeletal muscle myotubes 
to chronic and acute insulin exposure. 
6.3.1. Chronic and acute insulin exposure upon differentiating skeletal muscle 
cells. 
 Protein Concentration is increased following insulin exposure in 6.3.1.1.
differentiating skeletal muscle cells. 
C2C12 skeletal muscle cells were differentiated into skeletal muscle myotubes (Figure 6-4) 
whilst being exposed to either control or insulin supplemented media. Following 72 hours 
differentiation, protein assay was conducted to investigate if exposure to insulin increased 
protein concentration. Exposure to insulin resulted in a significant increase in protein 
concentration compared to control skeletal muscle cells t (22) = -2.651, p = 0.015 (Figure 
6-3). 
 
Figure  6-3 Protein Concentration of differentiating C2C12 skeletal muscle cells exposed to control or 
insulin-supplemented media. Data is mean ± SD are triplicate samples from 2 independent 
experiments. * Significant difference between conditions (p<0.05).
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Figure  6-4 Representative Desmin staining (Red) C2C12 skeletal muscle cells counter stained with DAPI (Blue) during differentiation when exposed to A) 
control or B) insulin (100 nM) supplemented media. Scale bar = 100µm
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 Protein expression in differentiating skeletal myoblast cells 6.3.1.1.
In order to assess the effect of hyperinsulinemia upon insulin signalling, we analysed three 
key proteins that are critical for insulin stimulated glucose uptake to occur. Phosphorylation 
of IRS-1 at tyrosine residue 632 indicated a significant difference between conditions (F (2, 
27) = 5.061, p = 0.007) (Figure 6-5). CON US was significantly greater compared to both IT 
treated conditions respectively (p<0.01). Furthermore, CON ST was significantly greater than 
IT US (p = 0.033) and approached significance between IT ST condition (p = 0.054). The 
changes in phosphorylation came with no changes in total IRS-1 expression (F (2, 27) = 
5.061, p = 0.007) (Figure 6-5C). 
 
Figure  6-5 Determination of phosphorylated and total Insulin Receptor Substrate -1 (IRS-1) 
expression in C2C12 myoblasts. C2C12’s were exposed to either control media (CON) or insulin 
treatment media (IT) for 72 hours. Cells were  either left un-stimulated (US) or re-stimulated (ST) 
with 100 nM insulin. * Significantly different vs. IT-US (P<0.05), # significantly different vs. IT-ST 
(P<0.05). 
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 P85 PI-3 kinase 6.3.1.1.
Although p85 protein content was elevated with insulin treated stimulated samples, one-way 
ANOVA revealed a violation of homogeneity of variances and was corrected for using 
Welch-F test for equity of means. Correction of the violated assumption showed a significant 
differences between conditions F (3, 13) = 8.08 p= 0.003 with an increase within insulin 
stimulated condition compared to all other conditions (p < 0.05) (Figure 6-6).   
 
Figure  6-6 Protein abundance of p85 subunit Phosphatidylinositol 3-Kinase (PI 3-Kinase) in C2C12 
myoblasts. C2C12’s were exposed to either control media (CON) or insulin treatment media (IT) for 
72 hours. Cells were either left un-stimulated (US) or re-stimulated (ST) with 100 nM insulin. * 
Significantly different vs. all other conditions (P<0.05). 
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 Total and Phosphorylation of Akt (Ser473). 6.3.1.2.
Akt is a key 14-3-3 domain protein which highly implicated within the insulin signalling 
cascade (Brozinick, Roberts, & Dohm, 2003), and has subsequently been found to have 
impaired phosphorylation activity upon its serine residue in type II diabetics (Krook et al., 
1998). Although there was a small increase in total protein content within the insulin treated 
condition, unsurprisingly there were no significant experimental effects upon total Akt 
protein content between condition F (3,28) = 2.763, p = 0.61. One-way ANOVA revealed a 
violation of homogeneity of variances and was corrected for using Welch-F test for equity of 
means. There was a significant experimental effect observed F (3, 11) = 3.33 p= 0.05. Post-
hoc analysis showed, unsurprisingly a significant increase in phosphorylation of Akt (Ser473) 
between un-stimulated and stimulated control samples (p = 0.08) and differences between 
control stimulated samples and insulin treated un-stimulated samples (p = 0.03). However, 
there was no significant difference between acute stimulation in chronically insulin treated 
cells (p = 0.74), or a differences between control unstimulated condition (p = 0.37) (Figure 
6-7). 
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Figure  6-7 Phosphorylated and total Akt protein abundance in C2C12 myoblasts. C2C12’s were 
exposed to either control media (CON) or insulin treatment media (IT) for 72 hours. Cells were  
either left un-stimulated (US) or re-stimulated (ST) with 100 nM insulin. * Significantly different vs. 
all other conditions (P<0.05). 
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 Gene expression following chronic insulin exposure in 6.3.1.1.
differentiating skeletal muscle cells 
 
Gene expression of PGC-1α mRNA expression was affected by both chronic F (1,18) = 
10.633, p = 0.004 and acute stimulation F (1,18) = 7.600, p = 0.013 which increased in 
control cells (p = 0.002) but not in insulin cells (p = 0.195) (Figure 6-8A). HKII was 
significantly different between conditions F (3,20) = 8.209, p = 0.001, with control stimulated 
samples showing greater mRNA expression compared to both insulin treated conditions (p < 
0.05) (Figure 6-8B). There was a significant difference in GLUT4 mRNA expression 
between groups with unstimulated control samples showing a significantly higher expression 
compared to all other conditions F (3,17) = 9.988, p =0.001 (Figure 6-8C). Similarly, rRAD 
expression was significantly different between conditions F (3,17) = 9.988, p =0.001, with 
control stimulated samples significantly higher compared to all other conditions (Figure 
6-8D). Myogenin mRNA expression showed there to be a significant difference between 
groups F (3,6.183) = 15.959, p =0.003, which acute insulin stimulation significantly in insulin 
treated samples to be lower compared to all other conditions (p < 0.001) (Figure 6-9). 
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Figure  6-8 Gene expression of in C2C12 myoblast cells. C2C12’s were exposed to either control 
media (CON) or insulin treatment media (IT) for 72 hours. Cells were  either left un-stimulated (Open 
bars) or re-stimulated (Filled bars)., A; PGC-1α, B; Hexokinase II, C; Glucose Transporter 4 
(GLUT4), D; Ras Associated Diabetes (rRAD).   * Significantly different vs. all other condition 
(p<0.05). ‡ Significantly different vs. Insulin Unstimulated (p <0.05), † significantly different vs. 
Insulin Stimulated (p <0.05). 
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Figure  6-9 Myogenin (MyoG) gene expression of in C2C12 myoblasts. C2C12’s were exposed to 
either control media (CON) or insulin treatment media (IT) for 72 hours. Cells were  either left un-
stimulated (Open bars) or re-stimulated (Filled bars) * Significantly different vs. all other condition 
(p<0.05). 
 
 
Table  6.1 Raw Ct Values (mean ± SD) genes of interest during differentiation of skeletal muscle cells 
exposed to insulin. 
Gene of Interest Control - 
Unstimulated 
Control - 
Stimulated 
Insulin - 
Unstimulated 
Insulin - 
Stimulated 
HKII 23.43 ± 2.16 22.31 ± 2.18 21.91 ± 2.24 19.88 ± 1.15 
GLUT4 27.89 ± 1.94 30.24 ± 2.83 27.17 ± 0.72 26.52 ± 1.01 
PGC-1α 25.93 ± 1.31 27.13 ± 1.42 27.08 ± 1.83 25.27 ± 0.93 
rRAD 25.64 ± 1.51 25.83 ± 1.40 24.83 ± 1.26  24.81 ± 1.82 
MyoG 28.82 ± 3.20 29.38 ± 2.46 30.11 ± 2.69 28.00 ± 3.23 
 
  
130 
 
 
 3H-Deoxy-D-Glucose uptake 6.3.1.2.
Glucose uptake was measured as described in Section 3.7. As a result of chronic insulin 
exposure there was a significant difference in glucose uptake between conditions F (1, 26) = 
5.251 (p =0.030). As expected, there was a significant difference between acute stimulation F 
(1, 26) = 6.905 (p = 0.014). Interaction effects F (1, 26) = 4.865 (p =0.036) showed 
significant increases in glucose following insulin stimulation in the control skeletal muscle 
cells (p = 0.003) but interestingly a significant difference in unstimulated samples between 
conditions was observed (p = 0.005) (Figure 6-10).  
 
 
Figure  6-10 3H-Deoxy-D-Glucose uptake in differentiating C2C12 skeletal muscle cells. Skeletal 
muscle cells were exposed to low serum media supplemented without (Control) or with (Insulin) the 
addition of insulin (100 nM). Data are Mean ± SD of four independent experiments (N=4). 
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6.3.2. Chronic and acute insulin exposure upon post-mitotic skeletal muscle 
myotubes 
 
Figure  6-11 Phase contrast image of C2C12 skeletal muscle myotubes prior to treatment (A; PRE), 
following Control treatment (B; CON) or following Insulin treatment (C; INS). Scale bar = 100µm. 
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 Protein Expression in post-mitotic skeletal muscle myotubes 6.3.2.1.
Protein was extracted principally for investigation of specific proteins of interest in relation to 
insulin signalling. In addition to the role of insulin upon glucose metabolism, it also 
contributes to the regulation of protein synthesis (Proud, 2006). A significant difference was 
found between conditions in protein concentrations with post-hoc comparisons showing a 
significant difference F (2, 50) = 4.549, p = 0.016 between myotubes exposed to insulin 
compared to initial differentiated myotubes (PRE-T vs. IT) (p = 0.02). Despite insulin 
showing a slight increase in protein concentrations, there was no significant difference in 
protein concentration between control and chronically incubated myotubes (p = 0.064) 
(Figure 6-12). 
 
Figure  6-12 Protein concentration (µg•µl) of protein lysates collected from C2C12 skeletal muscle 
myotubes incubated in control media (CON) or chronically exposed to insulin (100 nM) (IT) 
following differentiation (PRE). * Significantly difference vs. PRE (p <0.05) 
  
133 
 
As investigated in skeletal muscle cells, phosphorylation of Akt (Ser473) was used to 
determine the effects of insulin exposure upon the insulin signalling cascade. There were 
significant differences between means F (2, 17) = 5.632, p = 0.007. Bonferroni corrections 
showed significant increase in Akt phosphorylation following acute insulin stimulation in 
post-mitotic skeletal muscle myotubes (p = 0.034). Acute stimulation in post-mitotic skeletal 
muscle myotubes was also significantly greater than control unstimulated (p = 0.016) and 
stimulated myotubes following chronic insulin stimulation (p = 0.01) (Figure 6-13A). As 
shown in previous experiments, there was no significant difference in total Akt expression F 
(2, 27) = 0.252, p = 0.935 (Figure 6-13B). In addition, there was no significant difference in 
total p85 PI-kinase expression between conditions F (2, 17) = 2.081, p = 0.138 (Figure 6-14).  
 
 
Figure  6-13 Total and phosphorylated Akt protein expression in C2C12 skeletal muscle myotubes 
incubated in control media (CON) or chronically exposed to insulin (100 nM) (IT) following 
differentiation (PRE). * Significantly difference between PRE ST (p <0.05). 
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Figure  6-14 Total p85 PI-3 kinase protein expression in C2C12 skeletal muscle myotubes incubated 
in control media (CON) or chronically exposed to insulin (100 nM) (IT) following differentiation 
(PRE).  
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 Skeletal muscle myotubes image analysis 6.3.2.2.
Immunohistochemical analysis was conducted following exposure of skeletal muscle 
myotubes to insulin or control media. Morphological characteristics were determined 
following formation of skeletal muscle myotubes and following chronic exposure to insulin. 
Myotubes length increased as a result of time in culture F (2,219) = 37.604 p < 0.001 with 
myotubes significantly longer in both control and insulin exposed myotubes compared to pre-
exposed myotubes (p < 0.001) (Figure 6-15). Differences in myotube length was observed 
between control and insulin exposed myotubes, however with no significantly different (p= 
0.081). Furthermore, as expected with an increased in myotube length (PRE 224.20 ± 46.28 
µm; CON 277.98 ± 64.68 µm; IT 299.16 ± 51.72 µm), there was a significant increase in the 
average number of nuclei per myotube (PRE 24.71 ± 6.60 µm; CON 26.21 ± 7.35 µm; IT 
23.94 ± 6.30 µm) F (2,217) = 45.584 p < 0.001 with both control and insulin myotubes 
significantly greater compared to pre-exposed myotubes (p < 0.001) (Figure 6-15).  
Other morphological characteristics were analysed by non-parametric tests to investigate 
differences between groups and further multiple independent t-tests, with Bonferroni 
correction for multiple comparisons to identify post-hoc differences between conditions. The 
number of myotubes significantly increased in culture t (2) = 42.875 p < 0.0001. Both control 
t (2) = 42.875 p = 0.001 and insulin exposed cultures presented significantly more myotubes 
compared to pre-exposed (Figure 6-15). In addition, there was significantly more myotubes 
in control compared to insulin exposed myotubes t (1) = 10.041 p = 0.001. There was no 
significant differences in myotube width between conditions t (2) = 3.411 p = 0.182 (Figure 
6-15). 
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Figure  6-15 Immunhistolchemical Analysis of C2C12 skeletal muscle myotubes. Data is mean ± SD 
from two independent experiments. * Significantly difference compared to PRE (p <0.01). † 
Significantly different compared to insulin (p <0.01). 
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Figure  6-16 Representative Desmin staining (Red) C2C12 skeletal muscle myotubes counter stained with DAPI (Blue) following (A) 72 hours differentiation, 
and a further 72 hours incubation in either (B) control or  (C) insulin (100 nM) supplemented media. Scale bar = 100µm.
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 Gene expression in post-mitotic skeletal muscle myotubes 6.3.2.1.
Insulin has been reported to affect a number of transcriptional regulators in skeletal muscle 
(O’Brien and Granner, 1996). Therefore genes involved in myogenesis (Myogenin) and 
glucose metabolism (PGC-1, HKII and, GLUT4) were investigated.  There was a main effect 
of GLUT4 expression between the same conditions (p = 0.043) (Figure 6-17A). In addition, 
there was a main effect between conditions (p=0.012) for HKII expression, with post-hoc 
comparisons showing a difference between pre-treated and insulin exposed myotubes 
(p=0.012) (Figure 6-17B). On the other hand, PGC-1α expression was not different between 
conditions, but was significantly affected by acute insulin stimulation (p = 0.011) (Figure 
6-17C). Myogenin mRNA expression showed no main effects for condition F (2, 38) = 0.116 
p = 0.89 or stimulation F (1, 38) = 0.689 p=0.41 however, there was a significant interaction 
affect F (2, 38) = 4.987 p = 0.012). Acute insulin stimulation significantly increased within 
pre-treatment condition (p = 0.016). Although this was not observed in the control condition, 
surprisingly there was a trend for down regulation of expression upon stimulation within the 
insulin treated condition (p = 0.065), which was lower compared to stimulated pre-treatment 
samples (p = 0.041) (Figure 6-17D). 
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Figure  6-17 Gene expression analysis (ΔΔCt) of C2C12 skeletal muscle myotubes incubated in control 
media (CON) or chronically exposed to insulin (100 nM) (IT) following differentiation (PRE). A; 
GLUT4, B; HKII, C; PGC-1α, D; MyoG. # Significantly different between unstimulated (open bars) 
vs. stimulated (closed bars). **Significant main effect between unstimulated vs. stimulated. § 
Significant main effect between PRE-T vs. IT. Data is Mean ± SD of three independent experiments 
(N=3). 
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Table  6.2 Raw Ct Values (mean ± SD) genes of interest during skeletal muscle myotubes exposed to 
insulin. 
 PRE TREATMENT CONTROL TREATMENT INSULIN TREATMENT 
Gene of 
Interest 
Unstimulated Stimulated Unstimulated Stimulated Unstimulated Stimulated 
HKII 20.30 ± 1.97 20.06 ± 0.55 19.96 ± 0.37 19.85 ± 0.72  20.80 ± 0.66 
 
20.01 ± 0.72 
GLUT4 25.31 ± 0.41 25.44 ± 0.49 25.66 ± 0.44 25.14 ± 0.69 25.98 ± 0.62 25.25 ± 0.64 
PGC-1α 23.72 ± 0.74 23.50 ± 1.36 24.02 ± 0.48 22.37 ± 1.17 23.54 ± 0.87 21.87 ± 1.67 
MyoG 23.65 ± 1.52 22.23 ± 0.99 22.53 ± 0.64 21.80 ± 0.83 22.63 ± 0.61 22.15 ± 0.74 
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 3H-2-deoxyglucose uptake in post-mitotic skeletal muscle myotubes 6.3.2.2.
 
Glucose uptake was measured in skeletal muscle myotubes following acute and chronic 
insulin exposure. Non-parametric tests were conducted to investigate differences between 
conditions however no significant differences were observed (p > 0.05) (Figure 6-18).  
 
Figure  6-18 3H-De-oxy-D-Glucose uptake in C2C12 skeletal muscle myotubes. Skeletal muscle 
myotubes were exposed to low serum media supplemented without (Control) or with (Insulin) the 
addition of insulin (100 nM). Open bars represent unstimulated filled bars represented acute 30 
minutes insulin incubation.  Data are Mean ± SD of three independent experiments (N=3). 
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6.4. Discussion 
The purpose of these experiments was to investigate the effect of insulin exposure upon 
skeletal muscle cells during and post differentiation. The experiments conducted in 
monolayer culture aimed to inform subsequent experiments as to the most appropriate 
method of for developing a model of insulin insensitive skeletal muscle through exposure to 
hyperinsulinemia.  Hyperinsulinemia is a symptom of non-insulin dependent diabetes 
mellitus (NIDDM) (Gaster et al., 2002), and has been shown to affect protein signalling 
within insulin sensitive tissues (Ueno et al., 2005). A method of investigating these effects 
upon skeletal muscle, a major endocrine organ, has been through the use of cell culture 
models (del Aguila et al., 2011; Kumar and Dey, 2003). 
PI-3 kinase contains a catalytic (p110) and regulatory (p85) subunit which are activated upon 
phosphorylation of the upstream IRS-1 tyrosine kinase (Peter R Shepherd et al., 1998). In 
normal conditions a pool of p85 monomers exist in balance with p85-p110 heterodimer. 
Subsequently, both monomer and heterodimer compete for the same binding sites therefore 
any imbalance between the two could potentially result in alterations in PI-3 kinase activity 
(Draznin, 2006). The current finding shows that within insulin treated samples, upon acute 
insulin stimulation, there was a significant increase in protein concentrations of p85 PI-3 
kinase. Similar findings have previously been reported in L6 skeletal muscle cells when 
exposed to dexamethasone (Giorgino, Pedrini, Matera, and Smith, 1997), as well as in human 
skeletal muscle from insulin resistant populations (Bandyopadhyay, Yu, Ofrecio, and Olefsky, 
2005). Therefore it could be speculated that exposure to a hyperinsulineamic environment 
during differentiation of skeletal muscle cells results in an alteration in the p85 monomer: 
p85-p110 heterodimer ratio resulting in a negative PI-3 kinase activity and therefore an 
impairment of effective phosphorylation of downstream insulin signalling proteins. If this is 
true, one would expect impairment in the serine/threonine kinase, Akt, and indeed this was 
the case in these experiments.  
Exposure of skeletal muscle cells to insulin during differentiation resulted in impaired acute 
insulin stimulated phosphorylation of Akt at Ser473, as observed in human primary skeletal 
muscle cells (Cozzone et al., 2008). Chronic insulin exposure has been shown to lead to 
degradation of IRS-1 leading to attenuated downstream signalling (Haruta et al., 2000), in the 
case of previous research and the current findings, attenuated Akt phosphorylation (Haruta et 
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al., 2000; Tremblay et al., 2001).  In contrast to differentiating skeletal muscle cells, chronic 
insulin exposure did not appear to have any effect upon phosphorylation of Akt in post-
mitotic myotubes. The protein Akt, is involved in a number of cellular functions, plays a key 
role in metabolism in insulin sensitive tissues (Brozinick & Birnbaum, 1998; Brozinick, 
Roberts, & Dohm, 2003). Phosphorylation of Akt at Serine 473 (Ser473), a key residue for 
ensuring full kinase activity, has been found to be impaired in both skeletal muscle cells 
(Cozzone et al., 2008) and muscle tissue from diabetic individuals (Krook et al., 1998). 
Metabolic diseases have been shown to alter transcriptional expression compared to healthy 
individuals (Bach et al., 2002; Ducluzeau et al., 2001). Although previous research has shown 
a large number of genes have been identified to be affected by insulin, a group which have 
previously been categorised as ‘diabetogenes’ were measured to investigate their response to 
chronic insulin exposure during both differentiation, and in post-mitotic skeletal muscle 
myotubes. Hexokinase II (HKII), which is important in catalysing glucose to form glucose-6-
phosphate, and mRNA expression has previously been shown to be increased upon insulin 
stimulation (Mandarino et al., 1995). In differentiating myoblasts, an increased HKII 
expression was found in control cells as a result of acute insulin treatment, however this 
increase was not evident when cells were chronically pre-treated with insulin. These findings 
concur with those reported in human skeletal muscle which has found impairment in mRNA 
expression of HKII upon insulin stimulation in both obese and diabetic subjects (Pendergrass 
et al., 1998). Skeletal muscle myotubes showed a different mRNA expression pattern with a 
reduction in mRNA expression when exposed to insulin, however were not affected by acute 
insulin stimulation. 
Peroxisome proliferator-activated receptor coactivator – 1α (PGC-1α), is an important 
mediator of mitochondrial biogenesis and has consequently been shown to be down regulated 
in insulin resistant subjects (Mootha et al., 2003). Chronic insulin treatment resulted in a 
reduced mRNA expression of PGC-1α upon acute stimulation, which is similar to recent 
findings in C2C12 myotubes (Philp et al., 2010). Philp and colleagues showed that chronic 
exposure to pyruvate resulted in a significant reduction in PGC-1α and subsequently 
reduction in glucose oxidation within these cells, developing a ‘diabetic-like phenotype’. 
Therefore, based on the current findings, under a hyperinsulineamic environment, a symptom 
of type II diabetes mellitus (Cha et al., 2005), and in concordance with the findings of Philp 
and colleagues, it could be suggested that the impairment in PGC-1α observed in the current 
models replicates that observed in diabetic human skeletal muscle (Cha et al., 2005). 
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Glucose transporters are integral proteins for glucose uptake. Glucose transporter 4 (GLUT4) 
is highly concentrated at the protein and transcriptional levels (Stuart et al., 2006) and is 
predominantly responsible for insulin stimulated glucose uptake in skeletal muscle (Ueyama, 
Yaworsky, Wang, Ebina, and Klip, 1999). Insulin stimulation increases GLUT4 mRNA in 
human and rodent skeletal muscle (Laville et al., 1996), primary human muscle cells (Al-
Khalili et al., 2003; Sarabia et al., 1992) as well as cell lines (Mitsumoto et al., 1991). Acute 
insulin stimulation increases GLUT4 mRNA expression in differentiating skeletal muscle 
cells however did not change in skeletal muscle myotubes. Furthermore, the effects of 
chronic insulin exposure showed to reduce GLUT4 mRNA expression. These findings 
support previous work conducted in adipocyte cells which, similar to skeletal muscle cells, 
has shown acute insulin stimulation to induce an increase in GLUT4 mRNA expression, with 
chronic stimulation with insulin abating an increase in gene expression (Kozka, Clark, and 
Holman, 1991). It has been proposed that the reduction in GLUT4 mRNA expression 
following chronic insulin exposure is due to the change in glucose uptake through alternative 
glucose transporters (Kozka et al., 1991). Furthermore, the reduced expression has been 
shown to reduce protein expression and subsequently insulin stimulated glucose transport via 
the GLUT4 protein (Tordjman, Leingang, James, and Mueckler, 1989). Although GLUT4 or 
GLUT1 protein concentration was not measured in these experiments, the impaired insulin 
stimulated glucose uptake following chronic insulin exposure, which has previously been 
reported in both adipocytes (Kozka et al., 1991; Tordjman et al., 1989) and skeletal muscle 
cells (Kumar and Dey, 2003), could suggest there to be a change in specific glucose 
transporter mediated uptake. 
Glucose uptake in skeletal muscle is mediated through insulin dependent and independent 
mechanisms (Antonescu, Foti, Sauvonnet, and Klip, 2009). Subsequent insulin stimulated 
glucose uptake is important for post-prandial glucose disposal with an impairment in the 
insulin signalling cascade resulting in attenuation of this response (R A DeFronzo et al., 
1983). Glucose uptake was therefore measured using a radioactive isotope tracer glucose 
analogue, 3H-Deoxy-D-Glucose uptake (3H-2DG) used widely within the literature the 
investigate cellular glucose uptake in vitro and considered the ‘gold standard’ for such 
experiments. From the experiments in differentiating C2C12 skeletal muscle cells, within 
control cells, acute insulin stimulated was shown to increase glucose uptake by 
approximately 1.5 fold which supports the increases previously observed within the literature 
using this cell line (Nedachi and Kanzaki, 2006; Philp et al., 2010). However, in comparison 
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to the work of Kumar and Dey with which this experimental protocol was based upon, there 
was a significant increase in glucose uptake within chronically exposed cells to insulin at the 
basal level which was maintained following acute insulin stimulation. In contrast to Kumar 
and Dey (2003), the result here resemble those previously reported in L6 skeletal muscle cells 
by Huang and colleagues (Huang et al., 2002). Importantly, they observed a reduction in 
GLUT4 exocytosis, without changes in GLUT4 expression following sustained insulin 
exposure (Huang et al., 2002). A potential cause of this increase in glucose uptake is mostly 
likely due to increases in basal glucose transporters namely GLUT1, which is responsible for 
basal glucose turnover (Klip & Pâquet, 1990), has been shown to be increased following high 
insulin exposure at the protein level within L6 muscle cells (Huang et al., 2002), and in the 
C2C12 skeletal muscle cell line (Nedachi and Kanzaki, 2006).  
6.5. Conclusion 
In this Chapter, C2C12 skeletal muscle cells were grown in standard culture conditions to 
investigate the effects of acute and chronic insulin exposure upon differentiating and post-
mitotic skeletal muscle. Skeletal muscle cells exposed to insulin during differentiation 
showed a reduction in cell signalling and mRNA expression in response to acute insulin 
exposure. The reduction in sensitivity at the molecular level in differentiating skeletal muscle 
cells translates to an increase in basal glucose uptake, ablating insulin stimulated glucose 
uptake. In contrast, despite a molecular response to acute insulin exposure in post-mitotic 
skeletal muscle myotubes, myotubes grown for longer periods and in the presence of insulin 
were not acutely affected by insulin at the translational level. In addition, the effect of insulin 
exposure upon skeletal muscle myotubes had minimal effect upon insulin stimulated glucose 
uptake. These findings would suggest that insulin has a greater effect upon differentiating 
skeletal muscle cells compared to post-mitotic skeletal muscle myotubes.     
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7 Insulin signalling and glucose uptake in skeletal muscle tissue 
engineering: The effect of acute and chronic insulin exposure. 
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7.1 Introduction 
Skeletal muscle is comprised of highly organised multinucleated myotubes surrounded by an 
extracellular matrix (Gillies and Lieber, 2011), mainly in the form of collagen (Kjaer, 2004). 
In order to further understand the complexities of skeletal muscle physiology, the use of 
human subjects, in vivo animal models (Joost, Al-Hasani, and Schürmann, 2012), as well as 
in vitro cell culture models have sought to disseminate individual factors which potentially 
contribute to skeletal muscle pathophysiology (Abdul-Ghani and Defronzo, 2010). As 
previously discussed (Section  2.4), cell culture provides an isolated environment in which 
single variables can be manipulated whilst in a controlled environment. Furthermore, the use 
of cell lines such as L6 and C2C12 skeletal muscle cell lines, provide a consistent population 
of cells, which are easy and readily available to grow and investigate various aspects of 
skeletal muscle physiology, including insulin signalling and glucose uptake (del Aguila et al., 
2011; Kumar and Dey, 2003). 
7.1.1 In Vitro skeletal muscle tissue engineering for investigating physiological 
applications 
Emerging research in the field of tissue engineering and the development of three 
dimensional (3D) skeletal muscle tissue engineered constructs, have advanced within the 
literature as an in vitro model to investigate physiological and clinical applications (Baar, 
2005; Stern-Straeter, Riedel, Bran, Hörmann, and Goessler, 2007). The development of 3D 
models have utilised various methods of ding skeletal muscle cells within biological 
hydrogels (Hinds et al., 2011) in order to mimic the extracellular milieu in which skeletal 
muscle resides in vivo. The ding of skeletal muscle cells between fixed anchor points results 
in ECM remodelling as the cells self-organise to form uni-axial multinucleated myotubes 
(Hinds et al., 2011; Khodabukus and Baar, 2009a). Previous literature has used 3D tissue 
engineered skeletal muscle models to investigate skeletal muscle development and maturation 
(Cheema et al., 2005, 2003; Mudera et al., 2010), force generation (Robert G Dennis and 
Dow, 2007; Robert G Dennis and Kosnik, 2000; Robert G Dennis et al., 2001), as well as the 
molecular responses to mechanical load (D J Player et al., 2014; Sharples et al., 2012). As a 
result, three dimensional tissue engineered skeletal muscle models have provided an 
alternative culture system, which bridges the gap between in vitro, ex vivo and, in vivo 
models (Baar, 2005).  
The field of skeletal muscle tissue engineering has advanced the field of regenerative 
medicine (Juhas et al., 2014). In addition, the use of these models for drug screening has 
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postulated these models as a method of reducing, refining and replacing the number of 
animals used in research (Vandenburgh, 2010). Furthermore, the use of 3D tissue engineered 
models has the potential provide an insight into various phenomena relating to skeletal 
muscle physiology and function (Khodabukus et al., 2007). Recent research has shown the 
metabolic phenotype of tissue engineered skeletal muscle models can be manipulated by 
glucose and serum exposure during development (Khodabukus and Baar, 2014a, 2014b). 
Despite these recent findings, the use of tissue engineered constructs to investigate insulin 
signalling and glucose uptake is very limited (Baker et al., 2003), despite a number of 
characterised models using various ECMs to investigate physiological responses of skeletal 
muscle (Martin et al., 2013; Player et al., 2014; Powell et al., 2002).  
As previously discussed cell lines such as C2C12 and L6 skeletal muscle cells have 
commonly been used to investigate the insulin signalling and glucose uptake (Nedachi and 
Kanzaki, 2006; Walker et al., 1990). Unlike L6 cells, the use of C2C12 skeletal muscle cells 
have been well characterised in models of skeletal muscle tissue engineering (Khodabukus et 
al., 2009; Player et al., 2014), and while there metabolic phenotype has recently been eluded 
to (Khodabukus and Baar, 2014a, 2014b), the effects of insulin stimulation upon skeletal 
muscle tissue engineered constructs is yet to be elucidated. Establishment of a 3D tissue 
engineered skeletal muscle model which is responsive to insulin and can be manipulated by 
this hormone would enable further understanding of the effects of a 3D environment upon the 
insulin signalling pathway. In addition, development of a culture model which recapitulates 
both the morphological and physiological aspects of native skeletal muscle tissue, and could 
have the potential to be used for a number of applications (Cheng et al., 2014). It was 
hypothesised that similar to the findings observed in monolayer culture (Chapter  6), exposure 
to insulin during differentiation of skeletal muscle tissue engineered constructs would impair 
insulin signalling and therefore, the objectives of this Chapter were to: 
1. Investigate the transcriptional and translational responses to acute and chronic 
insulin exposure in two 3D based skeletal muscle constructs. 
2. To investigate if the effect of chronic insulin exposure can recapitulate the altered 
signalling and transcriptional responses observed in monolayer culture. 
3. To investigate insulin stimulated glucose uptake in 3D tissue engineered constructs. 
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7.2 Methodology 
 
7.2.1 Cell Culture 
C2C12 skeletal muscle myoblasts were culture in GM as outlined (Section  3.1.1). Cells were 
passaged and cell counted (Section  3.1.2), before being seeded onto fibrin or into collagen 
based hydrogels. 
7.2.2 Preparation of fibrin constructs  
Fibrin gels were prepared and developed as previously described (Section  3.2.1). Constructs 
were allowed to proliferate in GM (20% FBS, 1% P/S) supplemented with aminocaproic acid 
(AA) until confluence was attained, before being switched to DM (2% HS, 1% P/S) 
supplemented with AA for two days. Thereafter, constructs were grown in maintenance 
media (7% FBS, 1% P/S, AA) with or without the addition of 100 nM insulin (Figure  7-1A). 
Media was changed daily with constructs maintained in culture for a total of 14 days. At day 
14, macroscopic images were obtained to measure gel width and images for observation of 
myotube formation were obtained by phase contrast microscopy. 
7.2.3 Preparation of collagen constructs 
Collagen tissue engineered constructs were prepared and cast as previously described 
(Section  3.2.2). Constructs were maintained in standard growth media for 4 days with media 
changed twice daily. Thereafter, constructs were changed to standard DM supplemented 
without or with insulin (100 nM) for the remainder of the culture period, with media changed 
daily (Figure  7-1B). Constructs were maintained in culture for a total of 14 days. Upon 
completion of the days in culture, macroscopic images were obtained to measure gel width 
and images for observation of myotube formation were obtained by phase contrast 
microscopy. 
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Figure  7-1 Protocol schematic of acute and chronic insulin exposure in A; Fibrin and B; Collagen 
skeletal muscle tissue engineered constructs. 
7.2.4. Optimisation of acute insulin stimulation in skeletal muscle tissue 
engineered constructs. 
Initial experiments were conducted to establish the responses to acute insulin stimulation. 
Acute stimulation was performed following 14 days total in culture. This culture period was 
based on the previous Chapter which investigated the transcriptional response of glucose 
transporters in fibrin and collagen skeletal muscle constructs (Chapter  5). On day 14 in 
culture, constructs were acutely exposed to insulin as previously described with some slight 
modifications (Section  6.2.1.3). In brief, the media was changed 1 hour prior to being washed 
twice in KRH buffer. Constructs were incubated twice for 30 minutes in KRH buffer before 
being exposed to insulin (100 nM) in a time dependent manner (0-30 minutes). Constructs 
were washed in PBS and blot dried before being snap frozen in liquid nitrogen before being 
quantified for protein as described above. Following these experiments it was decided that 
both fibrin and collagen constructs would be incubated in the presence of absence of insulin 
(100 nM) for 30 minutes and obtained for protein and gene expression analysis.   
7.2.5 Construct lysis for RNA extraction and qPCR 
Both fibrin (N = 4 constructs per condition) and collagen constructs (N = 3 constructs per 
condition) were lysed in TRI-reagent and immediately frozen at -20°C. Constructs were 
homogenised using an electronic stick homogeniser (IKA T10, Fisher-Scientific) in order to 
break down the ECM prior to RNA extraction which was performed as previously described 
(Section  3.3.3). As in the previous Chapter of this thesis (Chapter  6) qPCR analysis was 
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performed for the mRNA expression of HKII, GLUT4, PGC-1α and RPIIβ. Sequences for 
these primers are outline within the methods Section (Table  3-3) and PCR was conducted 
using the Stratagene MX3005p as described previously (Section  3.3.5). Analysis of mRNA 
expression was performed using the ΔΔCt method. 
7.2.6 Construct lysis for protein extraction 
Following the experimental protocol (Figure  7-1), constructs (N = 4 fibrin constructs per 
condition and N = 3 collagen constructs per condition)  were washed in cold PBS and blot 
dried before being snap frozen in liquid nitrogen. Samples were stored and -80°C for later 
analysis. 
Fibrin constructs were homogenised by a 2 minute cycle using a tissue lyser in RIPA lysis 
buffer as previously described (Section  3.5.4). Samples were allowed to rotate at 40rpm for 
60 minutes at 4°C in order to further dissolve cellular material. Samples were centrifuged at 
13,000g for 10 minutes and the supernatant transferred to a fresh 1.5mL Eppendorf tube. 
Protein concentration was determined as previously described (Section  3.5.5).  
Collagen constructs were homogenised by a 2 minute cycle using a tissue lyser (Qiagen 
Tisssuelyser, Qiagen, UK) in laemmli lysis buffer as previously used within this thesis 
(Section  3.5.3). Samples were allowed to rotate at 40 rpm for 60 minutes at 4°C in order to 
further dissolve cellular material. 100% 2-propanol (250 µl per 500 µl of lysis buffer) was 
added and samples were centrifuged at 17,000g for 10 minutes. The supernatant was 
discarded and the pellet was re-suspended in 300 µl of laemmli lysis buffer and allowed to 
rotate for a further 60 minutes at 40 rpm at 4°C. Samples were centrifuged for 5 minutes at 
13,000g after which, the supernatant was removed and placed in a fresh 1.5 mL Eppendorf 
tube. Protein concentration was quantified as previously described (Section  3.5.5). 
7.2.7 SDS-PAGE and Western Blots 
Based on previous optimisation experiments (Section  3.5.6), 5 µg of protein was loaded onto 
7.5% SDS-PAGE gels. Gels were run by electrophoresis for western blot as previously 
described (Section  3.5.7). 
7.2.8 Measurement of 3H-Deoxy-D-Glucose uptakes in fibrin skeletal muscle tissue 
engineered constructs. 
Glucose uptake was measured as previously described (Section  3.6.2). In brief, following 3H-
2DG exposure, constructs were removed from the sutures, blotted and weighed. Individual 
constructs were dissolved in a 1:10 (wt/vol) dilution of 1M potassium hydroxide (KOH) 
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solution, placed in boiling water for 2 min, placed on ice for 5 minutes. After this, samples 
were neutralized by adding 1M HCI in a 1:10 (wt/vol) dilution of construct wet weight, and 
20 µl of each sample was placed in a scintillation vial and counted on a scintillation counter. 
The calculation of 3H-2DG in these constructs was determined as previously described 
(Section  3.6.3). The amount of 3H-2DG uptake was made relative to the wet weight of each 
construct. 
7.2.9 Statistical analysis 
Statistical analysis was conducted using SPSS statistical software (IBM SPSS, Version 19, 
NY, USA) by analysis of covariance (ANOVA) with Bonferroni post-hoc comparisons to 
identify any differences between conditions and stimulation. Comparisons between 
conditions for gel width and protein concentrations were conducted using independent t-test. 
Non-parametric kruskal-wallis test was conducted on data which violated homogeneity of 
variance and/or normal distribution. All data is presented as mean ± standard deviation. 
Significance was set at an alpha level of p< 0.05. Data from fibrin constructs is presented as 
an accumulation of 4 constructs per condition from two independent sets of cells. Data from 
collagen constructs is an accumulation of three constructs per condition (n=3) with cells 
ranging from passage 4-10. 
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7.3 Results 
In this Chapter, two models of skeletal muscle tissue engineering were used to investigate 
their molecular and functional responses to chronic and acute insulin exposure during 
maturation. Previously in monolayer culture (Chapter  6), chronic insulin exposure to skeletal 
muscle cells during differentiation resulted in the greatest changes in both molecular and 
physiological response. Therefore, both skeletal muscle constructs were exposed to chronic 
insulin media for the same duration (10 days) during differentiation. 
7.3.1 Macroscopic and microscopy observations in tissue engineered constructs 
 Fibrin tissue engineered constructs 7.3.1.1.
In the previous Chapter markers of myogenic differentiation and development were found to 
remain stable during incubation in maintenance media (Chapter  5). Insulin has been shown to 
affect proliferation and differentiation of cell in culture (Vandenburgh, Karlisch, Shansky, & 
Feldstein, 1991) and therefore, incubation with insulin began at this time point. Macroscopic 
(Figure  7-2A) and microscopic images (Figure  7-3) were obtained following exposure to 
control (7% FBS, 1% P/S) or insulin (7% FBS 1% P/S, 100 nM Insulin) maintenance media, 
which did not affect final gel width t (30) = 1.071 p = 0.293 (Figure  7-2B).   
 
Figure  7-2 A; Macroscopic images of fibrin gel skeletal muscle constructs following either 
control or chronic insulin exposure. B; Gel width measurement of fibrin gels incubated in the 
presence of absence of insulin. Data is mean ± SD from 16 constructs per condition.    
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Figure  7-3 Phase contrast images of fibrin gel skeletal muscle constructs following incubation 
in either A; control or B; insulin supplemented media. Arrow denotes myotubes in fibrin gels. 
Scale bar = 100µm. 
 
 Collagen tissue engineered constructs 7.3.1.2.
Following a 4 day growth period, collagen skeletal muscle tissue engineered constructs were 
incubated, in differentiation media supplemented without or with insulin (100 nM). 
Macroscopic images were obtained to analyse gel width at the end of the experimental period 
and compared by independent t-test (Figure  7-4A). Construct width was measured and 
subsequently showed a significant difference between conditions t (14) = 5.883 p < 0.001 
(Figure  7-4B). The development of myotubes was observed by phase contrast microscopy 
(Figure  7-4C), which showed clear formation skeletal muscle myotubes in both control and 
insulin treated constructs.  
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Figure  7-4 Macro and microscopic images of collagen gel skeletal muscle constructs 
following 10 days incubation in either control or insulin supplemented media. A; 
Macroscopic images of 1 mL skeletal muscle collagen gels. B; Gel width measurement of 
collagen gels incubated in the presence or absence of insulin (100 nM) for 10 days. Data is 
means ± SD from 6 constructs per condition. Phase contrast images of skeletal muscle 
myotubes in collagen gels following incubation in control of insulin supplemented media. 
Arrows denote the presence of myotubes. *Significant difference between conditions p <0.05. 
Scale bar = 100µm.     
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7.3.2 Chronic insulin exposure upon mRNA expression in tissue engineered constructs. 
 Fibrin Skeletal Muscle Constructs 7.3.2.1.
As previously conducted in monolayer cultures, the mRNA expression of HKII, PGC-1α, 
MyoG (key transcription factors involved in metabolism and myogenic development) were 
investigated in fibrin based constructs following incubation with or without insulin. GLUT4 
mRNA expression was significantly affected by acute insulin stimulation F (1, 10) = 7.269, p 
= 0.012, with mRNA expression increasing following acute stimulation in constructs which 
were chronically treated with insulin (p = 0.004), yet no significant difference between 
control constructs was observed (Figure  7-5A). Myogenin expression showed no differences 
between conditions F (1, 11) = 3.168, p = 0.103, or as a result of acute insulin stimulation F 
(1, 11) = 1.286, p = 0.281 (Figure  7-7). Surprisingly, PGC-1α expression was not effected by 
acute insulin stimulation F (1, 11) = 2.775, p = 0.124, or by chronic exposure to insulin F (1, 
11) = 0.078, p = 0.786. HKII mRNA expression data was found to have violated assumptions 
of the ANOVA by significant Levine statistics for homogeneity of variance, and shaprio-wilk 
statistics for normal distribution. Therefore, non-parametric test were conducted using 
kruskal-wallis test, which showed no significant differences between groups in for HKII 
mRNA expression H (3) = 0.800, p = 0.874 (Figure  7-6).  
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Figure  7-5 mRNA expression (ΔΔCt) in fibrin skeletal muscle constructs following insulin exposure. 
Constructs were exposed to control media or high insulin media for a period of 10 days in culture 
before being unstimulated (open bars) or stimulated (filled bars) with 100 nM insulin for 30 minutes 
A) GLUT4, B) PGC-1α. * Significantly different vs. unstimulated condition (p <0.05). Data is mean ± 
SD of 4 constructs per condition derived from two independent experiments. 
  
  
 
Figure  7-6 Hexokinase II (HKII) mRNA expression (ΔΔCt) in fibrin skeletal muscle constructs 
following chronic insulin exposure. Constructs were exposed to control media or high insulin media 
for a period of 10 days in culture before being unstimulated (open bars) or stimulated (filled bars) 
with 100 nM insulin for 30 minutes. Data is mean ± SD of 4 (N=4) constructs per condition derived 
from two independent experiments. 
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Figure  7-7 Myogenin (MyoG) mRNA expression (ΔΔCt) in fibrin skeletal muscle constructs following 
chronic insulin exposure. Constructs were exposed to control media or high insulin media for a 
period of 10 days in culture before being unstimulated (open bars) or stimulated (filled bars) with 100 
nM insulin for 30 minutes. Data is mean ± SD of 4 (N=4) constructs per condition derived from two 
independent experiments.  
 
 
Gene of Interest Control - 
Unstimulated 
Control - 
Stimulated 
Insulin - 
Unstimulated 
Insulin - 
Stimulated 
HKII 22.18 ± 0.38 21.86 ± 0.27 22.03 ± 1.07 22.12 ± 0.89 
GLUT4 26.57 ± 0.40 25.87 ± 0.33 26.67 ± 0.74 25.79 ± 0.28 
PGC-1α 26.50 ± 0.42 25.91 ± 0.25 25.91 ± 1.01 25.92 ± 0.46 
MyoG 23.34 ± 1.21 22.61 ± 0.35 23.29 ± 1.57 23.31 ± 0.60 
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 Collagen Skeletal Muscle Constructs 7.3.2.2.
Within native tissue, skeletal muscle fibres are surrounded by the extracellular matrix which 
is predominantly in the form of collagen (Kjaer, 2004). The ECM plays an important role in 
the function of metabolic tissues, and, in the case of skeletal muscle has been shown to be 
implicated in insulin stimulated glucose uptake (Berria et al., 2006). While the use of 
collagen as a biological hydrogel in 3D tissue engineering is common within the literature 
(Cheema et al., 2003; Player et al., 2014; Sharples et al., 2012), currently no work has 
investigated the role of insulin exposure upon collagen tissue engineered skeletal muscle 
constructs. 
Hexokinase II (HKII) is an important protein regulated the early stages of glucose 
metabolism (Bouché et al., 2004) and is responsive to insulin at the mRNA level 
(Vestergaard et al., 1995). Although, there was no significant effect of acute 30 minute 
stimulation upon HKII mRNA expression F (1, 12) = 0.059, p = 0.814, chronic insulin 
exposure significantly increased HKII expression compared to control constructs F (1, 12) = 
7.952, p = 0.025 (Figure  7-8A). Similarly, the mRNA expression of the insulin stimulated 
glucose transporter, GLUT4, was not affected by acute stimulation F (1, 12) = 0.089, p = 
0.762, however, in contrast to an increase in HKII expression, chronic insulin treatment 
significantly lowered the expression of GLUT4 F (1, 12) = 8.448, p = 0.023 (Figure  7-8B). 
The expression of myogenin mRNA was not significantly different in between conditions F 
(1, 7) = 0.955, p = 0.361, however its expression levels were significantly affected by acute 
stimulation F (1, 7) = 11.270, p = 0.012 in control samples (Figure  7-9).  A one-way 
ANOVA was conducted to compare means between conditions for changes in PGC-1α 
expression. There was no significant differences in PGC-1α expression between conditions F 
(3) = 0.202, p = 0.892 (Figure  7-10).   
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Figure  7-8 mRNA expression (ΔΔCt) in collagen skeletal muscle constructs following chronic insulin 
exposure. Constructs were exposed to control media or high insulin media for a period of 10 days in 
culture before being exposed to an acute insulin challenge A) HKII, B) GLUT4. Open bars represent 
unstimulated constructs and filled bars represent stimulated (100 nM insulin) constructs. * 
Significantly different between conditions (p <0.05). Data is mean ± SD of 3(N=3) constructs per 
condition. 
  
 
Figure  7-9 Myogenin mRNA expression (ΔΔCt) in collagen skeletal muscle constructs following 
chronic insulin exposure. Open bars represent unstimulated constructs and filled bars represent 
stimulated (100 nM insulin) constructs. * Significantly difference between control unstimulated 
constructs. Data is mean ± SD of 3 constructs per condition. 
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Figure  7-10 PGC-1α mRNA expression (ΔΔCt) in collagen skeletal muscle constructs following 
chronic insulin exposure. Open bars represent unstimulated constructs and filled bars represent 
stimulated (100 nM insulin) constructs. Data is mean ± SD of 3 constructs per condition. 
 
Gene of Interest Control - 
Unstimulated 
Control - 
Stimulated 
Insulin - 
Unstimulated 
Insulin - 
Stimulated 
HKII 23.01 ± 0.73 23.49 ± 0.47 21.91 ± 0.55 21.94 ± 0.36 
GLUT4 26.59 ± 0.64 27.26 ± 0.80 26.64 ± 0.60 26.54 ± 0.70 
PGC-1α 25.53 ± 0.62  25.63 ± 0.54 25.08 ± 0.39 24.87 ± 0.43 
MyoG 21.88 ± 0.55 22.69 ± 0.64 21.40 ± 0.82  21.77 ± 0.61 
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7.3.3 Chronic insulin exposure increases protein concentrations in tissue engineered 
constructs 
In addition to quantifying loading volumes for subsequent immunoblotting of insulin 
signalling proteins, protein concentrations as previously described (Section  3.5.5) to 
determine potential effects of chronic insulin exposure upon construct protein concentrations. 
Independent samples t-test was conducted between control and insulin exposed samples 
which showed insulin to significantly increase protein concentrations compared to control 
constructs in both fibrin t (14) = -2.323 p =0.036 (Figure  7-11A), and collagen tissue 
engineered constructs t (10) = -2.318 p =0.043 (Figure  7-11B). 
 
 
Figure  7-11 Protein concentrations (µg·µl) from A) fibrin and B) collagen skeletal muscle tissue 
engineered constructs exposed to  control (Open) or chronic insulin (Filled) media. * Significantly 
different vs. control condition (p <0.05). Data is mean ± SD of 8 constructs per condition in fibrin 
and 6 constructs per condition in collagen from two independent experiments. 
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7.3.4 Insulin signalling protein response in skeletal muscle tissue engineered 
constructs 
Exposure of insulin to skeletal muscle cells results in a cascade of events which enables 
facilitated glucose uptake into the cell. Several proteins are involved in the process of insulin 
stimulated glucose uptake of which a select group have been characterised as a ‘critical node’ 
of insulin signalling (Taniguchi et al., 2006). One of these proteins, Akt plays an important 
role within the insulin signalling cascade and within previous Chapters has been shown to 
increase as a result of insulin stimulation 
 Fibrin skeletal muscle constructs  7.3.4.1.
The expression of the p85 subunit, PI-3 kinase was not affected by acute F (1, 7) = 0.19, p = 
0.894 or chronic insulin stimulation F (1, 7) = 0.020, p = 0.892 (Figure  7-13). Similarly, 
despite a small increase in phosphorylation of Akt at serine 473 (Ser473), there was no 
significant effect of acute insulin stimulation F (1, 4) = 0.549, p = 0.500, r = 0.121 or chronic 
insulin exposure F (1, 4) = 4.136, p = 0.112, r = 0.501 upon Ser473 phosphorylation 
(Figure  7-12A). Furthermore, there was no significant effect upon total Akt protein 
expression as a result of acute F (1, 8) = 0.514, p = 0.494, or chronic insulin exposure F (1, 8) 
= 0.105, p = 0.754 (Figure  7-12B).  
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Figure  7-12 Western blots analysis of p85 PI-3 kinase following acute and chronic insulin stimulation. 
Constructs were either left Unstimulated (open bars) or stimulated (filled bars) with 100 nM insulin 
for 30 minutes. Representative images of western blots for p85 PI-3 kinase and B-actin. Data is mean 
± SD of 3 constructs per condition. 
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Figure  7-13 Western blots analysis of total Akt and phosphorylation of Akt (Ser473) following acute 
and chronic insulin stimulation. Constructs were either left Unstimulated (open bars) or stimulated 
(filled bars) with 100 nM insulin for 30 minutes. A; phosphor Akt Ser473 B; total Akt, Data is mean ± 
SD of pAkt N=2 constructs per condition. Data is mean ± SD of tAkt N=3 constructs per condition. 
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 Collagen skeletal muscle constructs 7.3.4.2.
Protein expression of the p85 subunit of PI-3 kinase was also not affected by acute insulin 
stimulation F (1, 8) = 0.0339, p = 0.577, however there was a trend toward significance an 
increase in expression within chronically exposed constructs F (1, 8) = 4.957, p = 0.057, r = 
0.380 (Figure  7-15).Optimisation of insulin stimulation within collagen tissue engineered 
constructs showed an increase in phosphorylation of Akt as a result of acute insulin 
stimulation (Figure  7-14A). Although there was a tendency for an increase in Akt Ser473, 
phosphorylation (Figure  7-14B), there was no significant effect of acute stimulation F (1, 7) 
= 2.248, p = 0.177, r = 0.243 or effect of chronic insulin exposure F (1, 7) = 2.2015, p = 
0.199, r = 0.224. Furthermore, there was no effect of acute stimulation F (1, 7) = 0.052, p = 
0.792 or chronic exposure F (1, 7) = 0.052, p = 0.826 upon total Akt expression 
(Figure  7-14C).   
 
Figure  7-14 Western blots analysis of p85 PI-3 kinase following acute and chronic insulin stimulation. 
Representative images of western blots for p85 PI-3 kinase and B-actin. Data is mean ± SD of 3 
constructs per condition. 
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Figure  7-15 Western blots analysis of total Akt and phosphorylation of Akt (Ser473) following acute 
and chronic insulin stimulation in collagen gel skeletal muscle constructs. A; phospho Akt Ser473 
graph B; total Akt graph. . Data is mean ± SD of 3 constructs per condition.   
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7.3.5 Glucose uptake of fibrin skeletal muscle constructs 
As outlined within the previous Chapters of this thesis (Chapter 4) the measurement of 
glucose uptake through the use of radioactive tracers, in particular tritium labelled (3H) 
glucose analogue 2-D-oxy-d-glucose (3H-2DG) was used to investigate changes in insulin 
stimulated glucose uptake in fibrin tissue engineered skeletal muscle constructs. Despite a 
mean increase in 3H-2DG uptake within control fibrin based skeletal muscle constructs 
following 30 minutes insulin stimulation, there was no significant difference in insulin 
stimulated glucose uptake within these constructs t (10) = -1.831 p =0.09 (Figure  7-16). 
However, the differences between groups showed there to be a large effect of insulin 
stimulation upon glucose uptake in these constructs (r = 0.50).  
 
Figure  7-16 Insulin stimulated glucose uptake (3H-2DG) in fibrin based skeletal muscle constructs. 
Constructs were incubated for 30 minutes in the presence or absence of insulin followed by 30 
minutes 3H-2DG incubation. Data is mean ± SD from 6 constructs per condition. 
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7.4 Discussion 
Skeletal muscle is responsible for the majority of insulin stimulated glucose uptake 
(DeFronzo, Tobin, & Andres, 1979), however impaired glucose clearance within skeletal 
muscle is a major symptom of metabolic disease and often precedes the onset of metabolic 
diseases such as diabetes mellitus (Abdul-Ghani and Defronzo, 2010). While the use of 
monolayer cell culture continues to be utilised to investigate the complexities of insulin 
signalling and glucose uptake within skeletal muscle (Rudich and Klip, 2003; Sell et al., 
2012), little research has investigated the response of skeletal muscle to insulin in three-
dimensional culture at the molecular level (Baker et al., 2003). Therefore, the objective of 
this Chapter was to investigate insulin signalling and glucose uptake within three-
dimensional skeletal muscle tissue engineered models. 
7.4.1 Protein concentration differences in tissue engineered constructs following 
chronic insulin exposure 
Although protein concentrations were primarily used to quantify the loading volume for 
subsequent immunoblotting, in both fibrin and collagen constructs, chronic insulin exposure 
increased protein concentration. These findings support previous research in skeletal muscle 
tissue engineered constructs which have shown large increases in protein concentration 
following incubation with insulin (Vandenburgh, Karlisch, Shansky, & Feldstein, 1991). A 
number of protein-protein interactions, particularly within the proximal insulin-signalling 
cascade affect a number of signalling pathways (Virkamäki, Ueki, and Kahn, 1999). 
Although some of these signalling pathways have known mechanisms, some, such as those 
which affect structural proteins (integrin’s) and are implicated in the function of metabolic 
tissues (Huang et al., 2012), have been shown to increase IRS-1 phosphorylation independent 
of glucose transport (Bruning et al., 1998). While the mechanisms by which the increase in 
protein concentrations occur within these constructs as a result of chronic exposure to insulin 
requires further investigation, previous literature has shown constituently activation of Akt 
result in skeletal muscle hypertrophy (Bodine et al., 2001; Rommel et al., 2001). Due to the 
role of insulin upon phosphorylation of this protein and the various cellular functions Akt is 
implicated in (Schultz et al., 2000), it is clear that insulin doses exert a hypertrophic effect 
upon skeletal muscle in both fibrin and collagen tissue engineered constructs.  
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7.4.2 Insulin signalling response in skeletal muscle tissue engineered constructs  
Although the role of insulin and glucose stimulation within three-dimensional culture has 
focused predominantly around β-cell secretion, stimulation and survival (Weber et al., 2008), 
currently no research has investigated skeletal muscle insulin signalling and glucose uptake in 
this environment. Optimisation of acute insulin stimulation on these constructs showed that 
30 minutes stimulation within insulin (100 nM) would increase phosphorylation of Akt Ser473 
(Section  3.6.2).  
 Insulin signalling in fibrin skeletal muscle tissue engineered 7.4.2.1.
constructs 
The use of fibrin skeletal muscle tissue engineering constructs has provided an in vitro model 
for investigation of skeletal muscle force production (Huang et al., 2005; Khodabukus & 
Baar, 2009). However more recent research has used these models to investigate changes 
skeletal muscle phenotype in vitro (Khodabukus and Baar, 2014a). These current experiments 
are advancement on the current work in these models, in which the effects of hormonal 
exposure used to manipulate the molecular responses in these constructs. Although there was 
not a significant effect of acute insulin stimulation upon phosphorylation of Akt, the observed 
increase in serine phosphorylation and effect size observed suggest a level of biological effect 
as a result of acute stimulation in these constructs. The incubation period with insulin is 
similar to what has previously been shown to induce Akt phosphorylation of Akt in ex vivo 
skeletal muscle (Saini et al., 2014). Insulin stimulation in vitro has shown to range from five 
minutes, as conducted in the previous Chapter (Chapter  6), up to 30 minutes plus in skeletal 
muscle cells (Al-Khalili et al., 2003; Sell et al., 2008). The use of tissue engineered skeletal 
muscle aims to bridge the gap between monolayer, 2D cultures, ex vivo and in vivo animal 
models and therefore further time points would give further insight into the phosphorylation 
Akt as well as other proteins involved in the insulin signalling pathway.  Previous research 
using C2C12’s in fibrin skeletal muscle constructs has shown there to be high variability 
between clones of constructs and therefore the large variation in insulin signalling response is 
mostly like resultant of the batch to batch variation in their physiological and functional 
responses that have been associated with these constructs (Khodabukus et al., 2009). 
 Insulin signalling in collagen skeletal muscle tissue engineered 7.4.2.2.
constructs 
The use of collagen (collagen type I), has frequently been used as a representative matrix that 
present morphological and functional characteristics of the skeletal muscle ECM in vitro 
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(Cheema et al., 2003; Player et al., 2014; Sharples et al., 2012). The ECM plays an important 
role in metabolic tissues (Berria et al., 2006), and the ding of cells within a collagen matrix 
can improve insulin and glucose response (Weber et al., 2008). Although these constructs did 
respond to acute insulin exposure, the increase in phosphorylation of Akt was not 
significantly different within control conditions. However unlike findings observed in fibrin, 
there was a small but not significant increase in phosphorylation of Akt. With the exception 
of time in differentiation media and the ECM, these experiments involved exposure of insulin 
within the same differentiation media as experiments performed in monolayer culture. It is 
unsurprising that the results observed between the two culture systems are similar. Although 
further work is required in order to establish if insulin stimulated glucose uptake within these 
constructs is affected by the extracellular matrix, such variables are important to consider in 
further characterisation of this culture model for investigating insulin stimulated glucose 
uptake. 
In addition to the phosphorylation of Akt, like in monolayer, the p85 subunit of PI-3 kinases 
was investigated following acute and chronic insulin exposure. PI-3 kinase is an important 
mediator of insulin signalling (Shepard, 1999) and is activated by associated activity with the 
IRS-1, ultimately leading to recruitment and phosphorylation of  Akt downstream (Shepherd 
et al., 1998). Chronic insulin exposure to collagen skeletal muscle constructs showed there to 
be a trend toward significance (p=0.057) in expression levels of p85 PI-3 kinase. Expression 
of p85 has been shown to be important in recruitment and facilitation of proximal insulin 
signalling and subsequently is the predominant isoform which is recruited upon insulin 
stimulation (Shepherd et al., 1998). However, recruitment of p85-p110 heterodimers for 
effective insulin signalling can be effected by overexpression of p85 monomers. Research in 
skeletal muscle from rodents has shown that increases in p85 monomers result in impaired 
insulin signalling (Bandyopadhyay et al., 2005; Ueki et al., 2000) and the these findings 
which were replicated in monolayer culture (Chapter  6), could explain the alterations in 
insulin signalling as a result of chronic insulin exposure in culture and potentially show that 
the signalling responses to insulin are translatable between monolayer cultures and collagen 
tissue engineered skeletal muscle constructs.
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7.4.3 Transcriptional response to insulin in skeletal muscle tissue engineered 
constructs  
In addition to the primary role of glucose uptake, insulin contributes to both positive and 
negative transcriptional regulation (O’Brien and Granner, 1996). Although insulin has been 
shown to regulate are large number of genes in vivo (Rome et al., 2003), a small number have 
been investigated in their role of glucose metabolism (Ducluzeau et al., 2001). 
 Transcriptional responses to insulin in fibrin tissue engineered 7.4.3.1.
skeletal muscle constructs 
Understanding the transcriptional responses of fibrin skeletal muscle constructs was a novel 
insight into the effects of insulin upon these models. Although a number of factors including 
serum origin and type have been found to effect a number proteins involved in glucose 
metabolism of fibrin C2C12 fibrin skeletal muscle constructs (Khodabukus and Baar, 2014a, 
2014b), the current work is the first to investigate mRNA expression using this cell line. The 
insulin stimulated glucose transporter, GLUT4, is an important candidate at both the 
transcription and protein levels for understanding insulin stimulated glucose uptake. In fibrin 
skeletal muscle constructs, acute insulin significantly increased GLUT4 mRNA expression 
following chronic insulin exposure. Acute stimulation with insulin has been shown in both 
cell culture (Yu et al., 2001) and ex vivo skeletal muscle (Moraes et al., 2014). 
As discussed in previous Chapters (Section  2.8.3), metabolic genes, which have been shown 
to be responsive to insulin such as, PGC-1α, and HKII and subsequently altered in monolayer 
cultures, showed no changes in expression following chronic or acute insulin stimulation. is 
an important regulator of metabolism in skeletal muscle (Olesen et al., 2010). As well as its 
role in the regulation of GLUT4 expression within skeletal muscle cells (Michael et al., 2001). 
These findings are surprising due to those previously observed in monolayer cultures 
(Chapter  6) as well as those recently reported by Khodabukus (Khodabukus and Baar, 2014a, 
2014b). Indeed, the only previous work which has reported transcriptional changes in these 
constructs, investigated the development and maturation of human skeletal muscle cells in 
this system (Martin et al., 2013). Neither acute nor chronic insulin exposure resulted in 
changes in mRNA expression of myogenin in fibrin skeletal muscle constructs (Figure  7-7). 
Previous experiments (Chapter  5), which showed that these constructs maintain a stable 
myogenic expression in maintenance media during skeletal muscle development, also show 
that this gene is not affected by exposure to insulin during the same time frame. This would 
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therefore suggest that the increase in protein concentration observed in these constructs 
(Figure  7-11) is not resultant of further myogenin-regulated differentiation of non-
differentiated skeletal muscle cells.  
 Transcriptional responses to insulin in collagen tissue engineered 7.4.3.2.
skeletal muscle constructs 
 
However in the collagen constructs, chronic insulin treatment resulted in a mean reduction in 
the expression of GLUT4. Both in vivo and in vitro research has shown there to be 
differential effects upon GLUT4 expression in response to insulin depending upon incubation 
periods and insulin concentrations observed (Moraes et al., 2014). As reported in the previous 
Chapter (Chapter  5), GLUT4 mRNA expression showed a significant increase during early 
skeletal muscle development (Day 2 of differentiation) and a subsequent return to basal levels 
thereafter. It could be speculated that the reduction in expression following insulin treatment 
could accelerate this transcriptional response in these constructs, Alternatively, insulin 
resistance and diabetes has been shown to reduce both protein and mRNA expression of 
GLUT4 in skeletal muscle (Camps et al., 1992). The exact cause of this response is not 
currently know and further research is required to investigate if the changes in mRNA 
expression following chronic insulin exposure result in a translational response to GLUT4 
protein expression either in a positive or negative fashion. Particularly as the mRNA 
expression of HKII, was shown to be increased following chronic insulin treatment. Acute 
insulin stimulation has been shown to increase HKII mRNA in response to insulin in vivo 
(Pendergrass et al., 1998) and in vitro (Printz et al., 1993). However, this is shown to be 
attenuated in insulin resistant human who present hyperglycaemia and hyperinsulinemia 
symptoms (Vestergaard et al., 1995), and diabetic animal models (Burcelin et al., 1993). 
However, collagen constructs which were exposed to chronic insulin had an increase in HKII 
mRNA expression. The increase in expression of HKII as a result of exposure to a 
hyperinsulineamic environment could suggest that this environment is not responsible for the 
impaired HKII expression observed in vivo, but rather other systemic factors which are 
associated with metabolic diseases (Vestergaard et al., 1995). In contrast, the response n with 
in these constructs are potentially more indicative of the transcriptional responses associated 
with acute physiological hyperinsulinemia which increases, but no exclusively, skeletal 
muscle HKII mRNA expression (Coletta et al., 2008). 
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A surprising finding in collagen skeletal muscle constructs was the attenuated myogenin 
expression following acute stimulation (Figure  7-9).  Both monolayer and fibrin skeletal 
muscle constructs showed either no change or an increase in MyoG expression following 
acute stimulation. Previous research using IGF-1 to induce skeletal muscle differentiation has 
shown opposing effects upon myogenin mRNA expression during skeletal muscle 
differentiation (Adi et al., 2000). Due to the similarities in structure and function of insulin 
and IGF-1 (Werner, Weinstein, and Bentov, 2008), further explanation to the effects of 
insulin upon the regulation of skeletal muscle myogenisis in collagen skeletal muscle tissue 
engineered constructs is required. 
7.4.4 Insulin stimulated glucose uptake in fibrin skeletal muscle constructs 
In order to investigate the function response of these constructs to insulin stimulation, glucose 
uptake was assessed by 3H-2DG as performed within previous Chapters of this thesis 
(Chapter  4). Currently, only one paper has previously investigated the effect of insulin 
stimulated glucose uptake in tissue engineered constructs (Baker et al., 2003). Although there 
was a large effect (r = 0.50), there was no significant difference between unstimulated and 
insulin stimulated glucose uptake. Skeletal muscle tissue engineered constructs have been 
shown to present with a high level of basal uptake and although the basal level observed in 
the current experiments is not as high as that previously reported in primary cell constructs 
(Baker et al., 2003). Nonetheless, C2C12 themselves have a high basal glucose turnover in 
monolayer cultures (Nedachi and Kanzaki, 2006) and these characteristics are also present 
when these cells are grown in a three-dimensional environment. The elevated basal turnover 
is indicative of early skeletal muscle development during which the expression of the basal 
glucose transporter GLUT1, is the predominant mediator of glucose turnover (Santalucía et 
al., 1992). Therefore, although these constructs respond to insulin, similar to primary skeletal 
muscle cells in three-dimensional constructs C2C12 skeletal muscle in fibrin tissue 
engineered constructs. 
7.5 Conclusions 
In this Chapter, two types of skeletal muscle tissue engineered construct were investigated for 
their transcriptional and molecular signalling response to acute and chronic insulin exposure. 
In fibrin constructs, chronic insulin exposure has little effect upon construct width despite 
small but significant increases in protein concentration. In addition, while protein 
phosphorylation increased, but not significantly, there was little effect upon the 
transcriptional response to insulin within these constructs. In contrast, collagen skeletal 
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muscle constructs showed a response to insulin through significant differences in gel width 
and protein concentration, and although protein phosphorylation increased but was not 
significant, these constructs showed to be effected by insulin exposure at the transcriptional 
level through significant changes in HKII and GLUT4 expression.    
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8. Discussion  
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8.1 General Discussion 
Using the well-established C2C12 skeletal muscle cell line, a series of experiments were 
conducted in conventional monolayer culture and in three-dimensional tissue engineered 
constructs, to investigate the molecular response to insulin in these culture models. By 
exposing these models to insulin for acute and chronic periods, both 2D and 3D models were 
investigated for their molecular and functional responses to acute and chronic insulin 
exposure. In particular, the effect of insulin upon three-dimensional skeletal muscle 
constructs would provide the first insight into the potential use of skeletal muscle tissue 
engineering constructs as a novel in vitro model to investigate skeletal muscle insulin 
signalling and glucose uptake. 
Research investigating insulin signalling and glucose metabolism continues to be a major 
priority due to the increasing global prevalence of metabolic diseases, such as diabetes 
mellitus (Zimmet, Alberti, and Shaw, 2001). A combination of in vivo human trials (Krook et 
al., 2000), animal (Joost et al., 2012), and cell culture models (Sarabia et al., 1990; Sell et al., 
2012), are used to understand the physiological and patho-physiological factors associated 
with insulin signalling and glucose uptake. The use of cell culture models can be a useful 
model to better investigate the intricacies of insulin stimulated glucose uptake (Rudich and 
Klip, 2003). While the use of different cell types, primary or cell lines, have been used to 
study insulin signalling in skeletal muscle, the use of different models of cell culture, such as 
three dimensional skeletal muscle tissue engineered constructs, have not been used before. 
Techniques such as tissue engineering of skeletal muscle are enabling advancements in 
regenerative medicine (Juhas et al., 2014), but are also providing a platform to investigate 
skeletal muscle physiology and function (Cheng et al., 2014; Khodabukus et al., 2007), due to 
the ability of these models to recapitulate skeletal muscle tissue in vitro (Tibbitt and Anseth, 
2009). However, the use of these models to investigate glucose uptake and in particular 
insulin signalling has not be investigated extensively despite these culture models systems 
being identified as a key area for investigation within the field (Cheng et al., 2014). 
Development of tissue engineered skeletal muscle models which respond to insulin at the 
molecular and functional levels with regards to glucose uptake, would be an advancement 
upon the current literature which has investigated this area (Baker et al., 2003). 
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8.2 Key findings 
During development, glucose transporters 1 and 4 which are responsible for basal and insulin 
stimulated glucose uptake respectively, alter their transcriptional expression as skeletal 
muscle matures to a more insulin responsive tissue where GLUT4 becomes the 
predominantly expressed glucose transporter (Santalucía et al., 1992). In Chapter 4, both two-
dimensional cultures and the two three-dimensional skeletal muscle tissue engineered 
constructs, differentiation and development of multinucleated myotubes resulted in an 
increase in the mRNA expression of developmental genes as well as the expression of 
GLUT4, the insulin stimulated glucose transporter. The increase in GLUT4 mRNA 
expression in two and three-dimensional cultures provides evidence that all of these models 
have the potential to express this protein and could be a valid model for investigating insulin 
stimulated glucose uptake. 
Due to the complexity and numerous symptoms that are associated with insulin resistance 
and diabetes mellitus (Abdul-Ghani and Defronzo, 2010), various methods have been used to 
recapitulate the insulin resistance phenotype of skeletal muscle in vitro. For example, the use 
of cytokines (del Aguila et al., 2011), conditioned media (Eckardt et al., 2008; Sell et al., 
2008), and the exposure to a hyperinsulineamic environment (Kumar and Dey, 2003) have all 
shown to attenuate the insulin signalling pathway and subsequently insulin stimulated 
glucose uptake. By replicating previously published methodologies (Kumar and Dey, 2003), 
chronic insulin exposure impaired phosphorylation of key insulin signalling proteins but also 
increased basal glucose uptake at the expense of insulin stimulated glucose uptake in 
differentiating skeletal muscle cells. However, these effects were not replicated in skeletal 
muscle myotubes, suggestive that the greatest effect of insulin exposure upon insulin 
sensitivity and glucose uptake occurs during regeneration of skeletal muscle. 
Providing cells with a three-dimensional extracellular matrix in which to proliferate and 
differentiate results in cell behaviour which better replicates that observed in vivo (Tibbitt and 
Anseth, 2009). Skeletal muscle tissue engineering has advanced significantly within the past 
decade and exhibits great utility as a potential model for investigating skeletal muscle 
physiology and adaption (Baar, 2005; Cheng et al., 2014; Khodabukus et al., 2007). The final 
Chapter of this thesis aimed to investigate the response of fibrin and collagen skeletal muscle 
constructs to acute and chronic insulin exposure as well as the effect if any upon insulin 
stimulated glucose uptake. In both fibrin and collagen based models acute insulin exposure 
increased phosphorylation of insulin signalling proteins. Although these findings were not 
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statistically significant, the effect of insulin exposure to these constructs showed a large effect 
size, potentially a large biological effect. In addition, insulin stimulated glucose uptake was 
not significantly different from un-stimulated constructs; nonetheless there was a large 
experimental effect as a result of acute insulin treatment upon glucose uptake. These findings 
are the first to investigate the effect of insulin stimulated glucose uptake upon fibrin based 
skeletal muscle tissue engineered constructs, and the first to use an established cell culture 
line. Although there are a number of factors which require further investigation for the use of 
these constructs to investigate the physiological responses to insulin, the findings from this 
Chapter demonstrate a progression in the use of these models for research into insulin 
signalling and glucose uptake in skeletal muscle from what has previously been published. 
As reported in previous research, the most noticeable difference between two-dimensional 
and three dimensional skeletal muscle tissue engineering constructs is the uniaxial formation 
of skeletal muscle myotubes within 3D skeletal muscle constructs compared to the 
randomised formation of myotubes observed in 2D culture (Cheng et al., 2014; Hinds et al., 
2011). In addition, both 2D culture and 3D tissue engineered constructs followed a similar 
transcriptional pattern of myogenisis and development. However, differences in the 
expression pattern of GLUT4 mRNA during development differed during development 
between fibrin and collagen constructs. Further research is required in order to determine if 
the increase in mRNA expression in both of these 3D models results in a translational 
response. Furthermore, another difference between these culture models is the measurement 
of insulin stimulated glucose uptake. Although the use of radioactive isotope labelled glucose 
remains the most sensitive method for measurement of glucose uptake in both 2D (Sell et al., 
2012), and 3D skeletal muscle cultures (Baker et al., 2003), the high basal glucose uptake of 
3D cultures could have potential implications upon the assay window observed as a result of 
insulin stimulation. Therefore, in order to further characterise insulin stimulated glucose 
uptake in 3D skeletal muscle tissue engineering constructs, time and dose responses 
experiments provide further insight into this phenomena. 
Previous literature in the field of skeletal muscle tissue engineering has used larger collagen 
constructs to investigate skeletal muscle development and molecular physiology (Cheema et 
al., 2005; Cheema, Yang, Mudera, Goldspink, & Brown, 2003; Player et al., 2014). The use 
of a scaled down 1mL collagen construct, which developed to form mature myotubes, is a 
further refinement on previously used models and as a result are a more economic model for 
investigating transcriptional, translation and function responses. Additionally, the extraction 
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of cellular protein from these constructs is a novel technique which has been further 
optimised from previous work in collagen tissue engineered constructs (Player, 2013). As a 
result, the optimisation of these methods for extraction of cellular protein and visualisation of 
quantifiable western blots is a significant advancement with respect to investigating cellular 
signalling pathways in these models. 
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Table  8.1 Key findings from experimental chapters in this thesis. 
Thesis Chapter Summary 
Chapter 4 – Measurement of glucose uptake 
in C2C12 skeletal muscle cells using 
radioactive isotopes and fluorescent based 
methods. 
• Using a 96 well non-radiolabelled based assay did not provide a sufficient assay window to measure 
insulin stimulated glucose uptake in skeletal muscle myotubes. 
• Optimised specific activity of 3H-2DG (1µCi) for investigating insulin stimulated glucose uptake in 
both monolayer and tissue engineered skeletal muscle constructs. 
• Incubation of 15 minutes with 3H-2DG was chosen as an appropriate time in the monolayer culture. 
• Incubation with insulin and 3H-2DG was increased to 30 minutes in tissue engineered constructs. 
Chapter 5 – A time course of transcriptional 
and translational expression of glucose 
transporters in C2C12 skeletal muscle 
cultures. 
• Differentiation of skeletal muscle cells in monolayer, fibrin and collagen tissue engineered skeletal 
muscle constructs resulted in an increase mRNA expression of the myogenin. 
• The developmental gene MEF2a, which is an important transcription factor which regulates GLUT4 
expression, was increase during differentiation of skeletal muscle cells in monolayer and tissue 
engineered skeletal muscle constructs. 
• GLUT4 expression increased with time in differentiation in both monolayer and fibrin skeletal muscle 
tissue engineered constructs. 
• GLUT1 mRNA expression was unchanged throughout differentiation in both monolayer and tissue 
engineered cultures. 
Chapter 6 – The effects of acute and chronic 
insulin exposure upon C2C12 skeletal 
muscle cells in monolayer cell culture. 
• Chronic exposure to insulin impaired phosphorylation of insulin signalling proteins in differentiating 
skeletal muscle cells. 
• The mRNA expression of metabolic genes was impaired following acute stimulation in differentiating 
skeletal muscle cells chronically exposed insulin. 
• Basal glucose uptake in differentiating skeletal muscle cells was increased following chronic insulin 
exposure. This increase hindered any observation of insulin stimulated glucose uptake in these cultures. 
• Acute insulin stimulation did not change mRNA expression of skeletal muscle myotubes. 
• Chronic insulin exposure increased GLUT4 mRNA expression while reducing HKII mRNA 
expression. 
• Chronic insulin exposure in skeletal muscle myotubes did not alter insulin stimulated glucose uptake. 
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Thesis Chapter Summary 
Chapter 7 – Insulin signalling and glucose 
uptake in skeletal muscle tissue engineering: 
The effect of acute and chronic insulin 
exposure. 
• Acute insulin stimulation showed a trend toward an increase in phosphorylation of Akt (Ser473) in both 
fibrin and collagen skeletal muscle tissue engineered constructs. 
• Chronic insulin exposure increased hexokinase II mRNA expression while reducing GLUT4 mRNA 
expression in collagen skeletal muscle tissue engineered constructs. 
• Chronic insulin stimulation had no effect upon mRNA expression of metabolic genes in fibrin skeletal 
muscle tissue engineered constructs. 
• Incubation time was increased to 30 minutes insulin stimulation and 30 minutes 3H-2DG in tissue 
engineered skeletal muscle constructs. Insulin stimulated glucose uptake approached significance in 
fibrin skeletal muscle constructs (p = 0.09). 
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8.3 Future Directions 
The development of the methods within this thesis for investigating insulin signalling and 
glucose uptake in 2D and 3D cultures has the potential to be translated into primary cells 
across species.  
The use of human skeletal muscle cells from donors have been used to investigate insulin 
signalling and insulin stimulated glucose uptake of skeletal muscle in vitro (Aas et al., 2013). 
The use of this cell type enables for further elucidation of the specific response of the donor 
to insulin within a controlled milieu independent of extracellular factors (Aas et al., 2013). A 
number of researchers have used human skeletal muscle cells to further understand glucose 
metabolism in healthy and diseased populations (Al-Khalili et al., 2005; Al-Khalili, Krämer, 
Wretenberg, and Krook, 2004; Gaster et al., 2002; Henry et al., 1995) (Table 2-1). While the 
use of human skeletal muscle cells from diseased populations differentiate to form skeletal 
muscle myotubes, (Al-Khalili et al., 2004; Thompson et al., 1996), differences in expression 
of myogenic genes have shown to differ between insulin resistant and healthy individuals. 
Similar responses have been reported in healthy human skeletal muscle cells and when 
exposed differentiated in adipocyte conditioned medium (Sell et al., 2008). None of the 
aforementioned studies have investigated the use of skeletal muscle cells from diseased 
populations, in particular insulin resistant or diabetic skeletal muscle cells in 3D tissue 
engineering. Although recent research using skeletal muscle cells within 3D tissue engineered 
constructs has established the optimum conditions to culture human skeletal muscle cells 
from healthy donors in fibrin skeletal muscle constructs (Martin et al., 2013), further research 
would be required in order to understand if the findings for optimal tissue engineering of 
healthy human skeletal muscle can be translated to diseased skeletal muscle cells. Indeed, 
utilisation of 3D human skeletal muscle models for investigation of insulin signalling and 
glucose uptake would potentially provide further insight into the role of a 3D environment 
upon development of glucose transporter expression and the response of these cells to insulin, 
as well as provide a more valid cell culture model for investigating human skeletal muscle 
metabolism. 
In addition to the role of the 3D environment upon glucose transporter expression, the role of 
innervation upon skeletal muscle glucose transporter expression is important in GLUT4 
expression and insulin stimulate glucose uptake mediated through this protein (Jensen et al., 
2009; Jones et al., 1998). Within the literature the use of skeletal muscle cells from human 
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donors (Ciaraldi et al., 1995) and rodent cell lines (Sarabia et al., 1990) have reported 
increases in basal glucose uptake, which is likely attributed to the increased GLUT1:GLUT4 
ratio reported in this cell culture (Nedachi and Kanzaki, 2006; Sarabia et al., 1992), compared 
to ex vivo skeletal muscle (Baker et al., 2003). Subsequently, a number of researchers have 
attempted to develop and characterise an in vitro model of a neuromuscular junction (Larkin 
et al., 2006; Morimoto et al., 2013). While such models are used to investigate contraction 
and force generation of 3D tissue engineered models, innervation of skeletal muscle in 
culture could enable maturation and development of glucose transporters and thus, a mature 
skeletal muscle model with which to investigate insulin stimulated glucose uptake. Previous 
literature has established the use of electrical stimulation as a method of innervation, 
particularly in fibrin skeletal muscle constructs using C2C12 and primary cell sources 
(Khodabukus and Baar, 2009a; Powell et al., 2002). However, the effect of upon insulin 
signalling and glucose metabolism using these methods could not only affect the 
development of these skeletal muscle models, but also a more valid models for investigating 
insulin independent glucose uptake in skeletal muscle. 
Since a number of authors have successfully developed tissue engineered skeletal muscle 
models to investigate force production (Dennis & Kosnik, 2000; Khodabukus & Baar, 2009; 
Mudera et al., 2010), a natural line of research is to investigate the effects of electrical field 
stimulation, in order to mimic a controlled action potential initiation, upon insulin 
independent signalling pathways and contraction mediated glucose uptake (Richter and 
Hargreaves, 2013). While previous authors have elucidated to the effects of cyclic stretch 
(Iwata et al., 2009) and electrical stimulation (Nedachi et al., 2008) upon insulin independent 
signalling and glucose uptake in C2C12 skeletal muscle cells, currently no research has 
investigated these parameters in a 3D skeletal muscle tissue engineering model. Recent 
research by Player and colleagues has elucidated to the effects of mechanical strain upon 
lactate production in collagen 3D models using the C2C12 cell line (Player et al., 2014) 
however the effects of mechanical or electrical stimulation upon glucose uptake and insulin 
independent signalling pathways in three-dimensional tissue engineered constructs are yet to 
be investigated. 
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8.4 Conclusions 
The work described in this thesis provides a basis for investigating insulin signalling and 
glucose uptake in two-dimensional and three-dimensional skeletal muscle cultures. These 
models respond to exposure to insulin and are affected by prolonged incubation with this 
hormone. In monolayer culture, skeletal muscle cells exposed to insulin during differentiation 
presented with attenuated phosphorylation of Akt, which is implicated in insulin signalling as 
well as attenuation of mRNA expression of genes implicated in metabolic function upon 
acute insulin stimulation. In contrast, post-mitotic skeletal muscle myotubes presented with 
small responses to acute insulin stimulation, however, were affected by chronic insulin 
exposure particularly at the mRNA level. In tissue engineered skeletal muscle constructs, 
both fibrin and collagen skeletal muscle tissue engineered constructs show a tendency to 
respond to insulin through the phosphorylation of insulin signalling proteins such as Akt. In 
contrast, these constructs differ in their mRNA expression of metabolic genes following acute 
and chronic insulin exposure. Further research is required to understand the difference 
between the tissue-engineered skeletal muscle models and their response to insulin both 
acutely and chronically. These findings show that skeletal muscle tissue engineered 
constructs are a model which could be used to further elucidate the mechanisms of insulin 
signalling and glucose uptake. 
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10.1 Appendices A 
10.1.1 Amplification plot from qPCR 
 
Figure  10-1 Amplification plot of RNA-Polymerase II beta (RP-IIβ) mRNA from qPCR using 
Stratagene Mx3005p PCR machine. 
  
213 
 
10.1.2 Dissociation/Melt Curve Profile 
In order to identify primer specificity, a dissociation melt curve was run following 
amplification. 
 
Figure  10-2 Dissociation/melt curve analysis of RNA-Polymerase II beta (RP-IIβ) mRNA from qPCR 
using Stratagene Mx3005p PCR machine. 
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10.2 Appendices B 
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10.3  Appendices C 
10.3.1 Optimization of glucose transporter expression in skeletal muscle cell culture 
Based on the findings of glucose transporter mRNA expression (Chapter  5), further analysis 
was conducted on protein lysates from monolayer cultures and skeletal muscle tissue 
engineered constructs. The objective was to investigate if the increases in mRNA expression 
observed translated to an increase in protein of GLUT1 and GLUT4 respectively in 
monolayer and tissue engineered skeletal muscle constructs. 
We firstly attempted to investigate GLUT4 protein expression by western blot as performed 
for other proteins in this thesis (Section  3.5.7). Despite this, the expression of GLUT4 protein 
was not visible by the conventional method used to analyse the expression of the other 
proteins in this thesis. A potential cause of this could be due to the reducing method of the 
samples prior to loading.  
The addition of sample buffer and subsequent boiling of protein lysate’s denatures the out 
membrane of the cell. The denaturing of the lysate would therefore destroy any proteins 
located at the plasma membrane. A high concentration of the GLUT4 protein pool is located 
at the plasma membrane following insulin stimulation (Rudich and Klip, 2003) and GLUT1 
is mainly concentrated at the membrane. As a result samples were not boiled prior to loading 
and analysed for the abundance of GLUT4 protein. As shown in both monolayer (Figure  5-5) 
and fibrin constructs (Figure  10-3), GLUT4 protein was expressed. 
Despite higher expression of GLUT1 mRNA in skeletal muscle cultures, analysis of this 
protein could not be optimised despite initial attempts through western blot.  
The findings from this initial optimisation for investigating glucose transporter expression; 
however further optimisation is required for investigating the expression of GLUT4 in tissue-
engineered constructs. This is a result of the multiple bands presented upon ECL exposure. 
This is potentially due to factors such as inadequate blocking prior to primary antibody 
exposure, potentially resulting in non-specific proteins binding. . 
10.3.2 Considerations for investigating glucose transporter protein expression in cell 
culture models.  
 
Previous work has outlined a number of important considerations should be taken into 
account when analysing protein expression using antibody based techniques such as western 
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blot (Murphy & Lamb 2013). Although analysis of GLUT4 expression is has previously been 
investigated in skeletal muscle cell culture research (Philp et al. 2010; Wang et al. 1999) 
future research using skeletal muscle tissue engineered constructs should consider the 
following factors in order to further optimise the measurement of glucose transporter 
expression in this culture system.  
Typically, the concentration of protein loaded for the purpose of western blot analysis can be 
small. As previously outlined the expression of GLUT4 is lower in vitro and therefore by 
loading a greater concentration of protein. Alternatively, immunoprecipitation of the GLUT4 
protein would enable for investigation of GLUT4 abundance in these cultures. As previously 
discussed in the literature review (Section  2.11.2), the majority of the GLUT4 pool is 
sequenced within the cytoplasm of the cell. Upon insulin stimulation glucose storage vesicles, 
containing GLUT4 protein, translocate to the plasma membrane in order to facilitate glucose 
uptake. In order to investigate the distribution of GLUT4, subcellular fractionation is a crude 
method of disseminating the effects of insulin stimulation upon the location of GLUT4 as a 
result of both insulin dependent and independent stimulation. 
10.3.3 GLUT4 Protein expression in fibrin skeletal muscle tissue engineered constructs 
In Chapter 5, the mRNA and protein response of glucose transporters in both monolayer and 
tissue engineered skeletal muscle constructs were investigated (Chapter 5). Data from 
monolayer cultures is presented within the respective Chapter (Section 5.3.1).See section  
Following a similar the same protocol as that in monolayer with the exception of loading 
concentration (10µg), protein from 0 days and 14 day old fibrin skeletal muscle constructs 
was loaded and separated on 7.5% SDS-PAGE gels. In addition human skeletal muscle lysate 
was used as a positive control as a comparison to tissue engineered constructs. Proteins were 
transferred onto nitrocellulose membranes. Membranes for GLUT4 were block in non-fat dry 
milk (2% milk in TBS) with membranes for β-Actin blocked in BSA (2%, TBS). Antibodies 
were made up in 5% milk TBST and 5% BSA, TBST for GLUT4 and β-Actin at a 1:1000 
concentration. Membranes were washed in TBST and incubating overnight (4°C) in their 
respective antibodies. Membranes were washed and incubated in secondary antibody. A 
detailed description of the western blot protocol is outline within the methods section 
(Section  3.5.7). 
Western blot for GLUT4 were exposed for 2 hours however presented multiple bands above 
the molecular weight of GLUT4 (50 kDa) (Figure  10-3A).See figure In addition, the positive 
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control did not present a clean band and therefore quantification of this protein despite clear 
identification of bands for β-Actin, which was used as a reference protein (Figure  10-3B). 
 
   
 
 
Figure  10-3 Immunoblot from 0 and 14 day old fibrin gels for A; GLUT4 and B: B-Actin. Protein 
lysate (10µg) were separated on 7.5% SDS-PAGE gels as outlined in the methods section. 
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